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ABSTRACT 
In this thesis methods for the assessment of cerebral haemodynamics using 7 T 
Magnetic Resonance Imaging (MRI) are described. The measurement of 
haemodynamic parameters, such as cerebral blood flow (CBF), is an important 
clinical tool.  
Arterial Spin Labelling (ASL) is a non-invasive technique for CBF measurement 
using MRI. ASL methodology for ultra high field (7 T) MRI was developed, 
including investigation of the optimal readout strategy. Look-Locker 3D-EPI is 
demonstrated to give large volume coverage improving on previous studies. 
Applications of methods developed to monitor functional activity, through flow 
or arterial blood volume, in healthy volunteers and in patients with low grade 
gliomas using Look-Locker ASL are described.  
The effect of an increased level of carbon dioxide in the blood (hypercapnia) was 
studied using ASL and functional MRI; hypercapnia is a potent vasodilator and 
has a large impact on haemodynamics. These measures were used to estimate the 
increase in oxygen metabolism associated with a simple motor task. To study the 
physiology behind the hypercapnic response, magnetoencephalography was used 
to measure the impact of hypercapnia on neuronal activity. It was shown that 
hypercapnia induces widespread desynchronisation in a wide frequency range, 
up to ~ 50 Hz, with peaks in the sensory-motor areas. This suggests that 
hypercapnia is not iso-metabolic, which is an assumption of calibrated BOLD. 
A Look-Locker gradient echo sequence is described for the quantitative 
monitoring of a gadolinium contrast agent uptake through the change in 
longitudinal relaxation rate. This sequence was used to measure cerebral blood 
volume in Multiple Sclerosis patients. Further development of the sequence 
yielded a high resolution anatomical scan with reduced artefacts due to field 
inhomogeneities associated with ultra high field imaging. This allows whole head 
images acquired at sub-millimetre resolution in a short scan time, for application 
in patient studies. 
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GLOSSARY 
 
AFI: Actual Flip-angle Imaging 
ASL: Arterial Spin Labelling 
 
BBB: Blood Brain Barrier 
bFFE: Balanced Fast Field Echo (balanced, gradient echo) 
BOLD: Blood Oxygenation Level Dependant 
BS: Background Suppression 
 
CASL: Continuous Arterial Spin Labelling 
CBF: Cerebral Blood Flow 
CBV: Cerebral Blood Volume 
CMRO2: Cerebral metabolic rate of oxygen consumption 
CNR: Contrast-to-Noise Ratio 
CVR: Cerebral Vascular Reactivity 
 
DAM: Dual Angle Method (B1 mapping) 
 
EEG: Electroencephalography 
EPI: Echo Planar Imaging 
 
FA: Flip Angle 
FAIR: Flow-sensitive Alternating Inversion Recovery 
FiCO2: Inspired concentration of carbon dioxide 
FID: Free Induction Decay 
FiO2: Inspired concentration of oxygen 
fMRI: Functional Magnetic Resonance Imaging 
FOCI: Frequency Offset Corrected Inversion 
FOV: Field of View 
 
GE: Gradient Echo 
GM: Grey Matter 
GRASE: GRadient And Spin Echo 
 
HRF: Haemodynamic Response Function 
HSC: Hyperbolic secant 
Hypercapnia: Increased concentration of CO2 in the blood 
Hyperoxia: Increased concentration of O2 in the blood 
Hypocapnia: Reduce concentration of CO2 in the blood 
Hypoxia: Reduce concentration of O2 in the blood 
 
IR: Inversion Recovery 
 
LL: Look-Locker 
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MEG: Magnetoencephalography 
MPRAGE: Magnetisation Prepared Rapid Gradient Echo 
MRI: Magnetic Resonance Imaging 
MRS: Magnetic Resonance Spectroscopy 
MS: Multiple Sclerosis 
 
NMR: Nuclear Magnetic Resonance 
Normocapnia: Normal levels of CO2 in the blood 
 
OEF: Oxygen Extraction Fraction 
 
PASL: Pulsed Arterial Spin Labelling 
PCASL: Pseudo Continuous Arterial Spin Labelling 
PETCO2: End tidal partial pressure of carbon dioxide 
PETO2: End tidal partial pressure of oxygen 
PSIR: Phase Sensitive Inversion Recovery 
PW: Perfusion Weighted 
 
R1: Longitudinal relaxation rate 
R2: Transverse relaxation rate 
RF: Radio Frequency 
 
SE: Spin Echo 
SENSE: SENSitivity Encoding 
SNR: Signal-to-Noise Ratio 
SQUID: Superconducting quantum interference device 
SSI: Shot-to-Shot Interval 
 
T1: Longitudinal relaxation time 
T2: Transverse relaxation time 
TE: Echo time 
TFE: Turbo Field Echo, gradient echo 
TI: Post label delay 
TR: Sequence repetition time 
TrueFISP:  Fast Imaging with Steady Precession (balanced gradient echo) 
tSNR: Temporal Signal-to-Noise Ratio 
TurboFLASH: Fast Low Angle SHot (gradient echo sequence) 
 
UHF: Ultra-	ȋ ? ?Ǥ ?Ȍ 
 
WM: White Matter 
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1 INTRODUCTION 
1.1 OUTLINE 
The initial developments of magnetic resonance imaging (MRI) were made in the   ? ? ? ?ǯǤ   ? ? ? ?     ǡ    
use of magnetic field gradients to spatially encode signals from a sample [1]. 
1974 saw the development of slice selection by Peter Mansfield at the University 
of Nottingham [2]. These developments allowed the non-invasive imaging of the 
human body using magnetic fields and both Lauterbur and Mansfield were 
recognised by the Nobel committee in 2003 for their work. 
MRI developed rapidly from this point, by 1996 there were over 10,000 MRI 
scanners worldwide [3] and 10 years later an estimated 20,000 [4]. The first 
human images were acquired at field strengths of much less than 1 T; the first 
commercial cryogen cooled 1.5 T systems were available in 1985, with clinical 3          ? ? ? ?ǯ [4]. The field strength of 
MRI scanners used for research has increased at a much faster rate; in 1998 Ohio 
State University installed an 8 T system. The University of Nottingham 7 T 
scanner was installed in late 2004. This, along with those at Ohio State University 
and Vanderbilt University were the first 7 T Philips Achieva systems. In 2007, the 
University of Illinois, Chicago, installed a 9.4 T human scanner and NeuroSpin 
(CEA, Saclay, France) are currently developing an 11.7 T human system.  
The advent of high (3 T) and ultra-  ȋ ?  ? Ȍ   
signal, which allows for increased spatial resolution (see Figure 1-1), allowing the 
human body to be studied in greater detail, with no need for invasive procedures. 
Human imaging at 7 T began with the development of brain imaging [5], with the 
first demonstration of functional brain imaging in 2001 [6]. Demonstrations of 
perfusion [7, 8] and diffusion [9] imaging in the brain followed a few years later. 
Initial experiments have also been conducted to measure characteristic 
properties (T1, T2, T2*) of the brain that determine image contrast (e.g. [10-13]). 
These developments have led to comparisons between field strengths and the 
possible benefit of 7 T for clinical neuroimaging (e.g. [14]).  
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Figure 1-1: T2* weighted gradient echo images acquired at 7 T with 0.4 x 0.4 x 1.5 mm3 
spatial resolution. Box highlights expanded section shown on the left. 
Though the initial developments at ultra high field were for brain imaging, largely 
due to the availability of RF hardware, imaging of other regions of the body has 
been demonstrated (Figure 1-2) through the development of local 
transmit/receive coils. In 2007 Regatte et al. [15] demonstrated imaging of the 
musculo-skeletal system, including knee, leg and ankle in sub-millimetre 
resolution. Shortly after, this was followed by abdominal imaging by Vaughan et 
al. [16], and subsequently the hand [17] and heart [18] in 2009. Recently in 2011, 
a demonstration of high resolution kidney imaging has been shown [19]. 
 
Figure 1-2: Images from non-brain studies at 7 T (A) Finger from [17] using a 3D-gradient 
 ? ? ? ? ? ? ? ? ?Ɋ3 voxels (B) 3D-FLASH images of the ankle acquired at 254 x 
 ? ? ? ? ? ? ?Ɋ3 from [15] (C) 3D-FLASH image of the kidney, resolution of 1.3 x 1.3 x 1.6 
mm3 from [19]. Images reproduced with kind permission from John Wiley & Sons and 
Springer Science and Business Media. 
After 10 years of 7 T human imaging, techniques still need to be adapted and 
tailored to take full advantage of ultra-high field strength. There are still 
developments to be made to ensure the full benefits can be gained by optimising 
methodology used at clinical field strengths, as well as new specific 7 T 
techniques. 
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1.2 SCOPE OF THESIS 
This thesis describes the development of methods for the assessment of cerebral 
haemodynamics using ultra-high field magnetic resonance imaging. Chapters 
Two Ȃ Four describe the theory behind the experimental work presented in 
Chapters Five Ȃ Seven. 
Chapters Two and Three detail the theory behind nuclear magnetic resonance 
(NMR) and MRI. Describing how the behaviour of nuclei in magnetic fields can be 
exploited to image a sample. The imaging sequences used in the subsequent 
experimental chapters are introduced. The hardware of the MRI system used for 
the work in this thesis is also introduced. Also discussed are the safety and ethical 
considerations required for the use of human subjects in MRI studies. 
Chapter Four describes the human brain, the vascular structure and how 
neuronal activity impacts on the vascular system. The multi-modal methods that 
are used to gain insight into brain function are introduced. Including the blood 
oxygenation level dependant (BOLD) contrast mechanism and arterial spin 
labelling (ASL); a method of measuring blood flow detailed in Chapters 5 and 6. 
Chapter Five describes developments of techniques for the measurement of brain 
perfusion using arterial spin labelling at ultra high field (7 T). The experiments 
assess image readout type and Look-Locker [20] methods and their applications. 
The advantages and disadvantages of ultra high field imaging and the impact 
upon ASL are discussed. 
In Chapter Six the effect of inspired carbon dioxide, hypercapnia, on brain 
function is described. Measurements are made using ASL and BOLD at 7 T to 
investigate metabolic changes during a motor task. Magnetoencephalography 
(MEG) is used to assess the impact of hypercapnia on neuronal activity. 
Chapter Seven outlines methodology for tracking contrast agent uptake in the 
brain using longitudinal relaxation time (T1) changes. This applies Look-Locker 
methods [20] for fast acquisition times at ultra-high field. Simulations are 
performed to optimise the MRI sequence parameters. The sequence is used to 
monitor contrast uptake in Multiple Sclerosis patients, to look for breakdown in 
the blood-brain barrier and measure cerebral blood volume (CBV). Optimisation 
of high spatial resolution anatomical imaging for ultra high field imaging is also 
discussed. 
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The final chapter concludes the experimental work presented in this thesis and 
looks to future work that could build on these findings. 
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2 NUCLEAR MAGNETIC RESONANCE THEORY 
2.1 OUTLINE 
This chapter will describe the theory of nuclear magnetic resonance (NMR) and 
how this can be used to measure intrinsic properties of a system. Initially the 
system is described in terms of quantum mechanics, and then a classical 
description of the interactions between nuclei and static or time varying 
magnetic fields is outlined. The description will concentrate on the hydrogen, 1H, 
nucleus as this is the focus of all the work presented in this thesis. 
2.2 NUCLEAR MAGNETIC RESONANCE 
Nuclei have three important characteristics; mass, charge and spin. Spin angular 
momentum, or spin, is an intrinsic property of nuclei; it is not a physical 
movement of the particle like angular momentum [1]. Spin angular momentum, 
as described in non-relativistic quantum mechanics, is a vector quantity, P, with ȏ¾xǡ¾yǡ¾z]. The magnitude of P is expressed as, ȁ۾ȁ ൌ  ?ඥ ? ? ? ൅  ? ?, 2-1 
where I is the spin quantum number and there 2I+1 quantum states, given by mI. I 
which can take integer (bosons) or half integer (fermions) values and is an 
intrinsic property of the nucleus. The quantum number mI determines the 
number of spin states allowed in an applied magnetic field, mI = -I, - ? ?ǥI.  1H 
has a spin of ½ and mI = ± ½. In the absence of a magnetic field the 2I+1 states are 
degenerate, possessing the same energy. When placed in a magnetic field there is 
a resulting energy difference between the spin states. 
2.3 MAGNETIC MOMENT AND MAGNETISM 
Initially the case of a single spin shall be used, in later sections this shall be 
extended to an assembly of spins. A classical description can be used to explain 
the behaviour of a nucleus in a magnetic field. The magnetic moment, Ɋ, of a 
nucleus is given by  ? ൌ  ?۾, 2-2 ɀǢ1H 
it is 267.5 106 radT-1 [1]. The sign of the gyromagnetic ratio indicates whether the 
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ȋɀȌ-ȋɀȌǡTable 2-1 for examples.  
Nucleus Spin 
Gyromagnetic Ratio 
(106 radT-1) 
Abundance in the 
human body 
1H, hydrogen 1/2 267.5 88 M 
23Na, sodium 3/2 70.8 80 mM 
31P, phosphorus 1/2 108.4 75 mM 
17O, oxygen 5/2 -36.3 16 mM 
19F, fluorine 1/2 251.8  ?Ɋ 
Table 2-1: List of nuclei, their spin, gyromagnetic ratio and relative abundance in the human 
body (M = mole/litre). Adapted from [2]. 
The associated energy of this magnetic moment when it is placed in a magnetic 
field, B, is  ? ൌ െ ? ? ۰ ? 2-3 
which indicates that the energy is lowest when the magnetic moment is parallel 
to the magnetic field. Combining Equation 2-2  with Equation 2-3;  ? ൌ െ ?۾ ?۰. 2-4 
Standard convention for NMR is to define the main magnetic field, B0, to be along 
the z-axis, and equal to Bz, hence  ? ൌ െ ? ? ? ? ? ?. 2-5 
 
Figure 2-1: Demonstration of the energy gap between the two spin states induced by the 
application of a static magnetic field. 
For a spin ½ system mI = ± ½ which gives rise to an energy difference between 
the two states of  ȟ ? ൌ  ? ? ? ? ? 2-6 
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when a magnetic field is applied. This is known as Zeeman splitting, shown 
schematically in Figure 2-1. Transitions between the two energy states can be 
induced by the absorption or stimulated emission of photons with energy that 
match the energy gap between states. The frequency of the energy required for 
this to occur is  ? ൌ ? ? ? ? ? ? 2-7 ɋǤ ?ǡ
a 1H sample is ~ 300 MHz, which is in the radiofrequency (rf) range (~ 30 kHz Ȃ 
300 GHz). 
2.4 CLASSICAL DESCRIPTION OF MAGNETIC RESONANCE 
The behaviour of a single spin in a static magnetic field can be explored further 
classically. In the presence of a magnetic field, B, a magnetic moment will 
experience a torque which can be equated to a change in angular momentum:  ?۾ ? ?ൌ  ? ൈ ۰ ? 2-8 
Substituting for P using Equation 2-2 gives an expression in terms of Ɋǡ  ? ? ? ?ൌ  ? ? ൈ ۰ ? 2-9 
Assuming that the magnetic field is parallel to the z-axis this can be described in 
three components for the x, y and z direction.  ? ? ? ? ?ൌ  ? ? ? ? ? ?   ? ? ? ? ?ൌ  ? ? ? ? ? ? 2-10  ? ? ? ? ?ൌ  ? ?  
Solving these differential equations gives;  ? ? ? ? ?ൌ  ? ?ȁ ? ? ? ? ? ? ? ? ?൅  ? ?ห ? ? ? ? ? ? ? ? ? ? ?    ? ? ? ? ?ൌ െ ? ?ȁ ? ? ? ? ? ? ? ? ?൅  ? ?ห ? ? ? ? ? ? ? ? ? ? ? ?  2-11  ? ? ? ? ?ൌ  ? ? ? ? ൌ  ? .  
This describes the precession of the magnetic moment about the z-axis, with an 
angular frequency of Ȃɀz, shown schematically in Figure 2-2. This is the Larmor 
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frequencyǡ ɘL, and is equivalent to the frequency required to drive transitions 
between the two spin states, (Equation 2-7). 
 
Figure 2-2: Precession of a magnetic momentǡɊǡ due to a static magnetic field, B, applied 
along the z-axis. The small arrows indicate the direction of motion around the z axis. 
2.5 INTERACTIONS WITH TIME DEPENDANT MAGNETIC FIELDS 
In the presence of a static magnetic field it was shown that a spin precessed with 
angular frequency Ȃɀz about the z-axis, now the application of time varying 
magnetic fields to the system is considered. A time dependant magnetic field, 
B1(t) is applied perpendicular to the main static field and can be expressed as ۰ ? ? ? ?ൌ  ? ? ? ? ? ? ?ො. 2-12 
To simplify the mathematics this can be considered as having a component which 
rotates anticlockwise (Ba) and one that rotates clockwise (Bc) (shown in Figure 
2-3); ۰ ? ? ? ?ൌ ۰ ? ? ? ?൅ ۰   ? ? ?,  ۰ ? ?࢚ ?ൌ  ? ? ? ? ? ? ?ො ൅  ? ? ? ? ? ?ො ?൅  ? ? ? ? ? ? ?ො െ  ? ? ? ? ? ?ො ? ? 2-13 
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Figure 2-3: Evolution of B1 (large black arrow), the anticlockwise (thin black arrow) and the 
clockwise (grey arrow) components with time. 
Ba  ɘ  -
resonance to the Larmor frequency (Ȃɀz). Hence we only need to include the 
clockwise component Bc in the equations of motion. Adding the time varying 
magnetic field into Equation 2-9:  ? ? ? ?ൌ  ? ? ൈ ? ? ? ?ො ൅  ? ? ? ? ? ? ?ො െ  ? ? ? ?ො ? ? 2-14 
At this stage, to simplify the mathematics, the frame of reference is changed from 
the laboratory frame to the rotating frame. The rotating frame rotates clockwise 
about z with frequency Ȃɘ1 appearing stationary, Figure 
2-4ǤȏǡǡȐȏǯǡǯǡȐǤ 
 
Figure 2-4: (A) The appearance of Bc in the laboratory frame (B) The relationship between 
the rotating frame (broken lines) and laboratory frame (solid lines) (C) The appearance of 
Bc in the rotating frame. 
From classical mechanics the velocity of vector r in the laboratory frame is equal 
to the velocity of r in the rotating frame with the addition of the relative angular 
velocity between the rotating and laboratory frame ( ? ൈ  ?); 
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൬ ? ? ? ?൰ ? ? ?ൌ  ? ൈ  ? ൅ ൬ ? ? ? ?൰ ?ᇱ ?ᇱ ? ? 2-15 
Replacing r with Ɋ to give the expression for the magnetic moment system and 
equating to Equation 2-14 gives 
൬ ? ? ? ?൰ ? ? ?ൌ  ? ൈ  ? ൅ ൬ ? ? ? ?൰ ?ᇱ ?ᇱ ?ᇱ ?  ൌ  ? ? ൈ ? ? ? ?ො ൅  ? ? ?ො ? ?. 2-16 
Hence, the velocity of Ɋ ȋǯǡǯǡȌ 
rearranging Equation 2-16; 
൬ ? ? ? ?൰ ?ᇱ ?ᇱ ?ൌ െ ? ൈ  ? ൅  ? ? ൈ? ? ? ?ො ൅  ? ? ?ො ? ?   ൌ  ? ? ൈ ? ? ? ?െ ఠఊ ? ?ො ൅  ? ? ?ො ? ?,  ൌ  ? ? ൈ ۰ ? ง?, 2-17 
where Beff is the effective magnetic field within the rotating frame of reference. 
Equation 2-17 represents a precession of the magnetic moment about the axis of 
BeffǤ  ɘ  ? ɘL, B1 is on resonance with the Larmor frequency, Bz ? ɘȀɀ ۰ ? ง?ൌ  ? ? ?ො ?, which describes Ɋ precessing about the ǯ axis at an angular   ɘ ?-ɀ1. This is represented in Figure 2-5 where the difference 
between an off-resonance and an on-resonance B1 field being applied is shown. In 
a time t, Ɋ will have rotated through an angle  ? ൌ ? ?ൌ  ? ? ? ?. 2-18 
This is further discussed in Section 2.6 and in Figure 2-7. 
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Figure 2-5: Rotating frame of reference and the impact of resonance (A) applied B1 field is 
off-resonance (B) applied B1 field is on-resonance. 
It is at this point where this classical treatment of the behaviour of a magnetic 
moment breaks down. The previous equation suggests that a single magnetic 
moment can be at any angle relative to the magnetic field. However, from 
quantum mechanics there are only two possible angles due to the two spin states ȁ ?ۄ (parallel to applied field, mI= ½) and ȁ ?ۄ (anti parallel, mI= -½) for 1H, yet the 
classical description can be used to look at an assembly of spins. 
2.6 EXTENSION TO AN ASSEMBLY OF SPINS 
Previously, only a single magnetic moment, Ɋ, in the magnetic field has been 
considered. However there will be of the order 1020 protons in a single MRI voxel 
and MRI/NMR experiments consider the signal from these together, or the bulk 
magnetisation Ȃ not on a spin-by-spin basis. The bulk magnetisation, M, is the 
sum of the individual magnetic moments in the system per unit volume V [2], 
 ? ൌ ? ? ෍  ? ? ? ? ? ? ? ? ? ? ? ?  2-19 
as represented schematically in Figure 2-6 A. The spins in the volume are 
described as a spin isochromat. 
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Figure 2-6: (A) Schematic of the concept of net magnetisation showing the applied magnetic 
field B and the net magnetisation M, each small arrow represents a spin (B) Zeeman splitting 
giving rise to an energy gap between the states. 
For simplicity, the system is thought to consist of non-interacting spins that 
precess independently. The distribution of spins in each of the two states ȁ ?ۄ and ȁ ?ۄ at thermal equilibrium in a static magnetic field can be described using the 
Boltzmann distribution (Figure 2-6 B);  ?ఉ ?ఈ ൌ  ? ? ? ൬െȟ ? ? ? ?൰ ൌ  ? ? ? ൬െ ?ɀ ? ? ? ? ?൰ ? 2-20 
where NȾ ȾǡȽ Ƚǡȟ  ǡb is 
the Boltzmann constant and T is the temperature (Kelvin). Looking at the high 
temperature limit where kbT  ? ? ȟ      
approximated using a Taylor series;  ?ఉ ?ఈ ൎ  ? െ ? ? ? ? ? ? ? ? 2-21 
Hence, the population difference, n = NȽ - NȾ can be approximated as 
 ? ?െ  ?ఉ ൌ  ? ൌ ?ఈ ? ? ? ? ? ? ? ? ? 2-22 
Furthermore, there will only be a small difference in the two states, NȽ  ?Ⱦ, and 
taking N as the total number of spins (N = NȽ + NȾ  ?  ?Ƚ); the population 
difference is given by 
 ? ൌ ? ? ? ? ? ? ? ? ? 2-23 
The fractional difference in spin states (n/N) at 3 T is ~ 3 x 10-6 and at 7 T ~ 7 x 
10-6. The magnitude of the net magnetisation can be calculated from this 
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ȁۻȁ ൌ  ?ఈ ? ?ఈ൅  ?ఉ ? ?ఉൌ  ?ఈ ? ?ఈെ  ?ఉ ? ?ఈൌ  ? ? ?ఈ  2-24 
where ? ?ఈൌ  ? ? ? ?giving 
ȁࡹȁ ൌ  ? ? ? ? ? ? ? ? ? ? ? ?  ? 2-25 
This indicates that the net longitudinal (parallel to field) magnetisation is directly 
proportional to the magnetic field strength. The transverse (perpendicular to 
field) magnetisation will vectorally add to zero if there is no phase coherence in 
the assembly of spins. The bulk magnetisation M obeys the same equations of 
motion as the individual magnetic moments;  ?ۻ ? ?ൌ  ?ۻ ൈ ۰ ? 2-26 
This equation can be used to predict the time evolution of the bulk magnetisation. 
RF pulses can be used to tip the magnetisation vector through an angle  ? ൌ  ? ? ? ? 
where t is the duration of the pulse. The bulk magnetisation can occupy any 
angle, unlike a single spin. A 90° pulse will cause zero net longitudinal 
magnetisation, as equal populations are in the two states, but maximum 
transverse magnetisation. A 180° pulse will invert the longitudinal magnetisation 
as demonstrated in Figure 2-7. 
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Figure 2-7: Bulk magnetisation in thermal equilibrium, and the process of a 90° and 180° 
pulse. 
2.7 NUCLEI INTERACTIONS AND THE PROCESS OF RELAXATION 
The above considered an ensemble of non-interacting spins; however there are 
interactions between the nuclei in the spin system and these must be accounted 
for in order to describe the evolution of the bulk magnetisation. Placing a sample 
in a magnetic field will cause the system to reach thermal equilibrium as 
described by the Boltzmann distribution. After an RF pulse perturbs the system it 
will return to equilibrium by a process known as nuclear spin relaxation.  
T1, the longitudinal relaxation time, describes the relaxation processes that cause 
Mz to return to equilibrium (M0). Longitudinal relaxation is the process in which 
the spin system returns energy to the lattice after being placed in a magnetic field 
or an RF pulse has been applied. T1 varies dependant on tissue type, in human 
tissue T1 is of the order of seconds (see section 2.8.1). 
T2, the transverse relaxation time, is the equivalent time constant for the 
relaxation processes for Mx/My. After an RF pulse, spins in the transverse plane 
are bought into phase which forms the measured signal. However after time 
these spins will start to dephase and the net magnetisation will be zero in the 
transverse plane. The mechanisms behind this are due to interactions between 
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neighbouring spins and any field inhomogeneities (e.g. due to hardware 
problems, magnetic susceptibility differences). 
For spin ½ nuclei, relaxation arises from the randomly fluctuating magnetic fields 
caused by the motion of the molecules in the system [1]. As a molecule moves, the 
magnetic field caused by one spin on a neighbouring spin changes. A second 
source of changing local fields is chemical shift anisotropy (CSA). CSA is caused 
by electron currents induced by the external magnetic field. Again, as the 
molecules move the magnitude and direction of these fields change. 
In a system of many spins, they all experience the same externally applied field 
(ignoring effects from inhomogeneous B0), but will each experience a slightly 
different, time varying, transverse magnetic field, Bx. It is assumed that, over 
either time for one spin or for many spins at the same time, the fluctuating field 
has zero mean, but a non-zero average magnitude: ۃ ? ? ? ? ?ۄ ൌ  ,  ۃ ? ? ? ? ? ?ۄ ്  . 2-27 
To describe how fast the field fluctuates an autocorrelation function is defined, ॳ ? ? ?ൌ ۃ ? ? ? ? ? ? ? ൅  ? ?ۄ ്  ?. 2-28          ɒǡ   
fluctuating field will decay slowly. The corresponding spectral density function, ॵ ? ? ?, is defined as twice the Fourier transform of the autocorrelation function; ॵ ? ? ?ൌ  ? ? ॳ ? ? ? ?െ ? ? ? ? ? ? ? ? . 2-29 
Assuming that the autocorrelation function, ॳ ? ? ?ǡ       ɒɒǡ
the expression for ॵ ? ? ?; 
ॳ ? ? ?ൌ ۃ ? ? ?ۄ ? ? ? ?െ ȁ ?ȁ ? ? ?    ? ॵ ? ? ?ൌ  ?ۃ ? ? ?ۄ  ? ? ? ൅  ? ? ? ? ? ? 2-30  
where ɒc     ȋ  Ȍǡ     ɒc        ɒc. Equation 2-30 is normally 
expressed in terms of the normalized spectral density, ࣤ ? ? ?, which is related to ॵ ? ? ? by ॵ ? ? ?ൌ  ?ۃ ? ? ?ۄࣤ ? ? ?. 
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The fluctuating transverse field causes transitions between the two spin 
states,ȁ ?ۄ and ȁ ?ۄ. The transition probability is predicted to be equal in the two 
directions (ȁ ?ۄ  ? ȁ ?ۄ) and proportional to the normalised spectral density at the   ȋɘL) [1]. This can be used to derive expressions for the 
relaxation time constants T1 and T2 in terms of the normalised spectral density 
function [1, 3];  ? ? ?ൌ  ? ? ? ? ? ?ࣤ ? ? ? ?൅  ?  ࣤ?  ? ? ? ?    ? ? ?ൌ  ? ? ? ? ? ?  ࣤ?  ?൅  ?  ࣤ? ? ? ?൅  ?  ࣤ?  ? ? ? ?  2-31  
where b is the dipole-dipole coupling constant; 
 ? ൌ െ ? ? ? ? ? ? ? ? ? ? 2-32  
and r is the separation of the spins. The expressions for T1 and T2 in Equation 
2-31 demonstrate that T1 and T2 have a strong dependence on correlation time, 
and as such are temperature dependant. However these expressions cannot 
describe fully the dependence in biological systems due to their complexity, but 
are more valid for pure substances [3]. 
This description assumed that each spin experienced the same applied magnetic 
field. However, as will be described in Section 2.8.2, this is not true due to 
hardware inconsistencies and magnetic susceptibility differences in an 
inhomogeneous system causing non uniform longitudinal magnetisation. These 
introduce secondary effects that cause further dephasing of the transverse signal.  
2.7.1 THE BLOCH EQUATIONS 
The equations of motion for the bulk magnetisation need to take into account the 
relaxation processes. The Bloch equations, in Equation 2-33, describe the 
evolution of the three components of the net magnetisation and take into account 
relaxation.  ? ? ? ? ?ൌ  ? ? ?൬ ? ?െ  ? ?൰ െ  ? ? ? ?   ? ? ? ? ?ൌ  ? ? ? ? ?െ  ? ? ?൬ ? ?െ  ? ?൰ െ  ? ? ? ? 2-33  ? ? ? ? ?ൌ  ? ? ? ? ?െ  ? ?െ  ? ? ? ?   
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where M0 is the equilibrium longitudinal magnetisation. Figure 2-8 demonstrates 
the evolution of the net magnetisation according to the solutions of the Bloch 
equations (initial conditions Mz = 0, Mxy = M0 and B1 = 0) in the laboratory frame 
(blue) and the rotating frame (red). 
 
Figure 2-8: Evolution of net-magnetisation in the laboratory frame (blue) and the rotating 
frame (red) after a 90° pulse. Filled circle indicates starting point (t = 0) and empty circle 
indicates end point (t = t). 
2.8 NMR EXPERIMENTS Ȃ MEASURING THE FID FOR T1 AND T2 
QUANTIFICATION 
The application of an RF pulse can produce signal in the transverse plane (Mxy)            ȋ  	ǯ
Law, the electromotive force is equal to the rate of change of magnetic flux [4]). 
The induced current is small, but has a well defined frequency, and decays 
according to the Bloch equations (Equation 2-27). This is known as the Free 
Induction Decay (FID), Figure 2-9. 
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Figure 2-9: FID with sample on resonance (solid line) and off resonance (broken line). 
The detection of the FID relies on pre-amplification and a phase sensitive        ? ? ?ǯ  Ǥ   
multiplies the detected signal (Vsig = M0ȋɅȌȋɘLt)exp(-t/T2)) by a reference ȋȋɘ0t));  ? ? ? ? ൌ  ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ൬െ ? ? ?൰  ? ? ? ? ?  ൌ  ? ? ?  ? ? ? ? ? ? ? ? ? ൬െ ? ? ?൰ ൫൫ ? ? ?൅  ? ? ? ?൯ ൅ ൫ ? ? ?െ  ? ? ? ?൯൯ ? 2-34 Ɂǡ the    ȋɘL  ? ɘ0) which average to zero, and the low  ȋɘL - ɘ0Ȍ       ɁǤ
Simplifying the integration leads to: 
 ? ? ? ?ൌ න  ? ? ? ? ? ? ? ?ఋ ? ?   ൌ  ? ? ?  ? ? ? ? ? ? ? ? ? ൬െ ? ? ?൰ ൫ ? ? ?െ  ? ? ? ?൯ ? ? ? 2-35 
This signal does not distinguish between positive and negative differences in 
phase as it is dependent on the cosine term which is symmetric about zero. To 
differentiate the sign of the phase, a further phase sensitive detector is commonly 
used, which has its reference signal 90° degrees out of phase to the first. This is 
known as quadrature detection, and results in a second signal: 
 ? ? ? ? ?ൌ  ? ? ?  ? ? ? ? ? ? ? ? ? ൬െ ? ? ?൰ ൫ ? ? ?െ  ? ? ? ?൯ ? ? ? 2-36 
These are added to give the complex FID signal 
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 ? 뼋? ? ? ? ?ൌ  ? ? ? ?൅  ? ? ?  ? ?  ൌ  ? ? ? ? ? ? ? ?൬െ ? ? ?൰ ? ? ? ? ?െ  ? ? ? ? ?  2-37 
Figure 2-9 is the FID with a frequency difference between the sample and 
reference (broken line) and the situation where the reference is on-resonance 
(solid line). The Fourier Transform of these signals will provide the frequency 
spectrum. With these tools, simple NMR experiments can be devised to measure 
the characteristic relaxation time constants of the sample, T1 and T2. 
2.8.1 MEASURING T1: INVERSION RECOVERY 
T1 is a useful characteristic as it provides information about the properties of a 
sample. In healthy tissue T1 is related to the concentration of macromolecules, 
water binding and water content [5]. It allows discrimination of different 
samples, e.g. white and grey brain matter, as demonstrated in Table 2-2. 
Tissue Type T1 / ms 
Cortical grey matter 2132 [6], 1939 [7] 
White matter 1220 [6], 1130 [7] 
CSF 4425 [6], 
Blood 2587 [6], 
Table 2-2: Example longitudinal relaxation times (T1) at 7 T. 
The inversion recovery sequence is the most common method of T1 
measurement, and is shown in Figure 2-10. 
 
Figure 2-10: Simple pulse diagram of inversion recovery sequence. 
The magnetisation starts in thermal equilibrium, M0, a 180° inversion pulse is 
then applied which inverts the longitudinal magnetisation to ȂM0. There is then a 
time delay termed the inversion time TI, between the inversion pulse and the 90° 
pulse used to generate the transverse signal that is measured by the receive coil. 
The inversion time is used to allow the longitudinal magnetisation to begin to 
recover towards thermal equilibrium with T1. The magnetisation measured at a 
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time TI is given by the solution of the Bloch equations, using initial conditions at t 
= 0; Mz = -M0, Mx = My = 0; 
 ? ? ? ??ൌ  ? ?൬ ? െ  ?  ൬െ ? ? ? ?൰൰ ? 2-38 
To measure T1, a series of delay times is used to sample the inversion recovery 
curve from inversion as it returns back to thermal equilibrium, as shown in 
Figure 2-11.  
 
Figure 2-11: Longitudinal signal recovery during IR sequence for white matter (T1 = 1.1 s, 
broken line) and grey matter (T1 = 2 s, solid line) at 7 T. 
2.8.2 MEASURING T2 TRANSVERSE DECAY: SPIN ECHO  
T2 is the time constant that characterises the decay of the transverse 
magnetisation due to the fluctuations in the resonant frequencies of the nuclei 
causing dephasing. The causes of the transverse magnetisation being destroyed 
can be split into two types; spin-spin and those due to B0 inhomogeneities [3]. 
Therefore a new expression for T2 is formed. T2* takes into account all the 
dephasing effects, spin-spin effects are characterised by T2 and B0 
inhomogeneities (e.g. due to susceptibility differences at air/tissue interfaces) 
are described by T2ǯ-time varying decay constant. The relationship between 
these three rate constants is  ? ? ?ൌ  ? ?൅  ? ?ᇱ  ? 2-39 
To measure T2 the effects of T2ǯǤ2ǯ
remain constant over time whereas T2 decay effects vary over time. A spin-echo 
(SE) sequence is used [8], which refocuses the effects due to T2ǯ
constant throughout the experiment allowing measurement of T2. 
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Figure 2-12: Simple schematic of spin echo RF pulse sequence to measure T2 and 
corresponding signal. 
The spin-echo sequence, Figure 2-12, consists of a 90° and a 180° pulse separated 
by time t, the signal is then sampled at a time t following the 180° pulse (the 180°    ǯ-axis; rather than inverting the magnetisation). The classical 
picture of the evolution of the bulk magnetisation can be used to explain how the 
SE sequence works.  
After the 90° pulse, the spin isochromat is in the transverse plane (Figure 2-13 
A). Due to slightly different precession frequencies the spins begin to dephase, 
after a time t the spin isochromat will have fanned out. Some of the spins will 
have a precessional frequency faster than the Larmor frequency, others slower 
(Figure 2-13 B). In the rotating frame this will appear as spins going in different 
directions.    ? ? ? ?   ǯ ȋFigure 2-13 C); ǯȋFigure 2-13 D). This 
will form the observed signal at time 2t since the first pulse.  
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Figure 2-13: Schematic of the spin evolution in a spin echo. (A) Magnetisation after initial 90° 
pulse (B) Spins have dephased over the time period t (C) 180° pulse causes spins to move 
ǯȋȌǤ 
The spin echo experiment will rephase any effects that are the same in the two 
sections of the pulse sequence Ȃ e.g. susceptibility differences caused by 
air/tissue interfaces. Molecular motion will change throughout the experiment, 
and as such these effects will not be rephased. Effects of static field 
inhomogeneities will be rephased. Similarly to the measurement of T1, this 
experiment is repeated using different values of t to measure T2 by fitting to 
M0exp(-2t/T2). The echo time of the experiment, TE, is equal to 2t. 
T2, measured with a GESSE (gradient and spin echo) sequence, has been shown to 
be approximately 45 ms in gray and white matter in the human brain at 7 T [9]. 
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The expression for the transverse magnetisation can be expressed to include a 
diffusion term [10]; 
 ? ? ?ൌ  ? ? ? ? ? ൬െ ? ? ? ?൰  ?െ ? ? ? 2-40  
where D is the diffusion coefficient and b (known as the b value of the sequence) 
for a constant applied gradient (G) is 
 ? ൌ ? ? ? ? ? ? ?  ? 2-41  
where t is the time of the echo. Hence diffusion will cause further signal 
dephasing and possible underestimation of T2 if not taken into account. At high 
field, the relative diffusion contribution to signal dephasing is increased due to a 
reduction in T2. Carr-Purcell (CP) [11] and Carr-Purcell Meiboom-Gill (CPMG) 
[12] sequences can be used for the measurement of T2 accounting for diffusion to 
minimise errors in T2 quantification, Figure 2-14. This can be used to measure the 
T2 of blood, and determine oxygenation (e.g. [13]). 
 
Figure 2-14: Schematic of the RF pulse sequence and envelope of the transverse signal from 
a CPMG sequence. 
2.8.3 MEASURING T2* TRANSVERSE DECAY  
The measured transverse signal after an RF pulse is proportional to exp(-t/T2*), 
where t is the measurement time after the RF pulse, as demonstrated in Figure 
2-9. Measurements performed at different times, t, will allow for T2* to be found 
with a mono-exponential fit.  
At 7 T T2* was measured to be 33.2 ± 1.3 ms in grey matter and 26.8 ± 1.2 ms in 
white matter using a multiple echo EPI sequence [14]. At lower field strengths 
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T2* increases, e.g. grey matter at 3 T is approximately 66 ms and at 1.5 T 84 ms 
causing less signal dephasing. T2* will be dependant on sample thickness, due to 
through plane dephasing of the spins, thicker slices will shorten T2*. 
2.9 CONCLUSIONS 
This chapter has introduced the basics of the interactions between a nucleus and 
both a static and time varying magnetic field. This has been extended to an 
ensemble of spins, and to include the interactions between spins and how they 
are characterised through decay times (T1, T2 and T2*). The measurement of 
these was demonstrated.  This forms the basis of magnetic resonance imaging; 
which is discussed in Chapter 3.  
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3 MAGNETIC RESONANCE IMAGING AND HARDWARE 
3.1 OUTLINE 
This chapter will outline the theory behind magnetic resonance imaging and the 
imaging techniques that are used in the experimental work presented in this 
thesis. The MR scanner hardware will also be introduced, concentrating on the 7 
T Philips Achieva system. Safety and ethical considerations are also outlined. 
3.2 IMAGING 
Previous discussion of NMR theory in Chapter 2 has concentrated on the total 
signal arising from the entire sample that has been excited by the RF pulse. 
However, for magnetic resonance imaging the signal needs to be encoded in such 
a way that signals from different parts of the sample can be discriminated. To do 
this, several techniques allow for the spatial separation of the signals. The 
concepts of magnetic field gradients slice selection, frequency and phase 
encoding shall be introduced. A number of imaging sequences that are used in the 
experimental work are also shown. 
3.2.1 MAGNETIC FIELD GRADIENTS FOR SPATIAL ENCODING 
Previously in Chapter 2 the case where the entire sample was excited was shown, 
commonly however only signal from a specific volume of interest is required. 
From Chapter 2 it was shown that the frequency of precession is linearly 
proportional to the magnetic field. Thus, by spatially varying the magnetic field, 
the Larmor frequency will also vary spatially, giving a degree of spatial 
specificity. To achieve this, magnetic field gradients can be applied, these can be 
applied along the three axes so that the Larmor frequency differs in every 
position. A gradient, G, is fully expressed as a tensor, with gradient field 
components along all three axis (Bx, By and Bz). However, as the main field is 
applied along the z-axis, the gradient can be simplified to only include the Bz 
components as at high field such as 7T it is assumed that the other components 
will have little effect on the resonant frequency of the spins; 
ࡳ ൌ  ? ? ?ො ൅  ? ? ?ො ൅  ? ? ?ො ൌ  ? ? ? ? ? ?ො ൅  ? ? ? ? ? ?ො ൅  ? ? ? ? ? ? ?ෝ 3-1 
This means the expression for the Larmor frequency experienced at a point r is 
now 
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 ? ?࢘ ?ൌ  ? ? ? ?൅ ۵ ? ?  3-2 
This can then be substituted into the equation for the FID, described in Chapter 2 
(Eq. 2-37), so that the signal from the sample is 
 ? ? ? ?ൌ න ? ? ? ? ? ? ?۵ ?  ? ? ?  ? ? ? 3-3         Ǥ ɏȋr) is the density of 
nuclear spins and ? ൌ  ?۵ ? can be substituted, where k refers to k-space, a spatial 
frequency (dimensions of length-1), to give 
 ? ? ? ?ൌ න ? ? ? ? ? ? ? ?  ? ? ? ?  3-4 ȋɏȋr)) by inverse Fourier transforming 
the expression for signal; 
 ? ? ? ?ൌ  ? ? ? ? ?න ? ? ? ? ?െ ? ? ? ? ? ? ? ? 3-5 
This allows the image to be formed from the signal (S(t)) providing adequate 
sampling of k-space has been performed using the field gradients, G. 
K-space comprises different spatial frequency components; generally the centre 
of k-space provides information on bulk image intensity whilst the higher spatial 
frequencies provide edge information. This is demonstrated in Figure 3-1, 
showing the effect of applying different k-space filters to an MR image. 
The sampling of k-space is related to the spatial resolution and field of view 
(FOV) in image space. The FOV is given by  ? ȟ ? ?  where ȟ is the step between 
samples in k-space (this can be asymmetric in the phase and frequency encode 
directions). The spatial resolution, or voxel size, is given by the inverse of the 
largest spatial frequency Ȃ or FOV in k-space [1]. 
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Figure 3-1: (A) K-space representation of the image in (B), (C, E, G) K-space filters where 
black indicates the signal that has been removed, (C) is half of k-space (E) is the centre of k-
space and (G) is the high k-space frequencies only and resulting images (D, F and H). 
3.2.1.1 Slice Selection 
The previous section has looked at signal arising from the entire excited 3D 
volume. However, commonly only a 2D image is needed, acquired by exciting a 
slice of the sample. This is known as slice selection. A linear gradient is applied 
along one axis (e.g. z), and an RF pulse of the same frequency and bandwidth as 
the slice of interest is applied so that only those spins are excited [2]. The RF 
pulse typically used for slice selection is a truncated sinc pulse, an infinite sinc 
pulse would give a square pulse profile (given by the Fourier transform), and 
truncation will cause an imperfect profile (ringing at the boundary). 
The bandwidth of the RF pulse determines the range of frequencies that are 
excited and hence the slice thickness. The slice thickness is proportional to the RF ȋȟɘȌȋ
z),  
 ? ? ൌ ? ? ? ? ? ? 3-6  
as shown schematically in Figure 3-2.  
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Figure 3-2: Schematic diagram of slice selection using magnetic field gradients. (A) The effect 
of gradient strength on slice thickness, (black line is a weak gradient, grey line a strong 
gradient) (B) The effect of bandwidth (BW) on slice thickness, adapted from [1]. 
This ensures that the measured signal will only come from the slice of interest as 
outside the slice of interest the spins will be off resonance. To facilitate multiple 
slice imaging, multiple excitation pulses with different carrier frequencies are 
required to select different slices within the sample. 
The slice select gradient pulse applied is a positive lobe followed by a negative 
lobe of half the duration, demonstrated in Figure 3-3. The negative lobe is used to 
rephase the signal, which is dephased by the application of the gradient, to 
maximise the measured signal. 
 
Figure 3-3: Slice select RF pulse and gradient. 
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3.2.1.2 Frequency Encoding 
Spatial specificity now needs to be incorporated into the measured signals; slice 
selection or volume excitation means the signal will originate from a specified 
volume but more information is needed. Frequency encoding (FE) uses a similar 
principle to slice selection; however the spatial dependence of the resonant 
frequency is used for spatially separating the measured signals. The frequency 
encoding gradient is applied after the RF excitation, so only affects the spins in 
the excited slice/volume. Commonly, a gradient is applied along the x-axis so that   ? ? ? ?ൌ  ? ? ? ?൅ 
 ? ? ? ? 3-7 
The resonant frequency varies linearly across the sample, along the x-axis. Hence 
the frequency of the received signal will provide spatial localisation, allowing a 
projection across a sample to be built up. 
3.2.1.3 Phase Encoding 
Frequency encoding allows a one dimensional image to be identified. To extend 
this to a 2D image, phase encoding, where the phase of the detected signals is 
dependent on their y-axis position, is used. A Gy gradient is applied for a short 
time to cause a phase change across the sample in the y direction; this is applied 
before the readout gradient. 
This means that each voxel in the image can be characterised by a unique 
frequency/phase combination allowing an image to be built up from different 
samples covering k-space. The use of x and y gradients to sample the kx-ky plane 
is shown schematically in Figure 3-4. 
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Figure 3-4: Example of how Gx and Gy magnetic field gradients can be used to traverse k-
space. 
3.2.2 IMAGING SEQUENCES 
Image contrast depends on the intrinsic properties of the sample; the proton 
density (PD), longitudinal relaxation time (T1) and transverse relaxation times 
(T2 and T2*). Sequence design and parameters will determine which contrast is 
dominant. For example, a gradient echo sequence with long echo time (TE) would 
give rise to contrast between tissues based on T2*. Similarly, a spin echo image 
with long TE would have T2 contrast. A T1 weighted sequence normally employs a 
preparation pulse that either saturates or inverts the longitudinal magnetisation 
prior to sampling. The delay between the preparation pulse and imaging will 
change the contrast. A sequence that has short TE and very long TR will reduce 
the dependence on relaxation effects and becomes proton density (PD) weighted. 
The contrast required depends on the information required. For example, 
multiple sclerosis (MS) lesions can be identified using a T1 weighted sequence 
called FLAIR (fluid attenuated inversion recovery) or DIR (dual inversion 
recovery) as their T1 differs from the local white matter. FLAIR uses an inversion 
pulse to null the signal from the fluid (e.g. CSF), whereas DIR uses two inversion 
pulses to null two tissues with different T1 values (e.g. CSF and white matter) to 
aid lesion identification. T2* weighted images highlight vessels due to the 
difference in T2* between blood and tissue. 
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There are many different techniques used for imaging, the sequence chosen will 
be dependent on many factors including the area of interest, contrast, spatial and 
temporal resolution required. Here the basic imaging sequence of spin warp and 
the main sequences that are used in the experimental work in this thesis are 
described.  
3.2.2.1 Basic Imaging Ȃ Spin Warp 
Spin warp imaging samples k-space in a regular grid, moving across the kx-axis 
and stepping through ky to sample 2D k-space [3], allowing an image to be 
formed. To step through k-space, ky phase encode gradients are applied along the 
y-axis, their strength being varied to target different spatial frequencies. A read 
gradient is applied along the x-axis to traverse kx. A negative read gradient is 
initially applied to move in the negative kx, a positive readout gradient of twice 
the duration is then applied to cover the whole of kx. This gives rise to a 
symmetric signal as the spins are rephased during the first half of the positive 
gradient and then begin to dephase.  
 
Figure 3-5: Schematic of the pulse sequence and k-space trajectory for spin-warp imaging. 
The spin warp sequence is a robust imaging sequence, however it takes a long 
time to acquire each image due to the acquisition of only one line of k-space per 
excitation. For maximum signal there needs to be a long time between the RF 
pulses to allow for recovery, if a flip angle of 90° is used. Dependant on the size of 
the image and the spatial resolution, this could be 256 lines taking approximately 
40 minutes per image.  
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To speed up the acquisition the TR, the time between RF pulses, is shorter than 
the time required for full recovery causing saturation of the signal, and so the flip 
angle is chosen to maximise the signal. The steady state signal, Mss, which is the 
signal that is created after a train of RF pulses, can be calculated using the Bloch 
equation for longitudinal recovery. Assuming all the transverse magnetisation is 
spoilt between RF pulses and does not contribute to the signal, this gives 
 ? ? ?ൌ  ? ? ? ? ? ? െ  ? ? ? ?െ ? ? ? ? ? ? ? െ  ? ? ? ? ? ? ?െ ? ? ? ? ?  ? 
3-8 
where TR is the time between RF pulses and M0 is the equilibrium magnetisation. 
Differentiating Equation 3-8    Ʌǡ    le which 
maximises the measured signal, this is known as the Ernst angle [4] 
 ? ൌ  ? ? ? ? ? ? ൬െ ? ? ? ?൰ ?  3-9 
For example, to maximise the signal for grey matter at 7 T (T1 = 2 s [5]) with a TR 
of 50 ms, a flip angle of approximately 13° is needed. White matter with a shorter 
T1 of 1.2 s [5] would require a larger flip angle of 16° to maximise the signal. 
Using a short TR, e.g. 50 ms, reduces the time to acquire a single slice to only a 
few seconds but Mss and so the signal-to-noise ratio (SNR) will be reduced 
compared to a longer TR. 
3.2.2.2 TFE 
TFE (Turbo Field Echo) or TurboFLASH (Turbo Ȃ Fast Low Angle SHot) is a 
gradient echo technique, typically a 2D sequence [6, 7]. This steps through ky as 
in Spin-Warp imaging and uses a short TR (order of ms) to acquire images 
rapidly whilst the flip angle is low to reduce suppression of the signal. The echo 
time, TE, of TFE, is the time from the centre of the RF pulse to the centre of the 
positive read gradient lobe. 
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Figure 3-6: Section of pulse sequence diagram for TFE, this will loop ~100 times for a single 
slice. RF spoiling or gradient spoiling may be incorporated to give T1 weighting. 
Figure 3-7 shows example 7 T TFE images (2 x 2 x 3 mm3, FA = 15°, TE/TR = 
2.5/5 ms, FOV = 192 x 192 x 12 mm3). TFE images are often preceded by a spin 
preparation pulse, e.g. inversion or saturation. A TFE image with an inversion 
preparation pulse is commonly known as an MPRAGE (Magnetisation Prepared 
RApid Gradient Echo), which is a T1 weighted scan with contrast dependant on 
the delay between inversion and readout. It is often used for anatomical 
reference scans. TFE is used in the experimental work described in Chapter 5.  
 
Figure 3-7: Example TFE images (2 x 2 x 3 mm3, FA = 15°, TE/TR = 2.5/5 ms, FOV = 192 x 192 
x 12 mm3). 
3.2.2.3 bFFE 
bFFE (balanced Fast Field Echo), balanced steady-state free precession (bSSFP) 
or TrueFISP is a 2D gradient echo technique [8, 9]. In contrast to TFE, this uses a 
train of high flip angle (~ 50°) RF pulses and uses both transverse and 
longitudinal magnetisation to build up the steady state signal [10]. The gradients 
are balanced which means the phase of the transverse magnetisation is retained 
and the evolution of magnetisation is equivalent between each TR, independent 
of the phase and read gradients. 
Commonly the first RF pulse of the bFFE train (order of 100 pulses per slice) has   ȽȀ ?ǡ        ȽǤ     
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signal and to reduce oscillations. To try and stabilise the measured signal further 
pre-scans where no data is recorded are normally inserted prior to data 
recording to ensure that the magnetisation is in the steady state. The contrast in 
bFFE is a mixture of T1 and T2 weighted, and is very dependent on the TR chosen. 
 
Figure 3-8: Pulse sequence for bFFE. 
Figure 3-9 shows example bFFE images acquired at 7 T (2 x 2 x 3mm3, TE/TR = 
1.8 / 3.6 ms, FA = 50°, FOV = 192 x 192 x 3 mm3). In the lower slice this shows a 
characteristic banding artefact associated with bSSFP techniques, which occurs in 
areas of large frequency offsets. This can be reduced by improved shimming 
techniques, and changing the TR of the readout. TR should be less than the 
inverse of the off resonance frequency to maintain phase coherence between the 
RF pulses. bFFE imaging is used in the ASL development work described in 
Chapter 5. 
 
Figure 3-9: Example bFFE images at a higher and lower axial position, arrow indicates 
banding artefact (2 x 2 x 3 mm3, FA = 50°, TE/TR = 1.8/3.6 ms, FOV = 192 x 192 x 3 mm3). 
3.2.2.4 Echo Planar Imaging 
Many applications require high temporal resolution to allow monitoring of 
dynamic processes within the body. For example, functional MRI (fMRI) relies on 
temporal resolution of a few seconds to monitor the haemodynamic response. 
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Similarly bolus tracking of contrast agents requires high temporal resolution. 
Spin-warp imaging, as described above, would not be able to deliver high 
temporal resolution due to the slower k-space sampling trajectory. 
EPI was developed by Mansfield et al. in 1977 [11] which was the advent of fast 
imaging techniques. EPI samples all of 2D k-space after a single excitation pulse Ȃ 
a single slice can be acquired in tens of milliseconds. To achieve this, the 
gradients are rapidly switched to traverse the entire 2D k-space after a single RF 
pulse, the most common trajectory is shown in Figure 3-10. Initial gradients 
move the sampling to a corner of k-space, they then scan back and forth across kx, 
with small steps in ky as shown schematically in the k-space diagram. 
 
Figure 3-10: K-space trajectory and pulse sequence for 2D echo-planar imaging (not to scale, 
read gradients typically ~ 10 times strength of phase encode gradients). 
Prior to Fourier transforming to reconstruct the image, the acquired signals must 
be reordered to account for the change in direction that k-space is sampled.  
The EPI readout can be divided into sections (segmented EPI), where a few lines 
of k-space are acquired following each excitation. This can avoid the signal 
decaying excessively with T2* due to the length of the readout and reduce some of 
the common artefacts associated with EPI (as detailed in Section 3.4), but can 
also introduce artefacts. Similar to spin warp imaging the Ernst angle is used to 
maximise the steady state signal, allowing for short TR imaging Ȃ acquiring slices 
in rapid succession. 
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3.2.2.5 3D EPI 
In Section 3.2.2.4 2D-EPI was used to acquire an image but it can be adapted by 
two possible methods to image a 3D volume. One method is echo volumar 
imaging (EVI) [12] which samples the entirety of 3D k-space after a single 
excitation. Alternatively, 3D-EPI can be used which uses multiple excitations, 
following each a plane of kx-ky space is acquired, and steps through kz with every 
excitation (Figure 3-11) [13]. The RF excitation is applied to the entire volume 
which increases the SNR as the signal comes from a volume rather than a single 
slab.  
 
Figure 3-11: Pulse diagram and k-space trajectory for 3D-EPI. 
EVI is not commonly used due to the long acquisition times causing signal decay 
with T2*; this is more problematic at higher magnetic field strengths as T2* 
shortens [14] increasing dephasing. 3D-EPI is more commonly used and more 
applicable for higher field imaging as it does not rely on long T2*. It has been used 
for fMRI at 7 T, as the 3D technique increases SNR over the 2D technique for a 
given volume [13]. The flip angle is typically low (~ 15°) so as not to suppress the 
signal for successive planes of k-space, which has the advantage of reducing SAR 
(see Section 3.6). 
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Figure 3-12: Example 3D-EPI images (2 x 2 x 3 mm3, FA = 14°, TE/TR = 10/27 ms, FOV = 192 x 
192 x 42 mm3). 
Figure 3-12 shows 3D-EPI images obtained at 7 T (TE/TR = 10/27 ms, voxel size 
of 2 x 2 x 3 mm3, FOV 192 x 192 x 42 mm3, flip angle (FA) = 14°). The benefit of 
3D sequences is that the centre of k-space is acquired simultaneously; the slices 
are not staggered in time which is helpful for fMRI. The SNR increases as the 
signal arises from a large volume rather than a small slice. Also, the slice profiles 
within the 3D volume are better as they are not defined by the slice-selective RF 
pulses used in 2D imaging. 3D-EPI is used for perfusion imaging which is 
described in Chapter 5. 
3.3 SPEEDING UP IMAGE ACQUISITION 
For many applications, such as fMRI, cardiac imaging and perfusion imaging, the 
image acquisition needs to be fast. This could be to track a contrast agent, 
monitor function or to reduce motion artefacts. By speeding up the acquisition, 
distortions and image artefacts can be reduced. Several different techniques are 
often used. In the following sections segmented k-space, partial Fourier and 
parallel imaging (or SENSE) are discussed. 
3.3.1 SEGMENTED K-SPACE ACQUISITION 
If T2/T2* decay is affecting image quality due to a long echo time, segmenting the 
acquisition can be helpful. Segmenting the readout divides the acquisition into 
multiple shorter segments, acquiring a section of k-space. This reduces the 
individual readout times following an excitation pulse, hence reducing signal 
decay due to T2/T2*. However this generally increases the time to acquire the 
image volume, also patient movement can be a problem as they can move 
between (acquisition of) segments. Segmentation has been used to allow higher 
spatial resolution (e.g. for ASL perfusion imaging [15] and fMRI [16]). 
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3.3.2 PARTIAL FOURIER IMAGING 
K-space is well characterised, the real component is symmetric and the imaginary 
component anti-symmetric about the centre, demonstrated in Figure 3-1 C/D. 
The relationship between the k-space signal, s, and the complex conjugate, s*, is 
[2]:  ? ?൫ ? ? ?  ? ?  ? ?൯ ൌ  ?൫െ ? ? ?െ ? ? െ ? ?൯ ? 3-10 
This can be used to reduce the amount of k-space sampled, the missing section 
can be estimated from the acquired section of data using these properties. 
Acquiring a fraction (> ½) of k-space can allow echo times to be reduced and/or 
reduced image acquisition time dependant on the direction that the partial 
imaging is applied. Reduced k-space acquisition in the frequency encode reduces 
the TE, reduction in the phase encode reduces the number of phase encode steps, 
and reduces the total acquisition time. 
This is beneficial in certain techniques, like fMRI where high temporal resolution 
is required and in breath-hold MRI for body imaging where fast acquisitions are 
necessary. The main benefit is to reduce the echo time for high resolution 
imaging, reducing imaging distortions. However as less k-space is acquired the 
SNR of the image is reduced. 
3.3.3 SENSE 
Sensitivity encoding (SENSE) was introduced by Pruessmann et al. [17] in 1999. 
It is a commonly used technique to reduce scan time when a receive coil with 
multiple elements is used, these type of methods are known as parallel imaging. 
By accounting for each receiver coil having a specific sensitivity profile you can 
reduce the amount of k-space that is sampled.  
To achieve this the distance between the sampled points in k-space is increased, 
but the maximum k-space values are unaffected thus maintaining spatial 
resolution. Reducing the sampling frequency would typically reduce the FOV 
causing aliasing (signal outside the FOV to wrap back into the image, shown in 
Figure 3-13) however with SENSE the FOV is maintained.  
Prior to acquiring a scan with SENSE, a reference scan is performed that 
measures the sensitivities of all the receive elements. The reference scan used on 
the 7 T is typically a gradient echo with large FOV, coarse voxel size and low flip 
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angle (FOV = 300 x 300 x 450 mm3, 4.69 mm isotropic voxels, FA = 1°). This 
creates an aliased image for each receive element (Figure 3-13). 
The subsequent images are then reconstructed based on this reference scan to 
remove the aliased images and to produce an image with the full FOV. The SENSE 
factor of a scan, is the amount that sampled k-space has been reduced by, which 
is limited by the number of receive coil elements.  
 
Figure 3-13: Schematic diagram of SENSE. A 4 coil receive set up is shown. For each coil the 
full FOV image and the reduced FOV image due to reduced k-space sampling frequency are 
shown. 
3.4 IMAGE ARTEFACTS 
Image artefacts can arise from a number of factors; distortions caused by image 
acquisition, T2* effects, chemical shift effects, image wrap, patient movement and 
sampling errors. The cause of these, the impact on the image and how they can be 
improved upon will be briefly summarised. 
40 
 
3.4.1 DISTORTIONS 
Image distortions, how much the MR image deviates from the sample, is 
dependant upon the imaging sequence. The receive bandwidth (BW) is the range 
of frequencies which the receiver will accept. It is dependant upon the readout, 
gradient strength and sampling rate, it impacts upon SNR as 
 ? ? ?  ? ? ? ? ? ? 3-11  
Hence a small bandwidth increases SNR, but it can increase image distortions. 
The receive bandwidth determines the amount which a signal is shifted due to 
the chemical shift. The spatial shift can be quantified as 
 ? ? ൌ  ? ? ? ? ? ? ? ? ? ? ? 3-12  
where ȟ is the spatial shift of the signal in mm, BWpixel is the receiver bandwidth 
per pixel (frequency of k-space sampling), ȟɘ is the frequency shift from the ȋɀ0) and x is the voxel size in mm.  Hence in areas of magnetic 
field inhomogeneity large image distortions can arise due to large ȟɘ. This is 
most problematic for EPI due to a small bandwidth increasing the distortions 
(typically the BWpixel is much shorter in the phase than the read direction, causing 
different distortions in the two directions). 
3.4.2 CHEMICAL SHIFT 
Further problems can be caused by chemical shift effects. The resonant frequency 
of a proton will be dependent on their chemical environment. This causes the 
protons in water and fat to have a different resonant frequency as they 
experience slightly different magnetic fields [2]. This can cause an artefact due to 
the spatial shift of the fat signal (Figure 3-14 A) in the frequency encode direction 
due to the frequency shift between fat/water [2]. The spatial shifting of the fat 
signal will be a problem if the frequency difference between fat and water is of 
the same order as the bandwidth per voxel. In brain imaging, the fat signal is 
generated from the scalp fat, this can be reduced by a technique called fat 
suppression, where either a suppression RF pulse at the resonant frequency of the 
fat is applied or an inversion pulse is used (e.g. STIR, short TI inversion recovery) 
prior to image acquisition to reduce the signal arising from the fat. 
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3.4.3 SAMPLING ERRORS 
Artefacts can arise due to the method of sampling k-space. The Nyquist theorem 
states that the highest frequency, fmax, that can be sampled is: 
 ? ? ? ?ൌ  ? ? ? ? ? ? ? ? ? 3-13  
where Tsample is the period between samples. If the FID contains signals with 
frequency greater than fmax (fmax ?Ɂ) they will be mapped to frequency fmax-Ɂ. 
Image wrap (Figure 3-14 B) can occur when the field of view (FOV) is smaller 
than the volume being excited. Signals from outside the FOV have frequencies > 
fmax and wrap into the opposite side of image. This can be resolved by either 
making the FOV larger or using suppression pulses (rest slabs) that suppress the 
signal from outside the imaging volume. Often sequences incorporate fold-over 
suppression where k-space is oversampled to reduce fold over artefacts. 
In EPI, due to the alternate direction of lines in k-space a phenomena called the 
Nyquist or N/2 ghost can occur. Some of the sampled lines of k-space need to be 
inverted to take account of the two read directions. However if the lines are 
acquired off centre due to imperfect acquisition this will cause a ghost image in 
the reconstructed image.  
3.4.4 MAGNETIC SUSCEPTIBILITY 
Magnetic susceptibility is defined as the ratio of the induced magnetisation M to 
the external magnetisation H; 
 ? ൌ 3-14 ɖǢ
materials have low negative values, paramagnetic materials have low positive 
values and ferromagnetic materials have high positive values. Diamagnetic 
materials, when placed in a magnetic field, acquire a magnetisation proportional 
to the applied field but in the opposite direction. Paramagnetic materials acquire 
magnetisation in the same direction as the magnetic field; both diamagnetic and 
paramagnetic materials lose their magnetisation when the field is removed. 
Ferromagnetic materials interact more strongly with applied fields, and can be 
permanent magnets Ȃ sources of magnetic fields [18]. Where there are 
boundaries of different magnetic susceptibilities, this causes a change in the local 
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magnetic field. The sinuses cause particular problems due to the large pocket of 
air next to the brain tissue, and EP images at this level are commonly distorted 
(Figure 3-14 C).  
Magnetic field inhomogeneity can stem from underlying poor magnet 
homogeneity, as well as disturbances to the magnetic field when a sample is 
placed in the magnetic field due to different magnetic susceptibilities. The decay 
of the signal after the RF excitation pulse due to T2* effects can be problematic, 
more so for EPI as the time between excitation and measurement is long. This is a 
problem in areas of poor magnetic field homogeneity where T2* is short as  ȟ ? ? ? ?  ? ? ? [19]. To improve image quality good shimming of the magnetic field is 
required to increase homogeneity. This can be achieved by using shim coils to 
apply a further field, or by placing blocks of diamagnetic materials (e.g. [20]) 
around the sample to correct the field inhomogeneities. Images can also be 
improved by reducing the echo time (e.g. through segmented acquisitions, SENSE 
or partial Fourier) as described in Section 3.3. 
3.4.5 PATIENT MOTION 
Patient movement can also cause significant artefacts Ȃ this is more commonly 
associated with body imaging where respiration causes organ motion. However 
subjects unfamiliar with the scanner environment can often move and can be a 
problem for brain imaging especially in patients and at high resolution. 3D scans 
are more susceptible to motion artefacts as the entire volume of k-space is 
sampled together. Figure 3-14 D is a 3D T2* weighted scan that took 
approximately 10 minutes to acquire and motion artefacts can be seen as 
blurring of the image, seen around the front of the brain. Motion can also cause 
image ghosting, where further faint reproductions of the image are seen around 
the main image. This is due to the time taken to acquire the phase encode lines, 
periodic motion such as respiration will cause ghosting, whereas other motion 
will cause general diffuse noise. Fast imaging techniques are used to reduce 
motion artefacts e.g. EPI / bFFE. 
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Figure 3-14: Image artefacts (A) cause by fat (B) fold over (C) susceptibility differences and 
(D) patient motion. 
3.5 HARDWARE 
The work presented in this thesis was performed on a Philips 7.0 T Achieva 
system. Therefore, specific hardware information will be provided for this 
system. A schematic diagram of an MRI scanner is shown in Figure 3-15. 
 
Figure 3-15: Schematic of an MRI scanner with local transmit/receive coils. 
3.5.1 MAGNET 
The magnet is a 7.0 T horizontal bore solenoid superconducting magnet 
produced by Magnex now Varian. Liquid helium is used to keep the coils 
superconducting, a cryostat and cryocoolers are used to keep the helium cool and 
reduce boil-off (older systems would have used a jacket of liquid nitrogen rather 
than a cryocooler). The stability of the magnet is 0.10 ppm in a 25 cm diameter 
spherical volume. To shield the magnet, an iron box weighing 200 tonnes 
surrounds the magnet to reduce the extent of the fringe field. The extent of the 
fringe field needs to be short to limit the field outside the building which would 
be dangerous for people with contraindications to strong magnetic fields (see 
section 3.6.1). A 5 Gauss (5 mT) line is marked, to indicate when you are entering 
the magnetic field. 
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3.5.2 SHIM COILS 
Shimming is the process of making the static B0 field more homogeneous to avoid 
distortions/signal drop-outs in the image. Passive shimming uses small pieces of 
diamagnetic material to compensate for inhomogeneities in the magnetic field 
(e.g. [21]). Active shimming uses current passing through small shim coils to 
correct the field; these are optimised for that particular session/subject. The 
scanner can implement its own optimisation of the shim fields using the 
FASTMAP technique. However, image based shimming provides the most robust 
technique, such as that developed by Poole and Bowtell [22] which was used in 
this thesis. This uses a B0 field map taken prior to the main image to optimise the 
shim fields to minimise the variation in the static B0 field. 
3.5.3 GRADIENT COILS 
Gradient coils are required to set up the linear gradients in all three directions (x, 
y and z) for imaging. The shape of the coils depends on the gradient required. As 
high currents are required to produce the required gradients the coils are cooled, 
typically water-cooled, to reduce the temperature due to resistive heating. The 
gradient coils on the 7 T can produce a maximum field gradient of 40 mT/m with 
a slew rate of 200 mT/m/ms (maximum rate of change). However to reduce PNS 
(see Section 3.6.3) these are limited to 33 mT/m and 166 mT/m/ms in the work 
in this thesis. 
3.5.4 RF COILS 
Here the set-up for brain MRI is described where separate transmit and receive 
coils are used. For transmission, a head volume transmit coil is used. A 16 or 32 
channel coil within the transmit coil is used for receive (Figure 3-16). The 
multiple receive elements allow for SENSE techniques to reduce acquisition 
times. At ultra high field the wavelength of the RF pulse is decreased (order of 
1m) this causes increased interactions between the RF pulse and the sample due 
to the comparable length scales [23]. This causes RF inhomogeneity and hence 
SAR profile inhomogeneities [23]. To reduce absorbed power the coil designs at 
7T have been generally restricted to volume coils as shown here. 
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Figure 3-16: (A) 7 T scanner showing RF volume transmit and 32-channel receive coils (B) 
32 channel receive coil. Photos courtesy of Dr O. Mougin, SPMMRC. 
3.5.5 CONSOLE 
The scanner is controlled through a console, which allows the user to set up a 
sequence. This calculates the RF and gradient waveforms, and then relays these 
to the spectrometer. The received signals, measured using a phase sensitive 
detector, will be amplified before being reconstructed and displayed on the Ǥ  ǯ       
temperature to ensure safe running of the scanner.  
3.6 SAFETY 
MRI utilises low frequency radiation of comparatively low energy and as such 
does not pose the risks that techniques that use ionising radiation, such as X-rays, 
do. However there are still dangers associated with MRI scanners, and 
precautions must be taken to ensure the safety of the volunteers and the scanner 
operators. Here the concerns associated with the static field, RF and gradients are 
considered separately. 
3.6.1 STATIC MAGNETIC FIELDS 
The static magnetic field used to create the MR images are potentially hazardous 
due to the attraction of magnetic objects towards the scanner bore. Large objects 
would be pulled with significant force, acting as a projectile. Also, implants such 
as aneurysm clips and pacemakers could malfunction due to the interaction with 
the magnetic field. To avoid these types of incidents, all subjects with access to 
the magnet must be screened for pacemakers and clips, all metal objects (e.g. 
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belts, keys) need to be removed beforehand. The areas that you can be exposed 
to magnetic fields greater than 5 Gauss (0.5 mT) are marked with red/white tape 
(5 Gauss line).  
To reduce stray fields the 7 T is shielded in an iron box, this is to ensure that 
people passing are not affected by the magnetic field. The field is contained so 
that access to the magnetic field can be restricted. The magnet room of the 7 T is 
situated in a control room behind a coded door Ȃ this is to stop accidental access 
to the magnet. 
 The static field can also cause people to feel nauseous, dizzy (vertigo), and give a 
metallic taste in the mouth or to see small flashes when moving through the field 
[24]. These can be avoided by moving slowly when around the magnet, and 
moving subjects into the magnet slowly. Particular care should be taken when 
swapping coils. 
3.6.2 RF FIELD 
RF radiation can potentially cause tissue heating due to the power deposited into 
the tissue. This could damage tissues particularly those that are not well perfused 
as the blood flow is not present to cool the area down by dissipating the heat. The 
measure of RF power deposition is called the Specific Absorption Rate (SAR), 
which is calculated by the scanner for each scan and coil configuration. SAR is 
dependent on the sequence (e.g. flip angle, pulse timings) and the tissue 
size/density. SAR is measured in Watts per kilogram of body weight.  
SAR limits are in place to avoid excessive tissue heating, the Health Protection 
Agency recommends for normal procedures that whole body temperature rises 
should not exceed 1°C and to follow the 2004 ICNIRP (International Commission 
on Non-Ionizing Radiation Protection) guidelines on whole body SAR, which are 
2 W/Kg for normal clinical procedures and 4 W/Kg for other procedures. 
Furthermore, RF fields can heat metallic objects which in contact with skin/tissue 
could cause burns. This risk is diminished by eliminating metal inside the bore of 
the magnet as far as possible and insulating where necessary (e.g. call button, 
VCG leads) and volunteers are screened for metal implants. Metal based or 
conductive dyes can also be present in inks used for tattooing Ȃ old, dark tattoos 
can cause skin burns. Again, patient screening is used to avoid this occurring. In 
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addition, circulating currents can be induced in the body, subjects are placed in 
the scanner without arms or legs crossing to avoid this. 
Patients need to be positioned in the magnet without their arms or legs crossing, 
or loops being formed due to the other equipment in the scanner. This can cause 
current loops to be set up and burns may result. 
3.6.3 GRADIENT FIELD 
The rapidly switching gradients that are used for imaging can induce currents 
along the nerves in the body. This effect is called Peripheral Nerve Stimulation, or 
PNS, and can cause discomfort. It is avoided by keeping the gradient switching 
rate low (< 60 mT/m/ms) [25]. As described previously, the gradients used in the 
experimental work described in this thesis were limited to a strength of 33 
mT/m and slew rate of 166 mT/m/ms. 
3.6.4 OTHER SAFETY CONSIDERATIONS 
Another safety concern is the acoustic noise generated by the scanner during 
imaging (values of 100 dB for fast imaging sequences at 3 T [26]). All volunteers 
must wear ear protection, as must anybody working around the magnet during 
operation. This is a concern in foetal imaging, as the sound can be transmitted 
through the mother so the sequences are designed to be quieter.  
MRI scanners use cryogens (e.g. liquid helium and nitrogen) to keep the magnet 
superconducting. A quench of the magnet, or emergency discharge of these 
cryogens due to the wires becoming resistive rather than superconducting 
resulting in heating, would release these as the form of gases. These would 
displace the oxygen if they were discharged into a closed/un-ventilated room, 
and asphyxiate the occupants. Oxygen depletion alarms are used to warn scanner 
operators of this situation. If working with cryogens, protective equipment 
(mask, gloves) must be worn to prevent cold burns and training given. 
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3.7 ETHICS 
When scanning patients and healthy volunteers all studies must be approved by 
an ethics committee to ensure appropriate guidelines are followed. All the 
studies in this thesis were approved by the University of Nottingham ethics 
committee, and all volunteers provided informed, written consent to take part in 
the studies. 
A concern when scanning patients is the possibility of incidental abnormal 
findings on scans. A protocol is in place in the event of an abnormal finding, the 
volunteer is not shown their images and the images are sent to a radiologist for 
review. Scans are not routinely sent for investigation as incidental findings can    ǯ    ǡ    Ǥ  
written consent, subjects must confirm their willingness to be informed of 
incidental findings.   
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4 INTRODUCTION TO BRAIN FUNCTION AND 
FUNCTIONAL BRAIN IMAGING TECHNIQUES 
 
4.1 OUTLINE 
This chapter describes basic brain anatomy and the metrics used to describe 
brain function. Methods to measure brain function with emphasis on MR 
methods of brain function are introduced; PET, SPECT, MEG, EEG, BOLD, arterial 
spin labelling (ASL), contrast agent based perfusion measures and magnetic 
resonance spectroscopy (MRS). The methodology for ASL is discussed in more 
detail including the mathematical model for perfusion quantification, as this 
forms an emphasis of this thesis. 
4.2 BRAIN FUNCTION PHYSIOLOGY 
The brain is only about 2 % of total body weight but uses a disproportionate 
amount of resources; 20 % of total oxygen consumption [1], 25 % of glucose, and 
approximately 14 % of the total cardiac output [1] at rest. The brain is supplied 
by four main arteries, the left and right carotid arteries and the left and right 
vertebral arteries (Figure 4-1 A). The vertebral arteries merge to form the basilar 
artery, which joins the carotid arteries at the Circle of Willis [1]. The large 
arteries branch into arterioles and capillaries to allow for perfusion of water, CO2, 
O2 and waste products between blood and tissue cells (Figure 4-1 B). These 
capillaries merge into venules and a network of smaller veins before the blood 
drains into the sagittal sinus and jugular vein in the neck. 
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Figure 4-1: (A) 7 T MR angiogram images of vessels in the brain and neck in coronal and 
sagittal planes, (B) schematic of capillary vasculature, arrows indicate direction of blood 
flow. 
The blood-brain barrier (BBB) allows essential molecules, such as glucose and 
oxygen, to enter the brain from the blood but restricts the movement of large 
molecules [2]. It aims to protect the brain from infections/viruses crossing from 
the blood, however some substances that could treat disorders cannot cross into 
the tissue due to the BBB. In comparison the capillaries in the rest of the body 
generally allow transport of larger molecules, e.g. hormones, which can be 
beneficial as well as harmful. Breakdown of the BBB can be seen in certain 
clinical conditions, such at Multiple Sclerosis (MS), bacterial meningitis, ǯȋȌ[3]. 
To monitor the function of the brain a number of measurable quantities are 
defined and summarised in Table 4-1. 
52 
 
Metric Symbol Definition Units 
Cerebral Blood Flow CBF Volume of arterial blood that is 
delivered to 100 g of brain tissue 
per minute 
ml/100g/min 
Cerebral Blood Volume CBV Volume of blood present in 100g of 
tissue 
ml/100g 
Oxygen Extraction 
Fraction 
OEF Amount of oxygen extracted by the 
brain from the available oxygen in 
the blood 
- 
Cerebral metabolic rate 
of oxygen consumption 
CMRO2 Amount of oxygen metabolised by 
the brain per minute 
Ɋl/min 
Table 4-1: Summary of metrics used to describe brain function. 
 
4.3 FUNCTIONAL BRAIN IMAGING 
Magnetic resonance imaging provides a method of imaging structures in the 
body, which can aid in the identification of abnormalities e.g. tumours. However 
it can also provide a measure of function to aid our understanding of how the 
body works and to improve clinical practices. In addition to MRI, other imaging 
modalities can provide a measure of brain function; PET (positron emission 
tomography), SPECT (single photon emission computed tomography), EEG 
(electroencephalography) and MEG (magnetoencephalography).  
PET uses radiopharmaceuticals that contain an isotope (e.g. 15O, 13N, 18F) which 
emit positrons. These, on colliding with an electron, emit two photons in opposite 
directions. The photons are detected by a ring of detectors; coincident detected 
pairs of events can be used to detect where the photons originated from. 
However this technique does have limited spatial resolution. The 
radiopharmaceuticals used tend to have a short half life, making it generally 
necessary to manufacture them on-site using a cyclotron leading to PET being 
expensive. Dependant on the tracer used, different aspects of tissue function can 
be investigated, e.g. CMRO2 and OEF. 
SPECT uses tracers that emit gamma rays (e.g. 99Tc, 123I), which are then detected 
by a gamma camera. SPECT imaging is complicated by scattering of the photons, 
as pairs of events are not being monitored photons that have scattered off objects 
can be reconstructed to the wrong origin. However, SPECT is less expensive than 
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PET and can be used for many of the same measurements, commonly for the 
assessment of CBF [4]. 
EEG and MEG both work on the principle that neurons within the brain have 
small electric currents passing through them which generate small electric and 
magnetic fields [4]. EEG uses an array of electrodes placed in contact with the 
scalp using a cap and conductive gel. The electric potentials generated by 
neuronal firing, which are of the order of micro volts, can then be measured. The 
measurements made on the surface of the scalp can be projected back into the 
brain to localise the active brain area. However, this is a mathematically ill-posed 
problem (no unique solution) and requires complex source localisation Ǥ  
       ǯ
heart beat, eye and muscle movement. Furthermore, the different conductivities 
of the brain, scalp and skin can disturb the electric fields, limiting the accuracy of 
the source localisation, resulting in low spatial resolution. However EEG has the 
benefit of being a relatively inexpensive method making it a useful clinical 
technique [4]. 
MEG uses the magnetic fields produced by neuronal firing to monitor brain 
function. Using SQUID (superconducting quantum interference device) 
magnetometers the small magnetic field (of the order of fT) produced by neurons 
can be detected [4]. Source localisation is better in MEG than EEG, as the 
magnetic field is not distorted by the skull/scalp. But, the spatial resolution is still 
low compared to other techniques, and like EEG, interference arises from eye and 
muscle movement. MEG is an expensive technique, due to the requirement of a 
magnetically shielded room, and liquid helium for the SQUIDS. However, it has 
superior temporal resolution to MRI (further detail on MEG is provided in 
Chapter 6). 
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4.4 BRAIN FUNCTION MEASUREMENTS MADE WITH MR 
The common MR measures used to probe brain function are summarised in 
Figure 4-2. Upon neuronal activity there are changes in cerebral blood flow, 
cerebral blood volume, and the cerebral metabolism of oxygen resulting in a 
change in deoxyhaemoglobin levels. Four MR functional imaging techniques, 
Arterial Spin Labelling (ASL), Blood Oxygenation Level Dependant (BOLD) 
contrast, MR spectroscopy (MRS) and the use of exogenous contrast agents, are 
common ways of measuring these aspects of brain function. Contrast agents and 
ASL can also be used to measure resting values of cerebral blood flow and blood 
volume, and MRS of metabolite levels respectively.  
 
Figure 4-2: Methods of measuring brain function using MR. 
4.4.1 BOLD 
The most common technique for monitoring brain activation is functional 
magnetic resonance imaging (fMRI) which uses the BOLD (blood oxygenation 
level dependant) contrast mechanism. The biophysics of the BOLD response has 
yet to be fully understood; however can be described simply as a change in the 
relative levels of deoxy- and oxyhaemoglobin in the blood [5]. Deoxyhaemoglobin 
is a paramagnetic molecule whereas oxyhaemoglobin is diamagnetic. 
Deoxyhaemoglobin in the blood causes a susceptibility difference between the 
blood vessel and tissue which causes variations in the local T2*, dependant on the 
concentration of deoxy- and oxyhaemoglobin [6].  
Upon neuronal activation, blood flow increases to supply the active area with 
more oxyhaemoglobin. This is induced by the release of neurotransmitters from 
the activated neurons which cause the local vessels to dilate reducing resistance 
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in the vessels increasing flow [7]. Vessels further upstream also dilate to allow 
the increase in flow, this effect has been attributed to different mechanisms (e.g. 
flux of potassium ions, nitrous oxide, adenosine (see [7])). Oxygen is then 
extracted from the blood to the cells at a slightly higher rate than at rest to keep 
up with demand, schematically represented in Figure 4-3. These changes result in 
an excess of oxyhaemoglobin (less deoxyhaemoglobin) and hence an increase in 
the MR signal, due to an increase in T2* resulting in less extravascular dephasing 
of the MR signal [5]. At higher field strengths (> 4 T) the intravascular 
contribution is reduced due to a reduction in blood T2 [8]. 
 
Figure 4-3: Schematic of the origins of the BOLD effect. 
The time course of this BOLD signal can be monitored by rapid image acquisition 
during the presentation of a stimulus (e.g. flashing checkerboard) or whilst the 
subject is performing a task (e.g. finger tapping). Functional imaging is performed 
using a sequence sensitive to T2* to monitor the changes in susceptibility, hence 
the standard sequence used is a gradient-echo (GE) EPI acquisition. The GE-EPI 
echo time chosen is crucial for optimal fMRI contrast. A sufficient echo time (TE) 
is needed for the difference in T2* between the two states (active and rest) to be 
apparent, but the echo time should not be so long that the signal has decayed. It 
can be shown that the optimal TE is that equal to the T2* of the grey matter [9], 
through maximising the difference between the two signals accounting for a 
small change in T2* between activation and rest. 
The BOLD signal change is delayed relative to the start of the stimulus; this is due 
to the haemodynamic response, it takes a few seconds for the vascular system to 
respond to the change in neuronal activity. The BOLD haemodynamic response 
can be characterised in terms of three main components. There is a possible 
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initial dip, thought to be due to an immediate increase in oxygen consumption 
[10]. The duration of the initial dip is short (~ 1s) compared to the other features 
of the BOLD response. It is thought that the initial dip has good spatial 
localisation to the site of the neuronal activity [11, 12]. The second feature is the 
main positive response or overshoot, which is delayed by a few seconds with 
respect to the stimulus and persists for a few seconds. The magnitude of the 
BOLD response is dependant on field strength, echo time and stimulus/location 
of activation, but is of the order of 6 % at 7 T and 4 % at 3 T. The third feature of 
the BOLD haemodynamic response is the post stimulus undershoot. The origin of 
the post stimulus undershoot is still debated [13, 14] but is thought to be most 
likely to be due to either a delayed vCBV recovery or prolonged elevation in 
CMRO2. The post stimulus undershoot can persist for many seconds (~ 45 s) after 
the positive response has ended.  
 
Figure 4-4: BOLD haemodynamic response function (hrf) to an event stimulus applied at t = 
0s.  
4.4.1.1 fMRI Data Analysis 
An fMRI experiment can be performed in two main ways; event related or a block 
design.  Event related uses brief stimuli, whereas a block design will have several 
repeats of the same task, shown schematically in Figure 4-5, to prolong the BOLD 
response for measurement. The task is typically repeated several times with 
periods of rest between. 
57 
 
 
Figure 4-5: Schematic of (A) event related and (B) a block design fMRI experiment showing 
the stimulus and modelled BOLD response. 
To localise active brain areas in response to a stimulus, the fMRI timecourse is 
fitted to a BOLD model (e.g. minimisation of square of residuals between data and 
fit), as described above. Prior to this, several processing steps are performed to 
maximise the success of detecting active voxels. The main pre-processing steps 
are motion correction (realignment), spatial smoothing and temporal filtering of 
the data.  
Motion correction realigns all the data across time into the same space, reducing 
errors introduced by patient motion. This is normally performed using a 6 
parameter, rigid body transformation, including three translation and three 
rotation corrections [15]. 
Sources of noise in fMRI data include thermal noise, physiological noise (heart 
beat, respiration), and non-task related neuronal activity [7]. Spatial and 
temporal smoothing are performed to increase the signal-to-noise ratio (SNR). 
Spatial smoothing is often performed using a Gaussian kernel with FWHM of a 
few mm, this increases the signal-to-noise ratio of the data by averaging 
neighbouring signals. Applying too much spatial smoothing blurs the response 
and reduces sensitivity as active voxels are averaged with non-active regions, 
typically the smoothing kernel should match the size of activation. A degree of 
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spatial smoothing is also introduced by the motion correction performed (and 
associated interpolation). 
Temporal smoothing helps remove noise that can arise from scanner drift (very 
low frequency noise), physiological noise (pulsatility effects) and thermal noise. 
Temporal smoothing can be achieved using linear or polynomial detrending to 
remove low frequency drift and filtering (e.g. a Gaussian) can be applied to 
remove specific frequency bands. The temporal smoothing applied needs to be 
carefully chosen so as not to remove the effect of interest and the typical cut off 
period is twice the task cycle duration. 
The effect of physiological noise can be further reduced by use of RETROICOR 
[16], a retrospective software correction method for fMRI data. Physiological 
data, respiratory and cardiac cycle time courses, are recorded during fMRI 
acquisition. The fMRI timecourse assumed to be corrupted by additive noise from 
respiration and the cardiac cycle. The physiological noise is modelled as a 2nd 
order Fourier series based on the phase of the respiratory and cardiac cycle, 
which is then subtracted from the timecourse to reduce contributions from 
physiological noise. 
Modelling the BOLD data to find active brain areas is most commonly performed 
using a general linear model (GLM) [17]. This assumes that the BOLD data (a 
vector X, with dimensions number of voxels x number of time points) is a linear 
combination of the stimuli (G, number of effects/stimuli x number of time points) 
plus noise (e).  ࢄ ൌ ࡳ ? ൅ ࢋ. 4-1 
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Figure 4-6: Schematic of GLM analysis (A) a binary representation of the stimulus (B) the 
BOLD hrf convolved with the stimulus to give G (C) simulated BOLD response (broken line) 
Ⱦ ? ?Ǥ 
By convolving the input stimulus with the expected BOLD hrf, an expression for G ǤȾǡ
this is shown in Figure 4-6. A statistical map is then formed, a T value is given by ȾȋȾȀȋȾȌȌǤȋȌǡ
upon the p value (e.g. p < 0.01). However due to the number of voxels analysed in 
a typical fMRI experiment, there would be a large numbers of voxels shown to be 
active by chance. To reduce the false-positive rate a further correction is applied 
to account for multiple comparisons (e.g. Gaussian random field theory), and the 
p-value is referred to as corrected. 
4.4.2 ARTERIAL SPIN LABELLING 
Arterial spin labelling (ASL) is a non-invasive technique for measuring perfusion, 
which is the delivery of blood and subsequent exchange of nutrients to a tissue or 
organ [18]. This thesis will present ASL developments and the applications of this ȋ ? ?ȌǤǡ
for ASL is described and the standard terms used to describe different sequences 
are defined. 
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ASL uses the magnetic labelling of inflowing blood to the tissue; two sets of 
images are taken, one where the inflowing blood water is labelled (the label 
image), the second without labelling applied termed the control image [19]. The 
difference between these signals will give an image of the labelled blood water 
which will have perfused into the tissue. This is summarised schematically in 
Figure 4-7. A post-label delay (TI), the time between labelling and imaging, allows 
time for the labelled blood to arrive at the tissue and perfuse into the tissue. The 
signal changes measured by ASL are small, ~1 % in grey matter at 3 T, so many 
measurements (~ 50) are made and the average of these taken. 
 
Figure 4-7: Basic method of Arterial Spin Labelling (ASL) perfusion imaging (this schematic 
ignores the effect of longitudinal relaxation on the labelled blood bolus). 
By modelling the expected ASL signal change, this perfusion weighted signal can 
be converted into physiological units of perfusion in ml/100g/min [18]. In the 
human brain, CBF ~ 70ml/100g/min for grey matter and ~ 20ml/100g/min for 
white matter [20]. As well as measurements of cerebral perfusion, ASL has also 
been used to measure perfusion in skeletal muscle [21], kidney [22], thyroid [23], 
pancreas [24] and heart tissue [25]. ASL techniques can be used to measure 
cerebral blood flow (CBF), arterial cerebral blood volume (aCBV) and transit 
times (time for blood to arrive at the arteries, tissue or to travel through tissue) 
[26].   
ASL can be used to measure (i) perfusion at rest to assess the vasculature, this is 
often used in patient groups where the blood flow is disturbed (e.g. stroke [27]) 
or (ii) the change in blood flow due to an external stimulus, thus performing fMRI 
using perfusion, a direct quantitative measure, rather than BOLD contrast (e.g. 
Control Ȃ Label         
= Perfusion 
Weighted Image 
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[28]).  Combining BOLD and ASL studies allows for the spatial comparison of 
BOLD and ASL changes, with BOLD arising predominantly from the venous side 
of the blood supply and ASL signal from the arterial side [29]. In addition, 
combined experiments allow further insight into the BOLD mechanism for BOLD 
modelling [30] and can be used in calibrated BOLD studies, as described in 
Chapter 6 [31]. 
In addition, ASL can provide measures of how arteries are feeding the brain 
tissue. In a technique called territorial ASL (TASL or selective ASL [32]) the major 
arteries are selectively labelled allowing identification of the vascular territories 
of the brain, typically the basilar artery and left and right carotid arteries are 
selectively labelled [33]. TASL is useful in the treatment of patients; for example 
in strokes where the blood vessels are blocked, which can lead to hypoperfusion 
due to a lack of blood supply [27].  
4.4.2.1 Labelling Schemes 
The labelling schemes for ASL can be divided into three main categories; PASL 
(Pulsed Arterial Spin Labelling [34]), CASL (Continuous Arterial Spin Labelling 
[35]) and PCASL (Pseudo Continuous Arterial Spin Labelling [36]), and these 
schemes are summarised in Figure 4-8. All the experiments presented in this 
thesis use PASL but a brief description of the three ASL schemes is included here.  
 
Figure 4-8: Schematic diagram representing the RF and gradient waveforms for PASL (FAIR 
scheme), CASL and PCASL. Acq represents the image acquisition module. 
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PASL typically uses short duration RF pulses to label (usually invert) a slab of 
spins. The two most common RF pulse shapes for labelling are hyperbolic secant 
(hsc) or frequency offset correction inversion pulses (FOCI). An hsc pulse has the 
form (A0ȋȾȌȌ ? ?Ɋ where A0 is the maximum B1 ǡȾ  Ɋ   [37]. The bandwidth of this pulse, which 
determines the slice thickness (as well as the ȌǡɊȾȀɎǤ
FOCI pulses were introduced to reduce spatial localisation errors due to 
frequency offsets for spectroscopy by giving a sharper pulse profile [38]. A FOCI 
pulse is based on a hsc pulse but scaled by a further factor A(t) which is 1 in the 
middle of the pulse, and larger than 1 at the ends to reshape the B1, gradients and 
frequency offsets. The parameters can be optimised to provide the most efficient 
inversion. 
There are many different pulsed labelling schemes proposed for PASL, Figure 4-9 
summarises three of these schemes. The labelling schemes require that there is a 
difference between the two states for only the inflowing blood not the static 
tissue. A control condition is used to match magnetisation transfer (transfer of 
longitudinal magnetisation between macromolecules and free water) and other 
effects such as eddy currents.  
FAIR (flow alternating inversion recovery [39]) uses a selective and a non-
selective 180° inversion pulse for labelling the inflowing blood, centred in the 
middle of the imaging volume. This matches the RF power between label and 
control. 
STAR (signal targeting with alternating radio frequency [40]) uses a 180° below 
the imaging slice to label the inflowing blood and then two 180° pulses for the 
control, equivalent to a 360°. This matches the power and MT effects between the 
label and control images. 
PICORE (proximal inversion controlling for off resonance effects [28]) uses an 
identical label to STAR but does not have a gradient for the control condition. 
This ensures that the same RF power has been deposited into the tissue to match 
MT effects, but labelling only occurs when the gradient and RF excite the same 
frequency of spins. 
The choice of labelling scheme is some what dependant upon scanner hardware 
capabilities. For example, STAR requires a 360° pulse to be made from two 180° 
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pulses; requiring very good B1 homogeneity.  Also STAR and PICORE require a 
sharp profile for the inversion to prevent the label bleeding into the imaging 
plane and the need for a large gap between the image volume and label. 
 
Figure 4-9: Schematic of three different ASL labelling schemes, solid line indicates imaging 
plane, broken line indicates placement of inversion pulse. 
CASL uses a long low power RF pulse to label the spins so that labelling takes a 
few seconds. The labelling is applied at a single location in the neck. The 
advantage of CASL is that it maximises the perfusion signal [18]. However the 
long RF pulse increases the power deposited in the tissue (SAR), which can limit 
the technique at higher magnetic field strengths. CASL can also require a separate 
transmit coil for labelling the spins to reduce SAR. When using a separate 
labelling coil magnetisation transfer effects are removed providing the two coils 
are decoupled [41]. 
PCASL uses a train of small, short-duration RF pulses to imitate CASL The control 
condition is achieved by alternating the sign of the RF pulses in the train to give 
average B1 of zero, but the RF power is matched maintaining MT effects between 
label/control. 
CASL/PCASL both have higher SAR relative to PASL due to the higher RF power, 
so can be limited at higher field strength. CASL can exceed SAR limits at 3 T if 
using the body coil for transmission, separate labelling coils must be developed 
to reduce SAR. Homogenous B1 is required for efficient labelling which is harder 
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to achieve at higher field with current hardware, PCASL was shown to be more 
dependant on B1 than PASL at 7 T [42]. This is due to the labelling for PCASL 
being applied in the neck where B0 (large offset frequencies) and B1 are less 
homogeneous (RF wavelength reduced increasing RF/tissue interactions). 
4.4.2.2 Modelling the ASL Signal 
To convert the perfusion weighted images into a quantifiable parameter in 
ml/100g/min a basic physiological model for ASL is needed, an example is shown 
in Figure 4-10. This shows the vascular tree, from a large artery, to arterioles into 
the tissue capillary bed and then the venous compartment. For pulsed ASL the ǡȟa for the 
leading edge to reach the imaging slice, this remains in the blood vessels for an   Ɂ    Ǥ     he tissue 
through venous flow, by which point the label will have decayed. The tissue 
perfusion curve, Figure 4-10 ǡǡȟa ?Ɂ
no tissue signal, the labelled blood then flows in for a time W after which 
unlabelled blood flows in. The imaging module should be used to sample the peak 
of this curve for maximum signal, but using a number of inversion times is 
optimal as this allows transit times to be assessed improving the accuracy of the 
perfusion quantification. 
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Figure 4-10: (A) Model of ASL compartments from Francis et al. [26] (B) Difference signal 
from blood compartment (broken line) and tissue compartment (solid line). 
Different methods for modelling the ASL signal have been proposed. The first 
model for PASL was proposed in separate studies by Kim [39] and Kwong et al. 
[43]. It is based upon the single compartment model and the Bloch equation 
incorporating a flow component that was initially proposed by Detre et al. [44]:  ? ? ? ?ൌ  ? ?െ  ? ? ? ൅  ? ? ?െ  ? ? ? 4-2 
where M is the tissue magnetisation, Mb is the blood signal, M0 is the equilibrium ǡɉ-brain partition coefficient. The +fMb term 
represents the magnetisation flowing into the compartment, and ȂȀɉ  Ǥ  ?Ȁɉ
to tissue magnetisation [45] as 
 ? ൌ ? ? ? ? ? ? 4-3  
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T1 is the tissue T1 for non-selective inversion, which is modified to apparent T1, 
T1,app, when accounting for flow as for the selective inversion;  ? ? ? ? ? ? ?ൌ  ?? ?൅  ? ? 4-4 
Using Equations 4-2 and 4-4, the signal difference for a FAIR scheme between a 
non-selective (Mns) and a selective signal (Ms) can be shown as  ? ? ? ? ?െ  ? ? ? ? ? ?ൌ  ? ?൫ ? െ  ? ? ? ?  ?భ ?ೌ೛೛? ൯ െ  ? ?൫ ? െ  ? ? ? ?  ?భ? ൯   ? ? ? ? ?െ  ? ? ? ? ? ?ൌ  ? ? ?൫ ? ? ?  ?భ? െ  ? ? ?  ?భ ?ೌ೛೛? ൯   ?  ? ? ? ? ?െ  ? ? ? ? ? ?ൌ  ? ? ? ? ? ?  ?భ? ൫ ? െ  ? ? ? ?ఒ ? ൯ 4-5 
assuming that TR >> T1, allowing full recovery. For times such that Ȁɉ ? ? ? then 
ȟ ? ? ? ?ൌ  ? ? ? ? ? ? ? ? ? ?Ȁ ?భ 4-6  ȟ   measured difference signal and Ƚ      Ƚ  ?  ?   Ǥ    
sufficiently long time has passed so that the entire labelled bolus has reached the 
imaging voxel [46]. This is a simple model as it does not take account of transit 
times. 
The modified Bloch equations can also be used to account for the different transit 
times of the blood, as used in Gardener et al. [47]. Solving the modified Bloch 
equations assuming plug flow and complete refreshment between TR periods it 
can be shown that  ȟ ? ? ? ?
ൌ
ۖۖەۖۖ۔
ۓ  ? ? ? ? ?  ? ? ൬  ? ? ? ? ? ?െ  ? ? ? ? ?൰ ? ? ?೟೔ೞೞೠ೐ ?భ ?್  ? ? ? ? ? ? ?೟೔ೞೞೠ೐ ? ?భ ?್ െ  ? ? ? ? ? ?೟೔ೞೞೠ೐ ? ?భ ?ೌ೛೛  ? ? ? ? ?  ? ? ൬  ? ? ? ? ? ?െ  ? ? ? ? ?൰ ? ? ?೟೔ೞೞೠ೐ ?భ ?್  ? ? ? ? ?భ ?್െ  ? ? ? ?భ ?ೌ೛೛ ? ? ? ? ? ? ?೟೔ೞೞೠ೐ ? ? ? ?భ ?ೌ೛೛
 
  ?ȟtissue ȟtissue  ? ?ȟtissue + W 
  ?ȟtissue + W 4-7 
ȟtissue is the tissue ȋȟa ?ɁFigure 4-10) and T1,b is the 
T1 or arterial blood. By acquiring data with a range of TI values it can be fitted for ǡȟtissue using the above equations.  
For quantification of CBF an estimation of the M0 of blood is needed, and there 
are different methods that are used [48]. The measurement of M0,b directly from 
vessel filled voxel is difficult, primarily due to the typical coarse spatial resolution 
increasing partial volume effects. Equilibrium magnetisation values of white 
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matter or CSF can be converted to M0,b by accounting for differences in proton 
density and T2* between WM/CSF and blood. However the more popular method 
is that the M0 of tissue can be measured (e.g. using inversion recovery) and 
converted to M0,b using the relationship in Equation 4-3. This can be performed 
globally, using an average value of M0 as the value of M0,b is constant over the 
brain. However often it is performed voxelwise, as this allows for correction of 
other effects (e.g. T2*, coil sensitivity profiles) [48]. 
4.4.2.3 Single TI Methods 
The most common use of ASL is the single TI method, where only one post-label 
delay time is used of ~ 1400 ms, as shown in Figure 4-7. The advantage to this is 
that it is easier to implement and easier to model the perfusion signal. However, 
perfusion is a dynamic process, and by only taking one time point the effect of 
transit time is not taken into account. Transit time is the time taken for the 
labelled bolus to arrive in the tissue (the time of zero signal change in Figure 
4-11). The transit time varies across the brain [49] and with age [50] and can 
lead to perfusion quantification errors. Buxton [46] provided several 
recommendations to ensure errors are minimised; these included waiting a 
sufficient time (~ 1200 ms) for the entire bolus to have reached the tissue. 
To assess transit time effects, the single TI experiment can be repeated at several 
different post-label delays (for example [49, 51]). This allows for mapping of 
perfusion and the transit time, however this method is slow. 
The imaging module used in combination with ASL can be of any type, however 
fast readout methods, such as EPI, are required. The magnetic label decays with 
T1 and hence there is a time limit before the perfusion signal decays to zero. An 
example ASL signal curve is shown in Figure 4-11. The echo-time chosen for ASL 
should be short, to ensure maximum signal change and reduce the contribution 
from BOLD. In addition, St Lawrence and Wang demonstrated that perfusion can 
be underestimated with a long echo time [52]. They concluded that at higher field 
strengths the reduced T2* of blood will reduce the capillary contribution to the 
ASL signal, underestimating CBF. 
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Figure 4-11: Perfusion signal change as a function of post label delay. Simulation parameters 
T1,b = 2.1 s, T1  ? ?Ǥ ?ǡ ? ?Ǥ ?ǡȟtissue = 0.8 s, f = 90 ml/100g/min. 
4.4.2.4 Multiple TI Methods 
As explained above, perfusion of blood into the tissue is a dynamic process, which 
has temporal characteristics that vary between brain regions [49]. Single 
inversion time imaging, as described above, does not take these temporal 
characteristics into account. A Look-Locker (LL) readout [53] allows several 
readouts to be acquired per shot, this method is commonly applied to T1 mapping 
(e.g. [54]) but has been combined with an ASL readout [26, 55-57]. The labelling 
scheme is applied and followed by several low flip angle readouts acquired prior 
to the next labelling module, as shown in Figure 4-12. This has the advantage of 
increased temporal information without increasing the scan time. However the 
application of multiple readout pulses perturbs the recovery of the 
magnetisation, resulting in lower signal and a more complex model for perfusion 
quantification [26, 56].  
 
Figure 4-12: Schematic of the Look-Locker ASL sequence. 
To fit the signal, the signal is modelled using the model in Figure 4-10 A, 
modelling the blood outside the voxel, intravoxel blood and the exchange 
compartment [26]. The signals are modelled in small time increments so that the 
effect of the RF pulses on the signal can be fully modelled as spins could 
experience many RF pulses whilst in the imaging voxel.  
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The blood outside the voxel will be an inversion recovery, and is unaffected by the 
RF pulses: 
Selective 
 ? ? ? ? ? ?ൌ  ? ? ? ?൫ ? െ  ? ? ? ?  ?భ ?್? ൯  ? ൏  ? ? 
4-8 
 
 ? ? ? ? ? ?ൌ  ? ? ? ?  ? ൐  ? ? 
Non Selective 
 ? ? ? ? ? ?ൌ  ? ? ? ?൫ ? െ  ? ? ? ?  ?భ ?್? ൯  ? ൏  ? ?൅  ?  ? ? ? ? ? ?ൌ  ? ? ? ?  ? ൐  ? ?൅  ? 
where t is the time since the inversion pulse, Mb,0 is the equilibrium 
magnetisation of the blood and T1,b is the longitudinal relaxation time of the 
blood. 
The intravoxel arteriolar blood Ɂ
the capillary bed (the exchange compartment).  The magnetisation of this 
compartment, Mb(t) can be described by  ? ? ? ? ? ? ? ?ൌ  ? ? ? ?െ ? ? ? ? ? ? ? ? ? ൅  ? ? ? ? ? ? ?െ  ? ? ? ? ? ?? ? 4-9  
where F is the arterial blood flow, Mout is the magnetisation flowing out of the 
blood compartment into the exchange compartment, this will depend on the RF ɁǤȋȌ	ɁǤ 
The magnetisation in the exchange compartment can be described by the 
modified version of Equation 4-2;  ? ? ? ? ? ? ? ? ? ? ? ? ? ൌ ? ? ? ? ? ? ? ? ?െ  ? ? ? ? ? ? ? ?? ? ? ? ? ? ? ? ? ? ?൅ ? ? ? ? ? ? ? ? ? െ  ? ? ? ? ? ? ? ?? ? 4-10  
where Mtissue,0 ǡɉ the blood:brain 
partition coefficient, Mout is the magnetisation flowing out of the intravoxel 
arteriolar compartment into the exchange compartment and f is the tissue 
perfusion. This compartment is perturbed by the application of the RF pulses and 
each of these must be modelled. 
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Figure 4-13: LLEPI FAIR signals for the arteriolar (broken line) and exchange (solid line) 
ȋȌȀȟ ? ? ? ?Ȁ ? ? ? ? ? ? ?ȋȌ
Ȁȟ ? ? ? ?Ȁ ? ? ? ? ? ? ?Ǥparameters are f = 90 ml/100g/min, F = 180 
Ȁ ? ? ?ǡɁ ? ?Ǥ ?Ǥȟa = 0.4s, W = 1.5s. 
Example LLEPI signals for two different sets of scan parameters are shown in 
Figure 4-13. For CBF quantification the contribution from the blood signal should 
be reduced, and that from the tissue signal increased to improve the fitting for 	Ǥȋ ? ? ?Ȍȟ
(~ 300 ms) so that the tissue signal is not suppressed extensively ensuring 
adequate SNR (Figure 4-13 A). To reduce the blood signal vascular crushing (see 
4.4.2.5) can be used to remove large vessel contributions. 
In addition to measuring CBF LL-ASL has been applied to measure arterial blood 
volume (CBVa) [55]. This uses the blood signal, thus the blood signal needs to be 
maximised and the tissue signal minimised. This is achieved by reducing the 
initial TI (~100 ms), increasing the flip angle (~ 45°) and reducing  ȟ ȋ ?
100 ms). The rapid application of high flip angle pulses suppresses the tissue 
signal, but the blood signal is continually refreshed due to fresh blood flowing in, 
giving high blood signal (Figure 4-13 B) 
An alternative method for Look Locker ASL is the model-free approach of 
Petersen et  al. [57]. Here two scans are acquired, one with and one without the 
use of vascular crushing. The difference signal between the non-crushed and 
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crushed timecourses gives signal that is weighted towards the arterial blood 
volume as the tissue perfusion has been removed: 
 ? ? ? ? ൌ ?  ? ? ? ? ? ? ?? ?െ  ? ? ? ? ? ? ? ?  ? ?  ? ? ? ?ൗ  ? ? ? ? ? ?  ? ? ? ? ?? ?  4-11  
where ȟncr is the perfusion difference signal from the non-ǡȟcr is 
the perfusion difference signal from the crushed data, T1,b is the T1 of arterial ǡ     ǡ Ƚ is the inversion efficiency and M0,b the 
equilibrium magnetisation of arterial blood.  
From the difference signal the arterial input function (AIF) is defined from a 
voxel containing a large artery. The CBVa is used to weight the AIF for each voxel 
to take into account blood volume fraction, then the perfusion is calculated by 
deconvolution of the perfusion timecourse with the local AIF. The method 
estimated grey matter perfusion in healthy volunteers to be 38 ± 2 ml/100g/min 
and CBVa as 0.93 ± 0.06 % which are on the lower bounds of literature values. 
The simulations performed in that study also predicted an underestimation of 
perfusion using this model free approach [57]. 
LL-ASL has been applied to monitor functional changes. Brookes et al. [55] 
investigated the effect of a motor task on CBVa using LL-EPI ASL. Ho et al. have 
looked at the impact of hypercapnia and visual stimulation on blood volume, 
transit time and perfusion [58, 59]. This method has also been applied in patient ǡǤǤǯ[60] ǯ[61]. 
Generally 2D-EPI is used in conjunction with Look-Locker ASL but other 
implementations have been shown. Wang et al. [62] demonstrated at 3 T the 
feasibility of combining a Look-Locker scheme with a FLASH readout for blood 
velocity mapping, and TrueFISP has been incorporated in a LL-readout for kidney 
perfusion imaging at 1.5 T [63].  
4.4.2.5 Vascular Crushing 
ASL is typically used to assess tissue perfusion, rather than the arterial blood 
signal (e.g. [55]). To reduce arterial blood signal contaminating the perfusion 
signal, techniques are used to decrease the contribution from the arterial blood. 
One way is to use a long post-labelling delay so that all the labelled blood has 
moved from the arterial blood into the tissue compartment. However for transit 
time mapping and more accurate perfusion quantification it is common to take 
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several measurements at different post-labelling delays (for example [49]). For 
this, vascular crushing is used to suppress the signal from arterial blood [64].  
Vascular crushing is achieved by applying a bipolar gradient after the RF 
excitation and prior to the readout gradients. Bipolar gradients with two lobes of 
equal duration and magnitude but opposite polarity will cause no resultant phase 
shift of stationary spins. However, moving spins will acquire a phase shift as they 
move during the application of the gradients as they do not experience both 
gradients equally [65]. For spins of a constant velocity the phase shift ? acquired 
during the bipolar gradient pair is linearly proportional to velocity ( ? ൌ ? ?ȟ ? ?,  ɀ    ǡ v  ǡ Ɂ      ǡ
ȟ
the gradient lobes [65]). Hence an expression for the encoding velocity can be 
formed;  ? ? ? ?ൌ  ? ? ? ?ȟ ? 4-12 
 The encoding velocity is the cut-off velocity, above which the spins will be 
dephased (calculated when  ? ൌ  ? ?; below this level the spins will still be visible 
in the final image. Example encoding velocity levels for a 5 ms bipolar pair lobe 
duration and required gradient strengths are shown in Table 4-2. 
Venc [mm s-1] Gradient Strength  
[mT m-1] 
b-value (s/mm2) 
15 31 5.7 
25 19 2.1 
35 13.5 1.1 
50 9.5 0.5 
75 6.3 0.2 
100 4.7 0.1 
Table 4-2: Example encoding velocities for vascular crushing (5 ms lobe duration). Typical 
values used in the experimental work presented in Chapters 5 and 6 shown highlighted. 
4.4.2.6 Saturation Pulses 
Saturation pulses, to null the signal in the imaging plane are applied prior to the 
labelling (pre-saturation) and directly after the label (post-saturation) [28], an 
example scheme is shown in Figure 4-14. The benefit of these pulses is that the 
tissue is always in the same state at the beginning of each TR period, without 
needing a long TR to allow recovery to simplify modelling. In-plane saturation 
can also be used to remove any effects of inversion of the inferior blood spins due 
to imperfect inversion pulse profiles. 
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Saturation can be achieved using sinc or WET (water suppression enhanced 
through T1 effects [66]) pulses. WET uses four RF pulses of different flip angles to 
achieve greater B1/T1 independence. The flip angles are optimised for a range of 
typical T1 and B1. WET pulses have the disadvantage of increased SAR due to 
multiple RF pulses. 
 
Figure 4-14: Schematic of the RF scheme for PASL with WET pre-saturation and sinc post-
saturation pulses with typical timings shown. 
4.4.2.7 Background Suppression 
ASL suffers from low signal as the theoretical signal change due to perfusion is 
only ~ 1 Ȃ 2 % of M0 at 7 T, therefore a number of different methods have been 
suggested to improve the signal-to-noise ratio of CBF measurements. To improve 
the sensitivity of ASL, Ye et al. [67] suggested the use of inversion pulses to 
reduce fluctuations in the static signal which can contaminate the perfusion 
signal. Background suppression (BGS) uses one or more inversion pulses to 
ensure that the static tissue signal is at its null point when the images are 
acquired [68]. Ye et al. [67] demonstrated a substantial reduction, ~ 70 %, in the 
variance in the measured perfusion signal with background suppression as 
fluctuations in static signal were suppressed.  
The timings of the BGS pulses need to be optimised for the post label delay, TI, 
and the longitudinal relaxation time (T1) of the tissue of interest. For example, 
Figure 4-15 shows a tissue recovery curve for grey and white matter at 7 T, 
having been saturated at t = 0. To find the optimum values of TI1 and TI2 the 
solutions of the Bloch equations for the longitudinal component of magnetisation 
are used to model the recovery of the magnetisation between the inversion Ǥ     ?    ǡ ɂǡ 0 and it can be 
shown that 
 ? ? െ  ??? ? ? ? ?൅  ? ? ൌ  ? ? ? ? ? ?െ  ? ? ? ? ? ? 4-13 
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Equation 4-13 can then be used to compute the required TI1/TI2 pairs for 
suppression of a tissue of longitudinal relaxation time T1    ɂ0 at 
time TI. The BGS pulses typically used are such that the data is not acquired as it ȋɂ ? ?Ȍǡ
be performed prior to image subtraction. For example, grey matter at 7 T with a 
post-  ?Ǥ ? ?Ȁ ?  ?  ? ? ?Ȁ ? ? ? ?ȋɂ ?  ?.1, these values are 
used in the experimental work in Chapter 5).  
 
Figure 4-15: Example recovery curves for BGS pulses at 402 and 1041 ms for grey (T1 = 2 s) 
and white (T1 = 1.2 s) matter after pre-saturation. 
 
4.4.2.8 Applications of ASL 
ASL has the major benefit of being a non-invasive technique and is now being 
used in clinical imaging. Wolf and Detre [18] highlighted the benefit of ASL to 
study conditions such as cerebrovascular disease (e.g. stroke), vascular 
malformations, tumours of the central nervous system, epilepsy and in the study 
of degenerative diseases. Pollock et al. [69] discussed the benefit of ASL over 
conventional imaging techniques which may miss some abnormalities due to a 
non-structural origin, for example in epilepsy and migraines. The work presented 
in Chapter 5 shows developments to methodology to allow more flexibility in the 
assessment of patients, and has been used to assess blood flow in Low Grade 
Gliomas. 
4.4.3 CONTRAST AGENTS FOR MR PERFUSION IMAGING  
In this thesis work on T1 mapping at 7 T (Chapter 7) and its application to steady 
state contrast agent monitoring for the measurement of CBV will be 
demonstrated. This section will briefly describe the principles of MR contrast 
agents for perfusion imaging and their clinical benefit. 
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The use of contrast agents is the clinical standard for assessment of cerebral 
perfusion using MRI [70]. ASL has the advantage of being a non-invasive 
technique, however as it is a relatively new technique requiring different scanner 
capabilities and it is not, to-date, a standard clinical tool. Currently contrast 
agents have higher sensitivity and are generally quicker to acquire. A contrast 
agent for MR imaging is commonly a paramagnetic agent e.g. a Gadolinium 
chelate. These are non-diffusible tracers and do not cross the BBB, unless it is 
damaged (as shown by Figure 4-18); contrast agents work by shortening the T1, 
T2 and T2* of the blood. The local tissues can be affected by the contrast agent due 
to susceptibility differences and water exchange occurring between the blood 
and tissue also reducing, also reducing T2/T2* of the tissue by diffusion [71].  
As a free ion Gadolinium is extremely toxic so it is chelated with other 
compounds for administration. The side effects of gadolinium contrast agent 
administration are possible anaphylactic shock due to an allergic reaction or NSF 
(nephrogenic systemic fibrosis) [72] which is a concern for patients with poor 
kidney function. Although, this is very dependant on the particular chelate used. 
There is a linear relationship between the concentration of contrast agent and R1 
(1/T1) which allows for the use of T1 weighted imaging for contrast agent 
monitoring and CBV quantification. There is also a linear relationship with 
change in R2* (1/T2*), which is proportional to the blood volume; allowing for 
CBV quantification. The administration of a contrast agent is typically monitored 
in one of two ways Ȃ dynamic monitoring in time for CBV, CBF and vascular 
permeability measures or steady state for CBV quantification.  
4.4.3.1 Dynamic Measurement  
Dynamic monitoring uses rapidly acquired images with T1 or T2* weighting 
during a quick infusion of contrast agent, to see the contrast agent flow into the 
imaging slice. This can lead to measurement of CBF, CBV (blood volume) and 
MTT (mean transit time). CBV is the fraction of the voxel occupied by blood, MTT 
is the time taken for the contrast agent to pass through the voxel [71]. Using the 
central volume principle CBF can be calculated as 
 ? ? ? ൌ ? ? ? ? ? ? ? 4-14  
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Further temporal parameters including onset time and time to peak can also be 
calculated. 
The draw backs of dynamic contrast agent monitoring include the recirculation of 
the contrast agent which makes it difficult to isolate the first pass curve. A 
measurement of the arterial input function in a major vessel needs to be made to 
calibrate the other CBV values. Measurement of MTT is complicated by bolus 
dispersion caused by the finite duration of the injection Ȃ hence the signal curves 
are normally deconvolved using the AIF (arterial input function, time course from 
large artery Figure 4-16) to counteract this.  
 
Figure 4-16: Example T1 weighted timecourse from an arterial vessel (AIF, solid line) and an 
area of tumour (broken line). Voxel positions shown inset. 
Further analysis can look at rate constants of the transfer of the contrast agent 
using pharmokinetic modelling. For example, Ktrans is the rate constant describing 
the movement of contrast from blood to the tissue of interest. This can be a ǮǯǤ 
Gadolinium uptake curves can also be used to measure vascular permeability. 
Figure 4-17 shows a two compartment model used for contrast agent analysis 
[73]. The two compartments of the blood plasma and extravascular-extracellular 
space are shown, with contrast agent arriving with rate ka and being eliminated 
with rate ke. The rate constants k12 and k21 describe the movement of contrast 
agent between them. 
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Figure 4-17: Two compartment model for contrast agent uptake modelling. k denotes a rate 
constant for the process shown by arrows and Vb/Ve are the volumes of the two 
compartments. Adapted from [73]. 
The net flux of contrast agent into the tissue is  ? ? ? ? ? ? ? ?ൌ  ? ? ?ȉ  ? ? ? ? ?െ  ? ? ?ȉ  ? ? ? ? ? 4-15  
where Ct is the concentration of the agent in the tissue and Cb is the concentration 
in the blood. The solution of this yields 
 ? ? ? ? ?ൌ  ? ? ? ? ? ?න ? ? ? ? ?ȉ  ?౪౨౗౤౩  ?౛ ? ? ? ? ? ?  ? ?  4-16  
where Cp is the concentration in the plasma ( ? ? ? ? ?ൌ  ? ? െ  ? ? ȉ  ? ? ? ? ? , h is the 
haematocrit), Ktrans is ? ȉ  ? ȉ  ? ? െ  ? ? (E is the extraction fraction and F the blood 
flow) and Ve is the extravascular-extracellular volume fraction. Cp and Ct are 
measured during the administration of a contrast agent and Ktrans and Ve can be 
calculated from fitting the data to Equation 4-16. 
4.4.3.2 Steady State Measurement 
Steady state techniques use pre and post contrast images, with several minutes 
between them to allow the uptake of contrast agent. Pre and post contrast images 
show where any gadolinium has been distributed; this can be used for CBV 
calculation. Areas of BBB breakdown (Figure 4-18) will be visible on steady state 
images as the contrast agent will reach the tissue. As this is not a rapid 
measurement, high resolution images, with large coverage can be acquired. 
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Figure 4-18: BBB breakdown shown in MS lesions after gadolinium contrast administration 
(post contrast MPRAGE, 0.8mm isotropic acquired at 3 T). 
4.4.4 MR SPECTROSCOPY 
MRI, generally, uses only the 1H molecule to provide structural and functional 
information. MR spectroscopy (MRS) can be performed to assess the chemical 
contribution of the signal rather than image the structure directly. MRS exploits 
the fact that the resonant frequency of a spin is dependent on the environment 
that it is in. This allows different molecules to be identified by their resonant 
frequency [74], from which metabolite levels and rates of change can be 
measured [4]. 
Proton, 1H, spectroscopy can be used to look at N-acetyl-aspartate (NAA) and 
compounds containing choline, creatine and glutamine, an example spectrum is 
given in Figure 4-19. NAA is thought to be related to neuron density, choline 
containing compound concentrations can be perturbed in disease and glutamate 
is an excitatory neurotransmitter [75]. Phosphorous (31P) is also widely used as it 
can provide information on oxidative metabolism; carbon-13 spectroscopy can 
look at glucose metabolism (through the tricarboxylic acid (TCA) cycle rate [76]) 
but requires administration of a 13C labelled compound due to the low natural 
abundance (1.1 %) [4]. 
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Figure 4-19: Example 1H spectrum from human brain acquired at 7 T, reproduced from [77] 
with kind permission from John Wiley & Sons. 
 
4.5 CONCLUSION 
This chapter has introduced methods for monitoring brain function, through the 
measurement of physiological parameters or through monitoring how the brain 
reacts to performing certain tasks. Arterial spin labelling has been introduced, 
including basic theory and physiological model of the process of measuring 
perfusion non-invasively. Other measures of brain function using MR (BOLD, 
contrast agents and MRS) have been included to illustrate how MR can aid in the 
monitoring of brain function and activity.  
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5 OPTIMISING ASL FOR 7T 
5.1 OUTLINE 
Ultra-  ȋ	ǡ  ?  ? Ȍ       
Labelling (ASL) [1, 2]. The lengthened longitudinal relaxation times of tissue and 
blood [3, 4] mean the peak of the perfusion signal is broader than at lower field 
strength, this coupled with the increased signal-to-noise ratio (SNR) gives 
improved contrast-to-noise (CNR) in the ASL images [2]. However, with this are 
challenges; shortened transverse relaxation time (T2*) causes increased signal 
dephasing, increased specific absorption rate (SAR), greater B0 and B1 field 
inhomogeneities leading to distortions resulting in image artefacts. To take full 
advantage of the increased signal that ultra-high field brings, imaging sequences 
used at 3T have to be modified and optimised for higher field strength.  
In this chapter methods for ultra-high field ASL imaging sequences are discussed. 
The experimental work in this chapter is divided into two main sections. The first 
is the development of ASL readout schemes; including the development of (1) 
high spatial resolution gradient-echo EPI, (2) the use of Balanced Fast Field Echo 
(bFFE) and Turbo Field Echo (TFE) and (3) the implementation of 3D-EPI. The 
second section of the chapter describes Look Locker (LL) multiple post-label 
delay (TI) ASL methods for 7 T imaging. This includes (1) the measurement of 
arterial cerebral blood volume at rest and during motor activation, (2) the 
combination of 3D-EPI with a Look Locker readout for increased high volume 
coverage imaging over 2D-EPI and (3) the assessment of the haemodynamics of 
Low Grade Gliomas with Look Locker TFE. 
5.2 READOUT SCHEMES FOR ULTRA HIGH FIELD ASL 
5.2.1 2D-EPI: EFFECT OF SPATIAL RESOLUTION 
ASL data are generally acquired at coarse spatial resolution, typical in-plane 
resolution ~ 3 mm with 5 Ȃ 8 mm slice thickness (~ 60 µl voxel volume). The 
spatial resolution is restricted by the intrinsically low perfusion-weighted ASL 
signal, of the order of 1 % at 3 T, and the image and temporal signal-to-noise ratio 
(iSNR / tSNR) available at conventional field strengths [5]. At this reasonably 
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coarse sp       ǯ 
thickness, which ranges from 1.5 to 4.5 mm [6]. 
Only a small number of prior studies have collected high resolution ASL data; 
single slice segmented TrueFISP ASL has been acquired at 3 T (1 mm in-plane 
and 6 - 8 mm slice thickness) [7], at 7 T a surface coil has been used to collect 
high resolution EPI data with a limited field of view (FOV) (1.5 x 1.5 x 3 mm3) [8], 
and the use of segmented GRASE has been demonstrated (1.5 x 1.5 x 5 mm3) [9]. 
Duyn et al. [10] demonstrate the feasibility of high resolution (1.5 x 1.5 x 2 mm3)  
ASL data using an EPI acquisition at 3 and 7 T in their study on the technological 
improvements for ASL perfusion imaging. 
Studies using dynamic susceptibility contrast (DSC) MRI [11, 12] and ASL [13-15] 
have suggested partial volume effects (PVE) at low spatial resolution lead to an 
underestimation of grey matter and overestimation of white matter perfusion. 
Partial volume effects arise due to a voxel containing different tissue types; this is 
made worse with coarse resolution/large voxel sizes. Donahue et al. [13] 
compared perfusion measurements (blood flow) made using PET with TILT 
(transfer insensitive labelling technique) pulsed ASL. Data were acquired at in-
plane spatial resolutions of 2.75, 3.0, 3.75, 5.0 and 7.5 mm with 3 mm slice 
thickness. Frontal grey matter (GM) cerebral blood flow (CBF) was found to 
increase from 48.8 to 54.4 ml/100g/min, and occipital GM CBF increased from 
49.3 to 58.3 ml/100g/min with reducing voxel size. These studies are suggestive 
of the benefit of high spatial resolution to avoid confounding results due to PVE. 
In this first experiment high spatial resolution ASL data is collected at 7 T in 10 
minutes using background suppressed, pulsed ASL with a gradient echo EPI 
readout. The feasibility of increasing spatial resolution and the improved cortical 
delineation of the grey matter perfusion weighted signal is demonstrated. 
5.2.1.1 Methods 
Five healthy subjects participated in the study, age 23 ± 3 yrs; all subjects gave 
informed written consent. Procedures were conducted with approval from the 
local ethics committee.  
Data were acquired using a Philips Achieva 7 T system with 16-channel SENSE 
receive coil. A FAIR labelling scheme (selective inversion 10 mm wider than 
imaging volume, 250 mm spatially limited non-selective inversion) employing an 
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optimised FOCI inversion pulse was used with in-plane saturation provided by 
WET (water suppression enhanced through T1 effects) pre-saturation and sinc 
post-saturation pulses [2]. To minimis  ǡ ǯ  
stabilised using foam padding.   
To correct for field inhomogeneities and minimise geometric distortions, an 
image-based shimming technique [16] was used which minimises the magnetic 
field inhomogeneity over a cuboid region within a field map placed over the slices 
of interest.  Field maps were generated using a B0-mapping sequence which 
acquired two gradient echo images at echo times TE1/TE2 of 6/6.5 ms. The   ȋȟɔȌ           ǡ      ȋɀȌ    
calculation of the field offset; ȟ ? ? ? ?ൌ  ? ȉ ȟ ? ?ȉ ȟ ? ? ? ? ? ?   ? ȟ ? ? ? ? ?ൌ ȟ ? ? ? ? ? ȉ ȟ ? ? ? 5-1  
where r is position, and ȟ is the difference in echo time [17].  
ASL data sets were acquired at voxel dimensions of 3 mm isotropic, 2 x 2 x 3 
mm3, and 1.5 x 1.5 x 3 mm3, with FOV = 192 x 192 x 15 mm3. Gradient echo EPI 
images were acquired using SENSE acceleration 2, (TE = 25 ms, 3/5 subjects) and 
a half scan (partial k-space) factor of 0.8 to achieve an echo time (TE) of 16 ms 
(2/5 subjects). An identical TE and a constant bandwidth of 21.2 Hz per pixel in 
the phase-encode direction was used for all spatial resolutions resulting in a 
readout time of 42 (TE = 16) / 51 (TE = 25) ms per slice at each resolution. 
All datasets were reconstructed to 1.5 x 1.5 mm2 in-plane resolution (128 x 128 
matrix) to allow the same grey matter masks to be applied to the different spatial 
resolution data sets for voxel-wise comparison. Ninety two dynamics (~ 10 
minutes) were acquired at 1.5 and 2 mm in-plane resolution, and 52 dynamics at 
the 3 mm in-plane. 
Five contiguous axial slices were acquired in ascending order with minimal 
temporal spacing. ASL data were acquired with a post-label delay of 1550 ms, 
and TR of 6 s per pair. Data were acquired using background suppression [18] 
(inversion pulses at TI1 = 402 ms and TI2 = 639 ms) to limit the effect of differing 
physiological noise contributions across different spatial resolutions [19]. At each 
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spatial resolution a base EPI equilibrium magnetisation image was acquired with 
a long TR.   
In addition an inversion recovery (IR) EPI series was acquired at 1.5 x 1.5 x 3 
mm3 to form a T1,tissue map (data collected with an identical EPI acquisition to the 
ASL data to match geometric distortions, with TI = 100 Ȃ 2500 ms).  
Data Analysis  
At each spatial resolution, ASL data were first pairwise subtracted and averaged 
across dynamics. Difference images ('M) were quantified voxel-by-voxel using 
the general kinetic model (Equation 4-6, assuming 0 transit delay), with M0,blood 
estimated from grey matter (GM) M0,tissue using the blood-brain partition  ȋɉ  ?  ?Ǥ ? ? Ȁ ? ? ?Ȍ, this was done voxelwise to account for image 
inhomogeneities [20], and a value of T1,blood of 2100 ms. IR-EPI data were fitted to 
a 3 parameter mono-exponential recovery for M0,tissue, T1,tissue and inversion flip 
angle and grey matter masks generated from T1,tissue maps. GM voxels were 
identified from the T1,tissue maps by thresholding from 1900 Ȃ 2300 ms. The T1,tissue 
based grey matter mask derived at 1.5 mm was then used to determine the mean 
perfusion rate at each spatial resolution (2 and 3 mm data reconstructed to 1.5 
mm). 
To quantify the effect of spatial resolution on cortical definition, the spatial 
correlation between the perfusion weighted images and the T1 maps was 
assessed using the Pearson correlation coefficient at the three spatial resolutions. 
The T1 map provides high resolution structural information, and high correlation 
coefficients would reflect improved structural information in the perfusion 
weighted images. 
The temporal signal-to-noise (tSNR) was calculated as the mean voxel perfusion 
weighted signal divided by the standard error in the voxel time course. This was 
averaged over the GM mask defined from T1 values. The perfusion contrast-to-
noise (CNR) was calculated from the mean GM perfusion weighted (PW) signal 
divided by the standard error in the white matter (WM) PW signal (WM defined 
as 1200 Ȃ 1400 ms on the T1 ȌǤǯ
at all three spatial resolutions. 
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5.2.1.2 Results 
Figure 5-1 shows example perfusion weighted images acquired at 3 mm and 1.5 
mm in-plane resolution. The expanded sections demonstrate the cortical 
structure that is visible at the two spatial resolutions. It can clearly be seen that 
the high spatial resolution data provides better information on cortical structure 
without significant loss of signal-to-noise.  
The average CBF value for all 5 subjects across the three spatial resolutions is 
shown in Figure 5-2, and summarised in Table 5-1 along with tSNR, CNR and 
correlation measures. The CBF measured at 1.5 mm in-plane is significantly (P < 
0.05) higher than that measured at 2 mm and 3 mm in-plane resolution. 
Temporal SNR decreases with voxel volume, the 1.5 mm tSNR is significantly 
lower than at 2 and 3 mm spatial resolutions. However CNR is improved in the 
1.5 mm data compared to the lower resolutions. Correlation coefficients between 
the T1 map and the perfusion weighted images did not show a trend across the 
resolutions. 
 
Figure 5-1: Perfusion weighted images acquired at 3 mm (green) and 1.5 mm (red) in-plane 
resolutions, demonstrating that high spatial resolution provides improved cortical 
information than the lower spatial resolution data. 
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Figure 5-2: CBF for each subject for all three spatial resolutions. Error bars represent 
standard error across grey matter mask. 
 
  ?Ǥ ?ȋ ?Ǥ ? ?ɊȌ  ?ȋ ? ?ɊȌ  ?ȋ ? ?ɊȌ 
CBF (ml/100g/min) 69 ± 12 + $ 57 ± 8 * 61 ± 8 * 
tSNR 5.5 ± 0.8 + $ 6.7 ± 1.4 * 7.3 ± 1.5 * 
CNR 91 ± 23 + 71 ± 18 * 76 ± 17 
Correlation 
Coefficient 
0.58 ± 0.08 0.54 ± 0.10 0.62 ± 0.08 
Table 5-1: CBF, tSNR, CNR and Pearson correlation coefficient between T1 map and perfusion 
weighted images averaged across all subjects for the three spatial resolutions, (* indicates 
significant difference with 1.5 mm, + indicates significant difference with 2 mm, $ indicates 
significant difference with 3 mm). 
 
5.2.1.3 Discussion 
This study presents high resolution FAIR ASL data collected at ultra-high field (7 
T) with a full field of view using a single shot, gradient echo EPI acquisition. This 
has shown that ultra-high field allows high spatial resolution ASL data to be 
acquired in relatively short acquisition times (10 minutes). 
The improved spatial resolution is shown to provide improved structural 
delineation in perfusion images, this is visually apparent in Figure 5-1. This is 
particularly evident in regions with high surface-to-volume ratios and high 
tortuosity such as the primary somatosensory cortex and the motor cortex. High 
spatial resolution ASL acquisitions in these areas will, for example, allow 
improved assessment of functional changes to somatosensory [21] and motor 
[22] paradigms. This would allow for more strict comparisons of BOLD and ASL 
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contrast fMRI, as highlighted by [23]. The improved spatial specificity associated 
with the high resolution acquisition would benefit clinical studies, and the 
comparison of perfusion data with anatomical information. 
tSNR was shown to reduce with increasing spatial resolution, tSNR reduced by a 
factor of 1.3 between 1.5 and 3 mm, which is less than the 4 fold reduction in 
voxel volume. This is likely due to the reduced partial volume effects at 1.5 mm 
increasing the GM signal. CNR increased at 1.5 mm compared to 2 mm in-plane 
resolution, again likely due to reduced partial volume effects. 
An increase in measured mean GM perfusion at higher spatial resolution was 
found (1.5 mm in-plane: 69 ± 12 ml/100g/min, 3 mm in-plane: 61 ± 8 
ml/100g/min). A similar trend for increased GM perfusion was also shown by 
Donahue et al. [13] who collected 3 T data at spatial resolutions up to 2.5 x 2.5 x 3 
mm3. There was less difference in this study due to small changes in voxel size, 7 - 
27 mm3 compared to the 19 - 169 mm3 range of voxel volumes used in [13]. 
Correction methods have been suggested to correct for partial volume effects at 
coarse spatial resolution to allow the assessment of pure grey matter perfusion. 
However, many proposed correction methods rely on measurement of white 
matter perfusion [24] or an assumed ratio between white and grey matter 
perfusion [14], all of which require accurate partial volume fraction estimation. 
Furthermore, correction methods cannot recover the improved structural 
delineation provided by high spatial resolution data. It is better to acquire the 
data at high spatial resolution for perfusion quantification than to apply post 
processing methods to correct for the coarse acquisition. 
In conclusion, ultra-high field provides improved SNR and perfusion contrast 
allowing ASL data to be collected at high spatial resolution, reducing partial 
volume effects and leading to improved delineation of cortical structure. This is 
likely to have particular applications in defining functional changes, improved 
delineation of borders for stroke and tumour lesions, and the quantification of 
perfusion with ageing due to brain atrophy or in patient groups where cortical 
thickness is reduced.  
5.2.2 COMPARISON OF TFE AND BFFE WITH EPI 
Echo Planar Imaging (EPI) is highly sensitive to B0-inhomogeneities and 
susceptibility effects, resulting in geometric distortions and signal drop out, as 
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discussed in Section 3.4. Furthermore, as spatial resolution (and matrix size) 
increase, the EPI echo time (TE) increases, leading to a reduction in perfusion 
weighted signal [25]. To fully exploit the benefits of 7 T to acquire high spatial 
resolution ASL data, image readout schemes robust to these effects must be 
explored. 
Alternative ASL image readout acquisition schemes include gradient-echo based 
acquisitions such as a Fast Field Echo (FFE or FLASH (fast low-angle shot)) [26], 
Turbo Field Echo (TFE, or TurboFLASH) [27-31], and balanced FFE (bFFE, or 
True-FISP (true-fast imaging with steady-state precession)) [32-37]; spin-echo 
techniques such as SE-EPI [38], RARE (rapid acquisition with relaxation 
enhancement) [39], HASTE (half-Fourier single-shot turbo spin-echo) [40], and 
3D fast spin-echo (FSE) [41, 42]; or combined gradient-echo and spin-echo 
(GRASE) contrast [39, 43]. Spin-echo (SE) techniques are advantageous due to 
reduced susceptibility effects from insensitivity to through-plane gradients. 
However, in-plane distortions and some T2* weighting will remain in SE-EPI, 
particularly at high spatial resolution and UHF due to the shortened T2* and long 
EPI readout (parallel imaging can limit this effect) [8, 44]. In addition, at 7 T SE 
readouts can be limited by SAR [45], particularly when considered in conjunction 
with labelling and background suppression schemes [18]. Single-shot 3D-GRASE 
(gradient and spin-echo) is widely used at 3 T to provide rapid simultaneous 
acquisition of a whole brain volume. However, this uses many refocusing pulses 
and so becomes SAR limited at 7 T, and typically spatial resolution is coarse (> 3 x 
3 x 5 mm3) [43]. Multiple-shot GRASE [46] allows increased spatial resolution at 
the detriment of loss of temporal resolution and stability, and again is SAR 
limited.  
Here, GE-EPI, TFE, and bFFE readout schemes for pulsed Arterial Spin Labelling 
at 7 T are evaluated. ASL data is collected using the three schemes at 2 and 1 mm 
in-plane spatial resolution. Image and temporal SNR (iSNR and tSNR), geometric 
distortions, perfusion-weighted contrast-to-noise ratio (CNR), and absolute 
perfusion quantification (CBF) are quantitatively assessed for each gradient-echo 
readout scheme. 
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5.2.2.1 Methods 
Simulations 
The theoretical iSNR (image SNR) and point-spread function (PSF) of grey matter 
(GM) for each readout scheme (GE-EPI, TFE, bFFE) was simulated at 1 and 2 mm 
spatial resolution assuming a T1 of 2000 ms and T2* of 30 ms for grey matter at 7 
T [3, 47], and sequence parameters given below (Data Acquisition).   
iSNR: For TFE and bFFE the magnetisation at the centre of k-space was modelled 
iteratively accounting for the effect of each RF pulse and relaxation period by 
repeated application of Bloch equations (including start-up echoes). The GE-EPI 
signal at the centre of k-space is simply given by  ? ? ? ? ? ?െ ? ? ? ? ??  ?. Thermal noise 
for TFE and bFFE schemes was scaled according to the acquisition bandwidth of 
each sequence. Simulated iSNR values for all readouts were then scaled to the 
measured iSNR of the GE-EPI acquisition at 2 mm in-plane resolution. 
PSF: For TFE and bFFE, the full width at half maximum (FWHM) of the PSF was 
calculated by ordering the simulated magnetisation in a centric phase encoding 
scheme (including start-up echoes), and performing a discrete Fourier transform 
[48]. The GE-EPI PSF was calculated assuming the GM signal exponentially 
decayed with T2* during the GE-EPI acquisition. All signals accounted for the 
post-saturation pulses in the ASL module resulting in an initial magnetisation of 
M0(1-e-TI/T1) and were convolved with a Riesz filter of width 80 % (to reflect the 
filtering applied by the Philips scanner system to the acquired k-space data) 
before Fourier transforming. A Riesz filter has the form 
 ? ? ? ?ൌ  ? െฬ  ? ? ? ? ?ฬ ? 5-2  
where xmax is the maximum x value. A width of 80 % refers to the middle 80 % of 
the filter being set to 1 (Figure 5-3). 
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Figure 5-3: (A) Riesz filter of the form given by Equation 5-2, (B) Riesz filter as in (A) but 
with a width of 80 %. 
Data Acquisition 
Ten healthy subjects participated in the study and procedures were conducted 
with University of Nottingham ethics approval. Data was acquired on a Philips 
Achieva 7 T system with head volume transmit coil and 16-channel SENSE 
receive coil.  
The FAIR scheme comprised a 25 mm selective inversion (control) and a 250 mm 
wide non-selective inversion (label). WET pre-saturation and sinc post-
saturation pulses [2] were applied around the inversion pulse.  All ASL data was 
collected at a post-label delay (TI) of 1550 ms with an ASL pair collected in a 
TRASL of 6.2 s. 
Image-based shimming [16] was used to correct field inhomogeneities. B0-field 
maps were generated from two interleaved gradient-echo images at echo times 
TE1 / TE2 = 6 / 6.5 ms.  
For each readout scheme, axial ASL data was collected with 192 x 192 mm2 FOV, 
and SENSE factor 2. Images were acquired at two in-plane spatial resolutions: 2 
mm (n = 8) and 1 mm (n = 6), with 3 mm slice thickness for all schemes. Ninety 
ASL pairs (~ 9 min) were acquired at 2 mm in-plane resolution and 125 pairs (~ 
13 min) at 1 mm in-plane resolution. 
GE-EPI Sequence: Multislice (4 slice) single shot gradient-echo-echo planar 
images (GE-EPI) were collected: TE = 10 ms at 2 mm in-plane resolution and TE = 
24 ms at 1 mm in-plane resolution (minimum achievable TE in both cases). The 
acquisition bandwidth per pixel was 29.3 / 10.9 Hz in the EPI phase direction 
(2225 / 1406 Hz in the frequency encoding direction) with a single slice readout 
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time of 30 and 73 ms for 2 mm and 1 mm respectively. GE-EPI ASL data were 
collected with background suppression (BGS) [18] using two inversion pulses at 
402 and 639 ms.  
TFE Sequence: 2 mm and 1 mm data was collected with a single shot TFE readout 
of TE/TR of 2.5 / 5.0 ms, 15° flip angle and centric phase-encoding (to optimise 
perfusion contrast [34]), with six start-up echoes. The acquisition bandwidth was 
506 Hz/pixel, resulting in a total slice readout time of 165/315 ms for 2/1 mm 
data. The acquisition was limited to four slices (with no spacing between slices) 
without BGS due to SAR limits.  
bFFE Sequence: bFFE images were collected with TE/TR of 1.8/3.6 ms and 
2.1/4.1 ms for 2 / 1 mm resolution respectively. An D/2 preparation pulse and 12 
pre-scans were followed by successive alternating50° pulses. The acquisition 
bandwidth was 1642 Hz/pixel with a readout time per slice of 120/260 ms for 
2/1 mm data. A non-segmented acquisition was implemented, and SAR 
constraints limited the acquisition to a single slice with no background 
suppression pulses. A four slice acquisition would require a TRASL of ~11 s/pair 
with a readout spacing of 522 ms between slice acquisitions. 
The slices were positioned in the cortical grey matter for half the subjects 
(superior slices) and an inferior level (level of deep gray matter) for the 
remaining subjects. 
For each readout, tissue equilibrium magnetisation was measured from the base 
images (acquired with long TR). For grey matter segmentation, inversion 
recovery (IR) data was collected at 10 inversion times of 100, 200, 300, 500, 700, 
1000, 1300, 1500, 2100 and 2600 ms, with a TR of 10s. To assess image SNR 
(iSNR), 20 repeats of a scan with zero RF power were acquired to estimate noise 
(noise scaling factors estimated in 1 subject). In one additional subject, 20 
repeats of the base images were acquired to assess temporal SNR (tSNR), 
Data Analysis  
Label and control datasets were subtracted and the resulting images averaged to 
form perfusion-weighted (PW) images. Perfusion maps were created assuming 
all signal arose from the centre of k-space using Equation 4-6, assuming zero 
transit delay. To estimate M0,blood a blood-ɉ  ?Ǥ ? ?
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blood/g tissue was used to correct the equilibrium magnetisation of grey matter 
M0,GM, [20], and T1,blood  assumed to be 2100 ms [49].  
IR data were fitted to a mono-exponential recovery for M0,tissue, T1,tissue and 
inversion efficiency; for each readout, a grey matter mask was then formed by 
thresholding T1 maps from 1900 Ȃ 2300 ms. For each subject, the average 
perfusion signal was found within the grey matter mask. Any voxels in the GM 
mask with an ASL percentage signal change of > 5% (~ 400ml/100g/min) were 
excluded, to remove any voxels with large vessels. 
Grey matter image and temporal SNR (iSNR and tSNR), and perfusion-weighted 
CNR were estimated for each readout scheme. iSNR was defined from S/V, where 
S is the mean GM signal in the base image and V is the mean of the standard 
deviation in the noise image timecourse in a 17 x 17 ROI. tSNR was estimated 
from S/VGM where VGM is the variance in the GM time course of repeated 
acquisitions of the base image. CNR was defined as (SSEL-SNS)GM ȀɐȌ  ȋSEL-
SNS) is the PW signal. The Coefficient of Variation in grey matter perfusion 
(CoVCBF(%)) between subjects was also estimated from the variance in CBF 
between subjects divided by the mean value. All statistical analysis was    ? ?Ǥ	ǯ-Way ANOVA by ranks 
including pairwise comparison (correcting for Type I error) was used for iSNR, 
CNR and CBF comparisons, with a significance threshold of P < 0.05. 
5.2.2.2 Results 
Simulations 
Figure 5-4 shows the simulated (A) theoretical iSNR and (B) FWHM of the PSF for 
grey matter. At 2 mm the GE-EPI readout has the highest simulated iSNR and TFE 
the lowest; whilst at 1 mm spatial resolution the iSNR of GE-EPI is significantly 
reduced to closer to that of bFFE. Considering the point spread function, GE-EPI 
has the narrowest FWHM at 2 mm; at 1 mm spatial resolution all three readouts 
have a similar FWHM.  
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Figure 5-4: Simulations showing (A) theoretical image SNR (all values scaled to measured 2 
mm GE-EPI result) and (B) point spread function FWHM (mm) for the 2 and 1 mm resolution 
data. Simulations assume a low-high acquisition, T1=2000 ms and T2*=33 ms used for grey 
matter and imaging parameters as described in the Methods section (5.2.2.1). 
In-vivo Experiments 
Figure 5-5 shows example base images of GE-EPI, TFE, and bFFE for superior-
inferior planes (data shown for four subjects (i-iv)). GE-EPI images display signal 
dropout, whilst for one subject the characteristic bFFE banding artefact was seen 
(arrows, Figure 5-5). TFE images show less field inhomogeneity effects, but have 
reduced signal compared to GE-EPI and bFFE.  
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Figure 5-5: Equilibrium base magnetisation images acquired at 2 x 2 x 3 mm3 for GE-EPI, TFE 
and bFFE readout schemes. Example data shows a single corresponding slice (of the multi-
slice set for GE-EPI and TFE) for four axial planes (i- iv). 
Figure 5-6 summarises measured iSNR, tSNR, CNR and CBF. At 2 mm spatial 
resolution, the iSNR of GE-EPI was significantly higher than TFE. In addition, the 
tSNR of GE-EPI at 2 mm was significant highly than bFFE, which in turn was 
higher than TFE (P < 0.05, t-test for means for tSNR). This reduction in tSNR in 
the TFE data at 2 mm is reflected in the perfusion maps, Figure 5-7, which was 
significantly higher for GE-EPI than bFFE. For 1 mm data, iSNR was significantly 
larger for GE-EPI than TFE, there was no significant difference between GE-EPI 
and bFFE, or bFFE and TFE. At 1 mm, tSNR was significantly largest for bFFE, and 
GE-EPI significantly higher than TFE (P < 0.05).   
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Figure 5-6: (A)Measured image (iSNR) and (B) temporal SNR (tSNR), (C) perfusion-weighted 
CNR (D) measured perfusion (CBF) for each of the three acquisition methods at both spatial 
resolutions. Mean ± standard error across subjects provided for A, C-D and mean ± standard 
error across grey matter for B. * P<0.05, comparison with GE-EPI; ゆ P<0.05, comparison with 
bFFE; ょ P<0.05, comparison with TFE, Ÿ indicates P<0.05 comparison between the 
resolutions. 
Figure 5-7 shows GE-EPI, TFE and bFFE equilibrium images and corresponding 
quantified perfusion maps for 2 and 1 mm resolution, for both superior and 
inferior planes. The increased iSNR and perfusion contrast (CNR) of bFFE at 
higher spatial resolution is clear. Quantified perfusion values within the GM 
mask, averaged over all subjects, are given in Figure 5-6 D. At 2 mm, the GE-EPI 
readout measured a significantly lower CBF than TFE (P < 0.05) (shown for each 
subject in Figure 5-8 A). Comparing calculated values at 1 mm in-plane 
resolution, the GE-EPI resulted in a large variability across subjects as reflected 
by the high coefficient of variation (CoVCBF, Table 2), and the lowest measured 
CBF value of each of the readouts (Figure 5-8 B); significantly lower than for TFE. 
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Figure 5-7: 2 mm and 1 mm equilibrium magnetisation images and corresponding CBF maps 
calculated for GE-EPI, TFE and bFFE. iSNR and perfusion-weighted 2 mm images shown are 
equivalent slices across the readouts, 1 mm images are the first slice in the multi-slice stack 
to match the post-label delay (TI). 
 
Figure 5-8: (A) Average GM CBF (ml/100g/min) calculated for each readout scheme at 2 mm 
in-plane spatial resolution (n = 8). (B) Average GM CBF (ml/100g/min) for all 6 subjects at 1 
mm in-plane resolution. Data divided to show superior and inferior planes separately. Error 
bars represent standard error in the mean. 
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Comparing readout schemes between 2 and 1 mm spatial resolutions, showed a 
significant reduction in CNR (P < 0.05), iSNR (assessed using Mann-Whitney U 
test, and Bonferroni corrected) and tSNR (t-test for means, Bonferroni 
correction) at 1 mm, as expected. There was also a tendency for CBF values to be 
higher at 1 mm compared to 2 mm for TFE (not significant accounting for 
multiple comparisons). tSNR reduced by a similar amount from 2 to 1 mm for GE-
EPI and TFE (factor > 2.5), and a lower factor  (~ 1.5) for bFFE. GE-EPI had the 
largest reduction in CNR between the resolutions (~ factor 4), whilst TFE and 
bFFE reduced by ~ 2.5, approximately equivalent to the voxel volume.  
Comparing superior and inferior planes, for the 2 mm data no significant 
differences were found in CBF, iSNR or CNR (Kruskal-Wallis, Bonferroni corrected 
for multiple comparisons), although the GE-EPI CNR tended to be lower for the 
inferior plane (not significant accounting for multiple comparisons (P = 0.102)). 
5.2.2.3 Discussion 
Ultra-high magnetic field provides a theoretical increase in perfusion-weighted 
CNR, however increased magnetic field inhomogeneities result, leading to 
geometric distortions and signal loss, meaning these gains may not be fully 
realised for GE-EPI acquisitions. Here GE-EPI, bFFE and TFE ASL readouts were 
compared at 7 T. 
At 2 mm resolution, GE-EPI had higher iSNR than TFE; however, the iSNR of GE-
EPI reduced rapidly with increasing spatial resolution due to an increased echo 
time (despite using parallel imaging). As expected, TFE and bFFE showed 
reduced distortion effects and signal voids compared to GE-EPI, with artefacts 
that appeared reduced compared to images previously shown in the literature 
[32, 33], likely due to the use of parallel imaging. 
Vascular crushing was not used in this study as bipolar gradients would 
significantly lengthen the GE-EPI echo time, and incorporating vascular crushing 
into TFE and bFFE acquisitions is challenging [27, 30]. Instead, a long post-label 
delay was used to limit vascular contributions.  Some vascular signal was visible 
in PW images, to ensure this did not bias average grey matter perfusion values, 
voxels with PW signal > 5 % were excluded. Measured GM CBF was higher for 
bFFE (P = 0.098) and TFE (P < 0.05) than GE-EPI. This may be attributed to the 
short TR of TFE reducing the tissue signal compared to the blood signal, Boss et 
al. [32] reported a similar increase (~15 %) for bFFE from the expected 
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physiological range. The larger difference in values at 1 mm may also be 
attributed to a significant reduction in iSNR of GE-EPI at high resolution, or 
differences in T2* between blood and brain tissue at 7 T [25].  
TFE and bFFE provide the advantage of a short TE. However, slice acquisition 
time is significantly increased compared to GE-EPI (TFE/bFFE/GE-EPI:  2 mm in-
plane 165/120/30 ms; 1 mm in-plane 315/260/73 ms) reducing the number of 
slices which can be collected and leading to different perfusion weighting 
between low and high k-space frequencies, although centric acquisition 
minimises this. A further constraint is that for TFE and bFFE readouts SAR 
limitations are met for a TRASL of 6.2 s, despite using PASL, which has lower SAR 
than other ASL methods (CASL and PASL). These limits prohibited the use of 
background suppression for TFE and bFFE, and multi-slice acquisition for bFFE.  
In conclusion, the choice of readout at 7 T depends on the site to be imaged, 
coverage and spatial resolution required; for large spatial coverage at reasonable 
spatial resolution in areas of low susceptibility GE-EPI is recommend. TFE has 
low CNR, but has low sensitivity to field inhomogeneity and is less SAR limited 
than bFFE, allowing the acquisition of multi-slice data with low geometric 
distortions and signal drop-out in a reasonable temporal resolution. bFFE 
provides a high SNR technique for use when high spatial resolution but limited 
coverage is sought. 
5.2.3 3D-EPI ASL 
2D-EPI is commonly used for the ASL image acquisition due to the short imaging 
time of the EPI readout allowing several slices to be acquired during the peak of 
the perfusion curve. 3D sequences have been noted to be of benefit to ASL due to 
the entire signal from the volume being acquired simultaneously, ensuring that 
each slice in the volume has the same perfusion weighting [50].  
There is a desire for large volume coverage in ASL measures, but this can be 
limited by the need to acquire slices within the peak of the ASL perfusion curve 
for adequate SNR. Wide coverage is important for assessment of vascular 
abnormalities in patients, and functional studies where changes can be 
widespread [51], such as attention and working memory tasks and pain studies 
where areas of interest range from inferiorly in the cerebellum to superior slices 
101 
 
3D-GRASE is the most popular 3D acquisition used in combination with ASL at 
lower field strengths (1.5 and 3 T) e.g. [43, 50]. 3D-GRASE uses a train of 180° 
pulses to form a refocused echo train with both gradient and spin echo contrast. 
Günther et al. [50] compared single slice 2D-EPI with 18-slice 3D-GRASE at 1.5 T 
at a spatial resolution of 2.5 x 3.4 x 6 mm3. SNR in grey and white matter 
increased by a factor of ~ 3 for 3D-GRASE, CBF quantification was unaffected. 
However, the implementation of 3D-GRASE at 7 T is challenging due to the 
shortened T2*, and the necessity to accurately refocus pulses which can be 
difficult to implement due to B1-inhomogeneity, and high SAR. Fast spin echo 
(3D-FSE) has been implemented for ASL-fMRI [53], but again is restricted at 7 T 
by SAR and B1 inhomogeneity. 3D-EPI is becoming widely used for BOLD fMRI at 
3 T [54] and 7 T ([55, 56]) providing improved image SNR, sensitivity and 
temporal SNR compared to 2D-EPI. Poser et al. [55] showed this increased 
sensitivity is more prominent at high resolution (< 1.5 mm in-plane) and further 
benefits from using a  parallel imaging acceleration factor in both readout axes to 
speed up image acquisition. 3D-EPI has not commonly been implemented with 
ASL, Gai et al. [57] demonstrated its advantages at 3 T to produce a 24 slice 
(resolution ~ 3 x 3 x 4 mm3) perfusion map. 
This experiment implements 3D EPI for large volume coverage ASL at 7 T. 
Simulations are performed to assess the impact of the readout parameters on the 
point spread function and perfusion quantification. In-vivo demonstrations of the 
optimised sequences are provided. 
5.2.3.1 Methods 
A schematic of the 3D-EPI sequence is shown in Figure 5-9. There is a train of 
small tip angle RF pulses, separated by a time TR. After each pulse a plane of Kz 
space is acquired, this is repeated until the whole of 3D k-space has been 
sampled. 
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Figure 5-9: Schematic of 3D-EPI ASL acquisition, showing the pre-sat, label and post-sat of 
the ASL scheme followed by the 3D-EPI acquisition. In 3D-EPI, after each RF pulse a plane of 
Kz space is acquired and this is repeated Nz times until the entirety of 3D k-space has been 
sampled. 
5.2.3.1.1 Simulations 
The effects of the sequence parameters on image quality (e.g. blurring) and 
perfusion quantification were theoretically assessed. The signal for the 3D-EPI 
readout can be formed by solving the Bloch equations. The measured transverse 
signal can be shown to be;  ? ? ? ?  ?ൌ  ? ? ? ? ?   ? ? ? ?  ?ൌ ൭ ? ? ? ?  ? ? ? ? ? ? ? ? ? ?൬െ ? ? ? ?൰ ൅  ? ? ? ? െ ? ? ?൬െ ? ? ? ?൰ ?൱  ? ? ?  ڭ  ? ? ? ? ? ?ൌ ൭ ? ? ? ? ? െ  ?? ? ? ? ? ? ?  ? ? ?൬െ ? ? ? ?൰ ൅  ? ? ? ? െ ? ? ?൬െ ? ? ? ?൰ ?൱  ? ? ? ? 
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for n > 1, where Mxy is the transverse magnetisation after pulse n, Ƚ
flip angle and TR is the time between readout pulses. This assumes complete 
spoiling of the transverse magnetisation between readout pulses.  
It was assumed that there were 23 RF pulses per 3D-EPI block and that TE = 10 
ms for both 2D and 3D acquisition of 2 mm in-plane resolution for a 192 x 192 
mm2 FOV with 25 slices. K-space was acquired in a centric ordering with 
Cartesian sampling. 
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Point Spread Function 
The point spread function (PSF) of the 2 x 2 x 3 mm3 3D-EPI readout was 
investigated by simulating the signal of a point source in k-space using rotation 
and relaxation operators to model the effect of the train of RF pulses assuming a 
centric k-space acquisition. The k-space signal was Fourier Transformed to give 
the signal in image space. The PSF was interpolated and the full width at half 
maximum (FWHM) of the PSF used to assess blurring; the effects of the 3D-EPI 
parameters of flip angle (10° - 20°) and TR (5 - 30 ms) on the PSF were simulated. 
 Effect of a 3D-EPI readout on Perfusion Quantification 
The nature of the 3D-EPI acquisition (introduced in Chapter 3) will cause the ASL 
perfusion signal to vary through the acquisition i.e. planes of kz space will have 
different perfusion weighting. Simulations were performed to assess this effect 
on perfusion quantification for a FAIR labelling scheme. The ASL perfusion signal 
was modelled using a three compartment model (compartments comprising 
blood outside imaging voxel, blood within voxel and tissue within voxel) as 
described in Francis et al. [58] for a Look-Locker readout scheme (simulation 
parameters summarised in Table 5-2).   
The model was adapted to estimate the transverse signal through k-space for the 
3D-readout, by Fourier transforming the k-space signal the image can be formed. 
The k-space signal following the selective and non-selective signals were each 
simulated, and then subtracted and Fourier Transformed to provide the 
difference signal in image space. Due to the linearity of the Fourier transform the 
order of subtraction/Fourier Transform is inconsequential. The peak magnitude 
of the FT is taken to be the measured signal.   
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Parameter Value 
Perfusion rate, f (ml/100g/min) 90 
Longitudinal relaxation time of grey matter, T1 (ms) 2100 
Longitudinal relaxation time of blood, T1b (ms) 2100 
Equilibrium magnetisation, M0 1 
Bolus duration, W (ms) 1500 ǣǡɉȋȀȌ 0.98 ɁȋȌ 400 ȟȋȌ 400 
Blood volume, CBVa (ml/100g) 1.2 
Grey matter transverse relaxation rate (ms) 33 
Single-TI post labelling delay (ms) 1500 
Table 5-2: Parameters used for 3D-EPI simulations. 
To quantify perfusion, the fractional signal change relative to tissue equilibrium 
magnetisation, M0ǡ       ǡ ɉǡ 
calculated. The fractional signal change was calculated by simulating 
measurement of M0 using 3D-EPI, simulated as described above. The relative 
signal change for a 3D-  ȋȟȀ0)3D, was then compared to that of a 
2D-ȋȟȀ0)2D with 90° flip angle, to examine the effects of fitting the 
3D data with a model typically used for a 2D acquisition. 
5.2.3.1.2 In-Vivo Study 
Two healthy volunteers were scanned with the optimised readout parameters; 2 
x 2 x 3 mm3, FOV = 192 x 192 mm2, matrix 96 x 96, TR/TE = 26/11 ms, SENSE 
reduction 3.5 (P)/ 1.5 (S), partial Fourier factors 0.879 (Y) / 0.9 (Z), linear phase 
encode order, flip angle 14° and bandwidth of 2538 Hz in EPI frequency direction 
(38.2 Hz/pixel). With these optimised parameters, the number of encoding steps 
and duration of the readouts is summarised in Table 5-3 for a range of 3D volume 
coverage values. 
Number of Slices Number of Encoding 
Steps 
Duration of Readout / 
ms 
8 7 181 
12 11 283 
16 13 334 
20 17 437 
24 21 539 
Table 5-3: Number of encoding steps and acquisition length for optimised 2 x 2 x 3 mm3 3D 
EPI acquisition 
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5.2.3.2 Results 
5.2.3.2.1 Simulations 
Point Spread Function: The FWHM of the PSF was largely unaffected by changes 
in TR, except at the larger flip angles (> 16°). The PSF broadened as flip angle 
increased leading to image blurring as demonstrated in Figure 5-10 A. The PSF 
can be seen to increase at larger flip angles due to increased signal decay across 
the readouts, the largest flip angle whilst remaining within a reasonable point 
spread function was chosen. Thus, a 14° flip angle was used for all 3D-EPI 
readouts.   
Effect of 3D-EPI readout on Perfusion Quantification: The simulations 
demonstrate a tendency for the 3D-EPI acquisition to lead to an overestimation 
of the fractional signal change. Figure 5-10 B shows the dependence of this 
overestimation in fractional signal change on flip angle and TR. For a given TR, 
varying the flip angle from 5 - 20° resulted in a small difference (~ 2 %) in the 
accuracy of perfusion quantification. Varying TR had a larger impact, with 
perfusion being further overestimated as TR increased (resulting in a lengthened 
readout train).  
 
Figure 5-10: (A) Full width at half maximum (FWHM) of the point spread function (PSF) for 
the 2 mm in-plane readout and (B) error in the perfusion estimation of 3D-EPI readout as a 
function of flip angle and TR. 
These simulations demonstrate that the TR should be kept to a minimum to 
reduce errors in perfusion quantification and that the flip angle should be around 
14° to reduce image blurring whilst providing adequate SNR. 
5.2.3.2.2 In-Vivo Study 
The quality of the 3D-EPI base images is shown in Figure 5-11, the signal and 
contrast is consistent across the majority of the slices. The lowest slices show 
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lower signal due to the extent of the coil Ȃ also seen in the scout image is the 
signal drop off due to the coil. 
 
Figure 5-11: Example 3D-EPI base images, scout image with slice coverage shown inset. 
Images acquired at 2 x 2 x 3 mm3, with a readout duration of ~ 500ms. 
 Figure 5-12 shows perfusion weighted 3D-EPI images acquired with two 
different slice positions, firstly with imaging volume and selective inversion 
centred within the brain in the foot-head direction, and secondly the imaging 
volume was moved upwards such that the slice selective inversion extended 
outside of the head. Artefacts were found to be associated with the selective 
being within the head as highlighted by white arrows. These artefacts are only 
present in the difference images; they are not visible in the label or control 
images. This is likely to be due to slight image wrap in the foot-head (FH) 
direction. This can be eradicated by widening the selective slab such that it 
extends out of the top of the head in the superior direction (Figure 5-12 B).  
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Figure 5-12: Perfusion weighted images where the selective slab is (A) inside the head 
(dotted box represents widening the selective inversion to reduce image artefacts) and (B) 
outside the head due to the stack being moved upwards. White arrows indicate position of 
artefact. 
Figure 5-13 shows the perfusion weighted images obtained from the optimised 
3D-EPI readout (2 x 2 x 3 mm3, FOV = 192 x 192 mm2, matrix 96 x 96, TR/TE = 
26/11 ms, SENSE reduction 3.5 (P)/ 1.5 (S), partial Fourier factors 0.879 (Y) / 0.9 
(Z), flip angle 14°). The added benefit of the 3D acquisition is the ability to reslice 
the data into coronal and sagittal views as each axial slice has the same perfusion 
weighting. The images show the extent of the slice coverage, with inferior 
coverage of the occipital cortex up to more superior coverage of the motor cortex. 
 
Figure 5-13: 3D-EPI perfusion weighted images shown as (A) all 23 axial slices and (B) 
coronal, sagittal and transverse views. Scan parameters  2 x 2 x 3 mm3, FOV = 192 x 192 
mm2, matrix 96 x 96, TR/TE = 26/11 ms, SENSE reduction 3.5 (P)/ 1.5 (S), partial Fourier 
factors 0.879 (Y) / 0.9 (Z), linear phase encode order, flip angle 14°. 
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5.2.3.3 Discussion 
Figure 5-13 shows the high quality of 3D-EPI ASL perfusion weighted images 
feasible at 7 T. These images show very good spatial coverage, with good image 
quality even in inferior slices towards the end of the RF coil. Artefacts that were 
initially seen were removed by widening the FAIR selective slab thickness slightly 
to encompass the top slices of the brain (represented by dotted box in Figure 
5-12 A), this will cause the magnetisation transfer effects to differ between the 
selective and non-selective but this effect will be minimal. With the optimised 
parameters coverage is 72 mm, which covers the majority of the cortex of the 
brain (excludes cerebellum).   
A previous implementation of 3D-EPI for perfusion imaging suggested 
modulating the readout flip-angle along the train [57]. This has also been 
suggested for MPRAGE [59] and FSE [60] anatomical imaging to reduce image 
blurring due to the reduction in signal for the outer lines of k-space (shown in 
Figure 5-14 A). By modelling the RF pulses it can be shown that to maintain the 
signal in the pulse train at a constant level the flip angle must be modulated in the 
following way;  
 ? ?ൌ  ? ?ۉۈ
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for n > 1 where fn is the flip angle of the nth pulse, mxy is the transverse signal 
being maintained which is dependent on the initial flip angle chosen ( ? ? ?ൌ ? ? ? ? ?), M0 is the equilibrium magnetisation, TR is the time between RF 
pulses and T1 is the longitudinal relaxation time of interest. For a TR of 30 ms and 
T1 of 2 s, starting at 14°, the 19th pulse would be 52°, beyond that it is not possible 
to maintain the signal at that level (shown in Figure 5-14 B). 
Modulating the RF pulse not only restricts the number of slices that it is possible 
to collect when trying to maintain the signal, but it will also increase SAR due to 
the large increase in flip angle. In addition the first few flip angles step up by less 
than one degree Ȃwhich would be difficult to implement in practice. The accuracy 
of achieving such specific flip angles, especially at high field, would be extremely 
difficult and signal decay will not be eliminated. Figure 5-14 A demonstrates the 
effect of B1 inhomogeneity on the k-space signal. The shaded region indicates 
how the signal could vary if there was a ± 20 % error in the flip angle. This 
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demonstrates that due to the high flip angles required at the end of the train the 
signal could deviate significantly from the ideal. Initial point spread function 
simulations and acquired data are indicative of minimal blurring. Therefore the 
use of modulated flip angles was not further pursued.  
 
Figure 5-14: (A) Transverse signal due to constant flip angle (Ÿ) and modulated flip angle 
(Ŷ), the flip angle has been rounded to an integer causing small signal oscillations. Shaded 
areas indicate signal where the flip angle achieved has an error of ± 20 % (B) Theoretical 
modulation of flip angle required to maintain the signal shown in (A). 
3D-EPI provides a fast way of achieving large volume coverage suitable for 
perfusion imaging. This is faster than the equivalent 2D-EPI acquisition as SENSE 
acceleration can be applied along both readout directions, as can partial Fourier 
acquisition. Further gains of a 3D-EPI scheme are that the perfusion weighting is 
identical across the slices as both the background signal and underlying 
perfusion signal are not altered across the readout volume.  
5.3 LOOK LOCKER ASL: ACQUISITION SCHEMES AND APPLICATIONS 
The standard methodology for ASL is to acquire an image at a single post-label 
delay (TI), by modelling the transit of labelled spins the perfusion can be 
estimated. However, as demonstrated in Gallichan et al. [61] the perfusion 
timecourse across brain areas is very different due to the different tortuous 
routes of the labelled blood from vessels in the neck to the tissue bed, causing the 
labelled blood to arrive at very different times. For example, the arrival time in 
the caudate nucleus and putamen is approximately 0.2 s but this is increased to 
nearer 1 s in the occipital regions [61]. 
Single TI ASL methods to account for such delays, such as QUIPSS/QUIPSSII [62], 
aim to remove such transit time dependence by applying an additional saturation 
pulse to define a fixed bolus. However, repeating the ASL acquisition at different 
post-label delay times allows for a better model fit by accounting for the different 
temporal characteristics. However, this lengthens the total scan time making it 
less appropriate in some studies, for example in patients where movement is an 
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issue. The development of Look-Locker methods for 7 T imaging is important to 
allow for transit times to be taken into account whilst benefitting from the 
increased SNR and lengthened T1. 
Look-Locker (LL) techniques [63] proposed for use with an ASL labelling scheme 
include the work of Francis et al. [58], Günther et al. [64] and Petersen et al. [65] 
for the measurement of perfusion and transit times. These can be also referred to 
as QUASAR [65] or multi-phase ASL [66] and the pulse sequence is shown 
schematically in Figure 5-15. Brookes et al. [67] used LL-ASL to measure arterial 
cerebral blood volume (CBVa), as opposed to cerebral blood flow (CBF). These LL 
based methods allow for temporal characteristics, e.g. arrival time and transit 
time, to be found in addition to CBF. This can be particularly useful for functional 
studies or in patient studies where the transit time is thought to be disrupted. 
Currently LL-based ASL methods have been applied in healthy people to 
investigate visual stimulation [68] and combined visual stimulation/hypercapnia 
[69]ǡȋǤǤǯ[70]). 
 
Figure 5-15: Schematic of Look-Locker ASL. TI is the post-ǡȟ
interval or time between readouts and N is the total number of readouts. 
The following describes the development of three Look-Locker based 
methodologies for 7 T which build on the readout schemes developed for ASL in 
Section 5.2; (1) The measurement of arterial cerebral blood volume (aCBV or 
CBVa) using Look-Locker FAIR with a 2D-EPI readout; (2) The combination of 
Look-Locker FAIR with a 3D-EPI readout scheme to increase volume coverage; 
(3) The study of perfusion using Look-Locker with a TFE readout and 
applications in patients with low grade gliomas. 
5.3.1 MEASUREMENT OF ARTERIAL BLOOD VOLUME USING LLEPI FAIR 
When using MRI, studies of brain activation commonly use BOLD fMRI due to the 
high SNR of the technique allowing high spatial and temporal resolution data to 
be collected. CBF, assessed using ASL, is advantageous for functional assessment 
due to the measurement of a physiological quantifiable value. Initially the arterial 
cerebral blood (CBVa) signal was not thought to be of interest as it was assumed 
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that the predominant change occurred in the venous CBV (CBVv) due to a 
ballooning of the elastic vessel walls [71]. However a study by Lee et al. [72] 
demonstrated that in fact the arterial blood volume changes on activation (up to 
a 60 % increase due to hypercapnia, accompanied by only a 10 % change in 
CBVv). Measurement of CBVa has now become an important measure for 
understanding fMRI changes. This study demonstrates the measurement of CBVa 
at ultra high field (7 T) using Look-Locker ASL, and applies the technique to 
assess the effect of a motor task on CBVa and transit time. 
5.3.1.1 Methods 
Theory 
It has been shown that CBVa can be measured using a Look-Locker ASL scheme, 
as outlined in Chapter 4. For the Look-Locker EPI sequence to be sensitive to 
arterial blood volume the signal from the tissue compartment must be 
suppressed. This can be achieved using closely spaced high flip angle pulses (~ 
45° - 50°) in contrast to lower flip angles (~ 35°) used in the measurement of CBF 
[67]. Also, since the arterial blood signal arrives quickly at the imaging slice 
leading to a short transit delay, the initial post label delay must be short (~ 150 
ms) to adequately sample the inflow of the arterial blood signal. 
The model of Brookes et al. [67] used a compartmental model to iteratively 
model the effect of the RF readout pulses in three compartments; the blood 
flowing into the voxel, the blood in the voxel and the perfusion into the tissue. 
This allows for measurement of CBVa from estim  Ɂǡ    
remains in the voxel, and F, the bulk flow as  ? ? ? ? ൌ ? 5-5 
Further parameters in the model include the bolus duration (W) and the time for ȋȟa). 
Data Acquisition 
Data were acquired using a Philips Achieva 7 T system with a head volume 
transmit and 16-channel SENSE receive coil. Volunteers were positioned in the 
scanner and foam padding was used to minimise head motion during scanning. 
To correct for field inhomogeneities and minimise geometric distortions in the 
EPI images, a parcellated shimming technique [16] was used. Field maps were 
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generated using a standard B0-mapping sequence, which acquired two gradient 
echo images at echo times TE1/TE2 of 6 / 6.5 ms.  
Baseline Study: 4 healthy volunteers took part in the initial study (3 female, 1 
male, 24 ± 3 years old). A Look-Locker EPI FAIR sequence was used with a 
selective inversion thickness of 13 mm and a 230 mm spatially limited non-
selective inversion. Optimised FOCI pulses were used for labelling, together with 
an optimised WET (water suppression enhanced through T1 effects) pre-
saturation and sinc post-saturation scheme for in-plane saturation. 
Data were collected with 192 x 192 mm2 FOV, SENSE acceleration factor of 2, half 
scan partial factor of 0.8, LLEPI readout flip angle 45°ǡ ? ? ? ?ǡȟ ? ? ? ?ǡ
TE = 10 ms, 21 phases per TR with a TR of 4.8 s per tag/control pair (see Figure 
5-15). Images were acquired with a resolution of 2 x 2 x 3 mm3. 15 contiguous 
axial slices were acquired. A 15-slice LLEPI-FAIR acquisition was achieved by 
acquiring one slice per dynamic, and the slices acquired sequentially (as shown in 
Figure 5-16 for the motor task). 150 dynamics were acquired in 12 minutes this 
gave 10 averages for each of the 15 slices. Only 10 averages were collected due to 
the high SNR from the blood signal. A base EP image with TR = 10 s was acquired 
for M0 estimation. 
 
Figure 5-16: Schematic of the aCBV functional paradigm. Numbers 1-5 represent the slice 
acquired (each slice, represented by a block, takes 4.8s to acquire). Shaded blocks denote 
the periods of finger tapping, unshaded blocks represent the rest periods. 
Motor task: 6 healthy subjects participated in the study, 4 females and 2 males, 
age 27 ± 5 years. A BOLD localiser scan was used to localise the motor cortex and 
so identify the slices for the functional task during perfusion data acquisition. The 
BOLD localiser comprised of 4 cycles of right handed finger tapping, 24 s tapping, 
and 24 s rest. A visual prompt was used to queue the subject to the finger tapping ǡǮ ?ǯǮǯ
fingers on their right hand. BOLD data was analysed on-line using IView-BOLD 
software to locate areas of motor activation. The EPI readout scan parameters for 
the BOLD localiser were as for the baseline study but with TE = 25 ms and 21 
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contiguous axial slices acquired. Look-Locker ASL scan parameters were identical 
to those used for the baseline study except:  180 tag/control pairs were acquired, 
1 slice (2 subjects) or 5 (4 subjects) contiguous axial slices were acquired. The 
functional paradigm during which perfusion data was acquired was a right 
handed finger tap with 10 cycles of 33.6 s tapping and 52.8 s rest (shown 
schematically in Figure 5-16). 
Data Analysis 
Baseline study: Label and control data were subtracted, visually inspected for 
motion and data averaged across the dynamics. The perfusion weighted images 
were then fitted to the model of Brookes et al. [67] ǡȟa and Ɂ (assumed W is infinite and that tissue signal is suppressed). M0,b 
was estimated from the base image intensities in a major vessel. It was assumed 
that T1,b = 2100ms. 
Motor task: Label and control data were subtracted, visually inspected for motion 
and data averaged across rest and active time periods to give perfusion weighted 
images at both rest and on activation. The rest and active data sets were then 
fitted separately, in a similar manner to the data collected in the baseline study. 
Spatial smoothing of 3 mm and a high pass temporal filter of 5 * TR, and FILM 
prewhitening was performed prior to GLM analysis (FEAT, FSL, FMRIB, Oxford, 
UK) to identify the activate motor region. For the CBVa data, the mean of the 1st 
eight phases was entered into the GLM. For BOLD analysis, the last phase of the 
control data was used, giving the same temporal resolution of 4.8 s for BOLD and 
CBVa measurements. Statistical maps were thresholded at Z > 2.3 with a cluster 
threshold of P < 0.05 to form an ROI of the motor area. The CBVa and transit time 
was calculated at rest and during activation, by taking the average of the CBVa 
and transit time maps in this motor ROI. Differences in CBVa and transit time 
between activation and rest were assessed using a non parametric Wilcoxon sign 
rank test. 
Correlation analysis was also performed on the functional data. The correlation 
coefficient between the stimulus convolved with a Poisson haemodynamic 
response function and the fMRI data was taken (Correlate, MEDX). Maps of the 
correlation coefficient for CBVa and BOLD data were produced. 
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The average CBVa in the grey matter and the major vessels was found from the 
baseline study and the rest periods of the motor task. Grey matter was defined as 
voxels which had a signal change between 0.5 and 5 % in the 7th readout phase, 
as by this readout time (750 ms) the early large vessel blood signal has dissipated 
and only small vessels in grey matter remain. A vessel mask was defined from 
those voxels with a signal change > 3 % in the 2nd phase images. The average 
LLEPI timecourses for the grey matter and vessels was also calculated and the 
mean CBVa and transit time estimated. 
5.3.1.2 Results 
An example single slice LLEPI perfusion weighted image across the 21 phases (1 
of 15 slices shown) is shown in Figure 5-17. The first few phases clearly show 
vessels (for example, along the midline).  
 
Figure 5-17: Example perfusion weighted LLEPI-CBVa data (1 of the 15 slices shown). The 
effective post labelling delay is given beneath in ms. 
The fitted multislice maps of CBVa are shown in Figure 5-18 for the 4 subjects 
scanned for the baseline study. As each slice was acquired in a separate dynamic 
with the same timings, the final images can be re-sliced into three orthogonal 
views. The grey matter clearly shows high CBVa values in the cortex, with vessels 
displaying very high CBVa values. An example LLEPI timecourse for the grey 
matter and arterial vessels is shown in Figure 5-19, it can be seen that the blood 
arrives and leaves the large vessels much sooner compared to grey matter voxels, 
with a much larger amplitude signal change. 
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Figure 5-18: Resting CBVa maps for each of the 4 subjects scanned for the baseline study. 
Four axial slices shown along with a sagittal and coronal view. 
 
Figure 5-19: CBVa weighted LL-EPI timecourses from grey matter (blue) and large vessels 
(red). Data is shown subject averaged ± standard error. ǡȟa Ɂ ? ?
are shown in Figure 5-20. The subject average grey matter CBVa was 3.0 ± 0.1 %,  ?Ǥ ? ? ?Ǥ  ?Ǥȟa was 145 ± 11 and 79 ± 
4 ms for grey ǡɁ ? ? ? ?  ? ? ? ? ? ?
ms respectively. CBVa was significantly (P < 0.05) higher in vessels compared to ǡȟa  Ɂȋ ? ?Ǥ ? ?Ȍ
expected. 
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Figure 5-20: Results of the baseline CBVa measurements for all 10 subjects, (A) CBVa and (B) 
ȟa ɁǤ
metrics (Wilcoxon sign rank test, P < 0.05). Error bars represent standard error across 
subjects. ȟa ɁFigure 5-21. These demonstrate that the     ȋȟa  ɁȌ       
regions, and watershed areas. ȟa Ɂǡ
likely due to be an artefact of the low signal to noise in the white matter. 
Additionally the spatial maps of ȟa Ɂ show similarities, this could be due to 
physiology or dependence of the two parameters in the data fitting. 
 
Figure 5-21ǣȋȌȟa ȋȌɁǤǤ 
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Motor Task 
One subject did not exhibit a significant BOLD response to the motor task, so was 
excluded from further data analysis. 
An example of the regions active in response to a unilateral motor challenge is 
shown in Figure 5-22 for both CBVa and BOLD data for a single representative 
subject. This demonstrates that the CBVa activation is more localised than the 
BOLD. In addition, BOLD activation is typically seen in the supplementary motor 
area (SMA) in addition to the primary motor cortex.  
 
Figure 5-22: Active motor regions from GLM analysis of BOLD (red) and CBVa (blue) 
timecourses. Representative subject shown. 
BOLD is more adversely affected by temporal fluctuations than CBVa, since the 
CBVa analysis is a subtraction technique this is more robust to low frequency 
temporal noise effects as the subtraction acts as a high pass filter, as 
demonstrated by a correlation analysis to detect motor activity, Figure 5-23, 
where the BOLD activity correlation maps show large fluctuation in the 
background compared to the CBVa correlation maps. The correlation analysis 
supports the fact that the CBVa activation is more localised, and that the smaller 
ROI in Figure 5-22 is not only be due to reduced SNR as the peak correlation 
coefficients are 0.84 for CBVa and 0.72 for BOLD. 
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Figure 5-23: Correlation coefficient maps from correlation analysis to locate motor activity 
in (A) BOLD and (B) CBVa data. 
Figure 5-24 shows the LLEPI timecourse from the CBVa GLM motor ROI averaged 
across the 5 subjects. This shows a clear difference in peak height and delay 
between rest and activation, with the fitted parameters shown in Figure 5-25. 
CBVa increased significantly on activation by 36 ± 4 %, from 2.0 ± 0.5 % to 2.7 ±  ?Ǥ ? ?ȋ ? ?Ǥ ? ?ȌǤǡȟa  ? ? ? ? ?ȋ ? ?Ǥ ? ?ȌɁ ? ? ? ?ȋ ? ?Ǥ ? ? ?ȌǤ 
 
Figure 5-24: Subject averaged CBVa weighted timecourses in the CBVa motor ROI during rest 
(blue) and finger tap (red). Error bars represent standard error across subjects. 
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Figure 5-25: Subject averaged results for the motor experiment. Significant differences were 
found between rest and activation for ȟa assessed using a Wilcoxon sign rank test 
(P < 0.05). Error bars represent standard error across subjects. 
5.3.1.3 Discussion 
This experiment has shown the feasibility of the measurement of arterial cerebral 
blood volume at 7 T using Look-Locker EPI ASL. The increased SNR at 7 T has 
allowed high spatial resolution data of 2 x 2 x 3 mm3 to be acquired, with only 10 
averages required to measure CBVa, taking less than 50 s to acquire a CBVa map 
per slice. 7 T has allowed an increase in the spatial resolution of CBVa 
measurements, 2 x 2 x 3 mm3, compared to those used at lower fields (e.g. 3.75 x 
3.75 x 7 mm3 [65], 3 x 4 x 6 mm3 [67]).  
A grey matter CBVa of 3 % was found which is comparable to that of 2.8 % found 
by Brookes et al. using this same method at 3 T [67]. Vessel CBVa was found to be 
9.2 %, again in agreement with the previous value of 9.3 % in Brookes et al. 
Significant differences in transit time between grey matter and large vessels, with 
blood arriving quicker and exchanging quicker in the large vessels compared to 
grey matter was found, as expected. At the increased spatial resolution used here 
the vessel CBVa is anticipated to be higher as partial volume effects are reduced 
compared to [67] (3 x 4 x 6 mm3). This was not seen, however the method of 
defining vessel ROI were different between the two studies. Here vessels were 
defined from those voxels which had high signal changes at TI = 250 ms, whereas 
in [67] 10 voxels containing vessels were manually selected. The method used 
here will include more voxels and those containing smaller vessels will be 
included, reducing the average CBVa. 
Subjects showed a large increase in perfusion weighted signal in the motor cortex 
on activation (Figure 5-24). An average increase in CBVa of 36 ± 4 % was 
measured upon activation, which corresponds well with the 33 ± 14 % measured 
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at 3 T, in addition to the increase in CBVa, a significant reduction ȟa by 26 ± 6 
% (P < 0.05) was seen. 
In this study only the steady state effect of activation on CBVa was studied. An 
extension of this would be to assess the temporal dynamics of the CBVa response 
to the motor task as in a previous study [67] it was shown that the CBVa 
undershoots after stimulus cessation.. Due to the acquisition method for multiple 
slice functional LLEPI data used here, the temporal dynamics would be difficult 
as there will only be one measurement at each time point, reducing SNR and 
fitting accuracy.  
5.3.2 LOOK-LOCKER 3D-EPI 
Current implementations of Look-Locker ASL are limited in slice coverage, as the 
entire multi-slice data set must be collected in the short time between the 
multiphase readouts (generally < 300 ms for CBF measurement). Previous 
studies have typically acquired a maximum of 7 slices [70, 73, 74], and so whole 
brain coverage can only be achieved by increasing slice thickness (> 6 mm) and 
including a slice gap. However this is detrimental as areas are missed and partial 
volume effects increase. 
This study combines 3D-EPI with a multi phase readout, providing the advantage 
of higher volume coverage per unit time compared to Look-Locker 2D EPI. The 
optimisation of the 3D-EPI readout previously performed in Section 5.2.3 is used 
here to demonstrate the feasibility of Look Locker 3D-EPI ASL. 
5.3.2.1 Simulations 
Using the model of Francis et al. [58] the Look Locker signal for the 3D-EPI 
readout was modelled. The haemodynamic parameters for all simulations were F 
= 180 ml/100g/minǡ   ?  ? ?Ȁ ? ? ?ȀǡɁȀȟa/W = 400 / 400 / 1500 ms with 
T1,b/T1,t = 2.1 s (symbols as in Chapter 4). Standard 3D-EPI simulation parameters Ȁȟ ? ? ? ?Ȁ ? ? ?ǡ	 ? ? ? ?ǡ ? ? ? ms and m = 10. The impact of TR, 
flip angle and the number of RF pulses per shot, here called m, was investigated. 
In addition the 3D-EPI readout was compared to a standard 2D-EPI acquisition ȋȀȟ ? ? ? ?Ȁ ? ? ?ǡ	 ? ? ? ?ȌǤ 
121 
 
 
Figure 5-26: LL-3D-EPI simulations showing the effect of (A) choice of 3D-EPI interpulse 
spacing (TR) (B) number of readout pulses per 3D-EPI block, m and (C) flip angle. (D) LLEPI 
curves for a 3D-EPI and a 2D-EPI readout. Signal from the arteriolar compartment shown in 
black and tissue signal shown in grey. 
Figure 5-26 shows the simulated perfusion timecourses for the arteriolar and the 
exchange compartments. These simulations demonstrate that interpulse spacing, 
TR, has little impact on either the blood or tissue signals. The number of readouts 
per 3D-EPI block, m, which is related to the number of slices acquired, does not 
impact the blood signal significantly but does suppress the tissue signal. This 
differing effect between blood and tissue results from the high flow rate of the 
blood in arterioles, meaning the signal in this compartment is refreshed at a 
faster rate, experiencing less RF pulses and suppression than the tissue 
compartment. Increasing the flip angle is shown to increase the arteriolar signal 
but reduce the tissue signal, as the blood is suppressed less due to the high flow 
and the blood signal is increased proportional to sin(FA). The comparison of the 
2D-EPI and 3D-EPI curves in Figure 5-26 D demonstrates that the signals are of 
similar magnitude between the two readouts and that the reduced flip angle of 
the RF pulses in 3D-EPI acquisition compensates for the increased number of RF 
pulses which could otherwise suppress the signal. For 2D-EPI there is one pulse 
per phase, whereas for 3D-EPI there are m pulses per phase where m is 
dependant on the number of slices. 
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A factor not included in these simulations is that the signal to noise of the 3D 
sequence will be proportional to the number of slices acquired,  ? ? ?  ?  ? ? ? ? ? ? ?as 
the signal arises from the entire volume [55]. This would mean that when the 
number of RF pulses is increased, which suppresses the signal, the SNR will 
increase as the number of slices acquired will have increased. The perfusion 
signal change was suppressed by a factor of 1.2 on increasing m from 8 to 10, but 
the SNR would improve by approximately 1.1 partially compensating. The SNR of 
the first phase of a LL acquisition is evaluated in Figure 5-27, this shows that 
after 7 slices the 3D-EPI has increased SNR compared to 2D-EPI due to the 
increased volume coverage (simulations look at signal from the grey matter in 
the first readout-phase after a post- ǡ  Ȁȟ  ?
340/300ms, T1 = 2000 ms, TE = 10 ms, TR3D = 16 ms FA = 14°/35° for 3D and 2D 
respectively). 
 
Figure 5-27: The effect of slice number on the relative SNR of the first phase of LL-3D-EPI and 
LL-2D-ǡȀȟ ? ? ? ?Ȁ ? ? ?ǡ1 = 2000 ms, TE = 10 ms, TR3D = 16 
ms FA = 14°/35° for 3D and 2D respectively. 
5.3.2.2 Phantom and In-Vivo Investigation 
All imaging was performed on the Philips Achieva 7 T system with head volume 
transmit and 32-channel SENSE receive coil. All volunteers gave written consent. 
Table 5-4 shows the duration of the 2 mm and 3 mm in-plane 3D-EPI 
acquisitions, with and without vascular crushing using the optimised parameters 
as described in Section 5.2.3. Common imaging parameters were FOV = 192 x 192 
mm2 and FA = 14°. 
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Number of 
Slices 
2 x 2 x 3 mm3 3 mm isotropic 
Non vascular 
crushed, TE/TR 
= 11/26 ms 
Vascular 
crushed, TE/TR 
= 21/36 ms 
Non vascular 
crushed, TE/TR 
= 7/16 ms 
Vascular 
crushed, TE/TR 
= 17/26 ms 
5 113 155 90 115 
10 241 335 155 249 
14 344 479 221 356 
18 395 551 253 409 
22 498 696 318 516 
Average time 
per slice 
23 ± 1  32 ± 1  15 ± 1  24 ± 1  
Table 5-4: Scan acquisition timings for 2 mm and 3 mm in-plane resolutions, with and 
without vascular crushing. 
Phantom Experiments 
To ensure that no systematic artefacts were introduced into the perfusion 
weighted images when using a 3D-EPI readout, as found in the single TI 3D-EPI 
method in Section 5.2.3, phantom studies were performed. A quadrant gel 
phantom that was doped with gadolinium was used; each quadrant had a 
different T1 and T2. Imaging parameters were: 2 x 2 x 3 mm3, 10 slices, 5 phases, 5 ǡ ? ? ? ?ȟ ? ? ? ?Ǥ
different FAIR selective inversion thicknesses of 40, 50, 60 and 70 mm, using a 
hyperbolic secant pulse for the inversion. In addition, two data sets with vascular 
crushing were acquired (strength 10 mT/m, lobe duration = 5 ms) with selective 
thickness of 40 and 70 mm. Further investigation into the effect of vascular 
crushing was performed by acquiring a LL-3D-EPI scan with 3 gradient strengths 
of vascular crushing, 0, 5 and 10 mT/m. Scan parameters:  ? ? ?ǡȀȟȀ
= 150/300/4000 ms, 12 phases, 8 slices of 2 x 2 x 3 mm3, selective inversion 
extended outside phantom. 
An artefact was present in the LL-3D-EPI ASL difference images acquired on a 
phantom, to investigate the origins of this an image with readout RF amplitude 
set to zero was acquired. This allowed determination of whether any signal was 
arising from the label, due to rephasing of the signal or foldover. This was 
repeated with increased initial TI to 450 ms, and another scan with reduced 
phase interval to 300 ms as this could impact on signal that has been rephased. 
Also investigated were the height of the gradient spoilers applied after the label, 
and the effect of using a FOCI pulse (A0  ?  ?Ǥ ? ?ǡ Ⱦ  ?  ?Ǥ ? ?  Ɋ  ?  ?Ǥ ? ?ǡ 
discussed in Section 4.4.2.1) instead of a hyperbolic secant for labelling.  
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In-vivo Study 
In healthy volunteers LL-3D-EPI data was collected with a range of scan 
parameters to assess the flexibility of the technique. These scans are summarised 
in Table 5-5. All data was acquired with FOV 192 x 192 mm2, selective thickness 
20 mm wider than imaging volume and non-selective of 250 mm.  
Parameters 
 ȀȟȀȀ ? ? ? ?Ȁ ? ? ?Ȁ ? ? ? ?Ȁ ?ǡ 
5 phases, 20 slices 
3 mm isotropic 
For large volume 
coverage ȀȟȀȀ ? ? ? ?Ȁ ? ? ?Ȁ ? ? ? ?Ȁ ? ?ǡ 
9 phases, 8 slices 
2 x 2 x 3 mm3 , 50 averages 
To demonstrate high 
resolution ȀȟȀȀ ? ? ? ?Ȁ ? ? ?Ȁ ? ? ? ?Ȁ ? ?ǡ 
12 phases, 8 slices 
2 x 2 x 3 mm3 , 40 averages 
Acquired with and without vascular crushing. 
To draw comparison 
with QUASAR [65] 
ȀȟȀȀ ? ? ? ?Ȁ ? ? ?Ȁ ? ? ? ?Ȁ ?ǡ 
13 phases, 10 slices 
3 mm isotropic 
To draw comparison 
with the coverage of 
QUASAR [65] 
Table 5-5: Overview of in-vivo LL-3D-EPI scan parameters. 
5.3.2.3 Results 
Phantom Experiments 
Initial experiments using the LL-3D-EPI sequence showed possible artefacts in 
the middle slices of the stack, similar to those seen in the single TI 3D-EPI ASL 
discussed earlier in Section 5.2.3. Figure 5-28 (A) shows the 10 slice 2 x 2 x 3 
mm3 LL-3D-EPI difference image acquired on a phantom with 5 phases with a 40 
mm selective thickness. The middle slices display a significant artefact. Figure 
5-28 (B) demonstrates the effect of altering selective inversion thickness on this 
artefact. As the selective thickness widens it is seen that the artefact is reduced. 
This is also seen in data acquired with vascular crushing, Figure 5-28 (C), where 
additional ripple artefacts are present. 
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Figure 5-28: (A) 2 x 2 x 3 mm3 LL-3D-EPI difference image acquired on a phantom (10 slices, 
5 phases, 5 averages, TI = 300 ms, TI = 350 ms, selective thickness = 40 mm) (B) Middle slice  
of LL-3D-EPI images (represented by dashed box in (A)) for selective thicknesses of (i) 
40mm (ii) 50 mm (iii) 60 mm (iv) 70 mm. (C) LL-3D-EPI difference images with vascular 
crushing (strength 10mT/m, lobe duration = 5 ms) at selective thickness of (i) 40 mm and 
(ii) 70 mm. 
Figure 5-29 shows LL-3D-EPI images acquired with different levels of vascular 
crushing, it is seen that the artefact is more prominent in the acquisition with 
crusher gradients applied. The artefact varies across the phases, and has a 
common spatial signature between the two vascular crushing levels. The 
difference in vascular crushing levels has not significantly changed the magnitude 
of the artefact but changes the readout in which it is most prominent. This 
signature at the different phases suggests the signal is being rephased by 
successive application of the RF pulses and spoiler gradients.  
 
Figure 5-29: LL-3D-EPI difference images with gradient strengths of (A) 0 mT/m (B) 5 mT/m 
and (C) 10 mT/m all acquired with matched TE. One slice shown. 
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Figure 5-30 shows the images acquired with RF set to 0, and shows a significant 
signal contribution (artefact) in the first phase suggesting signal remains from 
the label and arises from the difference between the selective and non-selective 
inversion as the artefact is not present in the raw images. Reducing the phase 
interval was found not to have an impact (B). However, increasing the initial TI to 
450 ms was found to remove the artefact in the first phase (C). Varying the 
heights of the gradient spoilers applied after the label was found to have little 
impact on the difference images. Altering the pulse for inversion, from a 
hyperbolic secant to a FOCI (A0  ? ?Ǥ ? ?ǡȾ ? ?Ǥ ? ?Ɋ ? ?Ǥ ? ?Ȍ
the artefact significantly worse (D).  
 
Figure 5-30: RF = 0 LL-3D-EPI difference images (A) 5 phase acquisition (B) with reduced 
phase interval to 300 ms (C) Increased initial TI to 450 ms and (D) inversion pulses type 
FOCI rather than hyperbolic secant. One slice shown. 
 
In-Vivo Experiments 
Figure 5-31 shows the 20 slice 5 phase 3 mm LLEPI acquisition, acquired with 30 
dynamics. This clearly shows the early blood signal in the first phase as no 
vascular crushing has been used, and the tissue perfusion which is predominant 
in the 3rd phase. Again the benefit of a 3D-EPI acquisition is visible with all the 
slices having the same perfusion signal weighting from simultaneous acquisition 
of all the slices, due to this and the large coverage it clearly shows how the transit 
times are very different across the brain, for example the signal persists longer in 
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the occipital regions due to the longer arrival times in that region [61]. This is 
further demonstrated in Figure 5-32, where the timecourse from an occipital ROI 
and a sensorimotor ROI are shown. 
 
Figure 5-31: 20 slice 5 phase LL-3D-EPI ASL acquisition, base images and the 5 phase are 
shown separately, all slices shown. 
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Figure 5-32: LL-3D-EPI perfusion weighted timecourse from an occipital cortex ROI (broken 
line) and a left sensorimotor ROI (solid line) from data shown in Figure 5-31. Error bars 
represent standard error across voxels in the ROI. 
Figure 5-33 shows a 9 phase, 8 slice 2 x 2 x 3 mm3 LL-3D-EPI acquisition. The 
high resolution allows the structure of both the vessels and the cortex to be 
clearly seen. There is a slight image artefact in the first phase of some of the 
slices. As seen with the phantom experiments, a short TI (here 150 ms) can 
exacerbate this artefact. 
 
Figure 5-33: 4/8 slices of the 2 x 2 x 3 mm3 9 phase acquisition. White arrows indicate 
presence of artefact that is predominant in the first phase but persists through the phases. 
Figure 5-34 shows example slices from the (A) non vascular crushed and (B) 
vascular crushed acquisition. The difference image (A-B) between the two 
acquisitions clearly shows the blood signal which arrives early and has mainly 
gone by the 4th phase. Artefacts are more pronounced in the vascular crushed 
acquisition, as the signal is of lower amplitude making artefacts more easily 
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visible, and the phantom experiments suggest additional affects may be present 
due to the vascular crushing. 
 
Figure 5-34: LLEPI data acquired, 9 phases, 8 slices, 2 x 2 x 3 mm3, TE = 21 ms. (A) without 
vascular crushing and (B) with vascular crushing, (C) = (A)-(B), the difference signal 
between the two showing the blood signal that is predominant in the first 3 phases. One slice 
out of eight shown. 
Figure 5-35 is the 13 phase acquisition, TRASL = 10 s/pair, to assess the signal at 
longer post labelling delays. The signal persists well into the 9th phase and into 
the 10th phase which has an effective post label delay of 3,040 ms. This is 
demonstrated in the perfusion timecourses shown in Figure 5-36. The large 
vessel signal has mainly gone after a post labelling delay of a 1 s, but the tissue 
signal peaks later due to the longer transit time to the tissue bed, and the tissue 
signal can be seen to persist until approximately 3 seconds at 7 T.  
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Figure 5-35: 13 phase, 10 
slice, 3 mm isotropic LL-
3D-EPI acquisition shown 
in transverse, coronal and 
sagittal orientations. 
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Figure 5-36: Timecourse of the perfusion weighted signal in (A) large vessels and (B) grey 
matter. Error bars represent standard error across voxels in the ROI. 
5.3.2.4 Discussion 
This experiment has shown that LL-3D-EPI ASL is feasible at 7 T, and that it 
allows high volume coverage ASL data to be acquired with high temporal 
resolution through the readout. It was demonstrated that the LL-3D-EPI 
acquisition can exceed the coverage and resolution that is currently implemented 
using QUASAR at 3 T [65], that of 7 slices acquired at 3.75 x 3.75 x 6 mm3 with 
interpulse spacing of 300 ms [70, 74].  
Simulations showed that the 3D-EPI readout should not suppress the signal much 
greater than that of a similar 2D-EPI acquisition, even though the number of RF 
pulses is significantly increased. Interpulse spacing was shown to have little 
impact on the signal from either the blood or the exchange compartments. 
Number of RF pulses per readout (linked to number of slices) and flip angle were 
shown to affect the tissue signal more, due to the prolonged time the label 
remains in the voxel compared to the blood. 
Phantom studies have shown artefacts that are dependant on the width of the 
selective thickness, as with the single TI 3D-EPI ASL shown in Section 5.2.3. This 
work shows a need for further development of the technique; investigation of the 
origin of the artefact is needed to make the technique more robust. The 
dependence on the selective thickness and the presence of an artefact when the 
readout RF amplitude was set to zero suggests that the artefact is linked to the 
label. Varying the gradient spoiling of the label did not have any significant 
impact. Further investigation would concentrate on variable height gradient 
spoiling after the label with each TR period and the use of RF spoiling [75]. 
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The use of bipolar gradients was also shown to give rise to large artefacts in the 
phantom data, which again were reduced on increasing the selective thickness. 
Vascular crushing is necessary to remove blood signal for CBF quantification and 
functional studies may wish to look at the variation in tissue perfusion with a 
functional task rather than the blood compartment. Currently the vascular 
crushing appears to make the appearance of the artefact worse; this could be due 
to the application of extra gradients rephasing the artefactual signal. 
An additional area for investigation would be the labelling scheme, as artefacts 
appear to be associated with the non-selective inversion. It would be important 
to investigate whether this artefact is reduced with a different labelling scheme, 
such as PICORE or STAR. These could help as the labelling slabs are applied 
inferior to imaging, whereas in FAIR the inversion slabs are centred on the 
imaging slices. Look-Locker methods could be combined with CASL/PCASL but 
this would reduce the temporal resolution of a tag/control pair as the labelling 
scheme takes ~ 1s, which for functional studies would be problematic. In 
addition, the SAR and inversion efficiency of these techniques at 7 T is likely to 
prohibit their use [1]. 
Further investigation would look at the impact of the RF pulse used for inversion. 
Here only the comparison between a hyperbolic secant and one FOCI (A0  ? ?Ǥ ? ?ǡȾ ?  ?Ǥ ? ?  Ɋ  ?  ?Ǥ ? ?Ȍ  Ǥ    	   
improve the profile, reducing the artefact seen in the difference images. 
A model to allow quantification of the different haemodynamic parameters needs 
to be developed from the simulations. Current fitting for LL-ASL, as used for the 
CBVa measurement, assume one RF pulse per slice, whereas here a train of small 
tip angle pulses are applied. The model used here for simulation has many 
parameters which would make data fitting difficult due to number of degrees of 
freedom but could be adapted for data fitting. Similarly the development of such 
a model would aid the quantification of LL TFE ASL data (Section 5.3.3) as that 
also uses a train of RF pulses for data acquisition. Further development, initially 
through simulation, could determine whether arterial blood volume could be 
measured through a similar methodology as used for the 2D-EPI where the tissue 
signal is deliberately suppressed. The use of high flip angle readout would 
achieve this, however this would cause large signal decay during the 3D readout 
which was found to cause perfusion quantification errors for the single TI 
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method. A method similar to that of Petersen et al. [65] could be implemented 
where data is acquired with and without vascular crushing, as in Figure 5-34.  
LL-3D-EPI is the first implementation of a 3D sequence with a Look-Locker 
readout for ASL imaging. 3D-GRASE is the most common 3D method for ASL 
imaging [76] and uses a train of 180° refocusing pulses after excitation, example 
images acquired at 3 T are shown in Figure 5-37. 3D-GRASE suffers from 
significant through plane blurring, and due to the use of a long train of high flip 
angle pulses is also at the upper limits of SAR, which would be exacerbated if 
combined with a LL readout strategy, especially at 7 T. Achieving high resolution 
is difficult with 3D GRASE due to the long echo train length, segmentation and 
parallel imaging are often used to achieve higher spatial resolution [9]. 3D GRASE 
has not currently been implemented at 7 T. 
 
Figure 5-37: (A) Example GRASE images acquired at 3 T with scan parameters TSE = 11, EPI = 
27, 10 slice, 3 x 3 x 5 mm, FOV = 192 x 192 x 50 mm, TE = 22ms, TR = 3s (B) Perfusion 
weighted images using a FAIR labelling scheme with post-label delay of 1400 ms, non-
selective = 250mm, selective = 60 mm. 
Development of a robust LL-3D-EPI method with associated fitting algorithm 
would have applications in several areas. The large volume coverage, for example 
Figure 5-31, would be useful for the definition of vascular territories through the 
assessment of voxelwise perfusion timecourses. This would be useful in the study 
of different pathologies that are expected to affect cerebral perfusion (e.g. aging, 
vascular diseases such as stroke). Also fMRI using perfusion would benefit from 
larger volume coverage when studying areas with non-focal activation, for 
example cognitive tasks. 
Overall LL-3D-EPI has been shown to be a promising technique for the 
acquisition of large volume coverage, high temporal resolution perfusion data at 
7 T. The 32 channel coil allows for parallel imaging to be applied in two 
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dimensions to speed up image acquisition. With each shot, over 100 slices can be 
acquired every 3 seconds. The high SNR available at 7 T allows high signal 
perfusion weighted images to be acquired in less than 5 minutes. Through further 
investigation it should be feasible to implement a robust method, and for it to be 
applied in the study of vascular territories and functional MRI studies. 
5.3.3 LOOK-LOCKER TFE: APPLICATION IN LOW GRADE GLIOMAS 
As with single TI ASL, presented in Section 5.2, the use of image acquisition 
methods that are less affected by geometric distortions is important for Look-
Locker (LL) ASL at high field. Wang et al. [77] demonstrated the feasibility of 
combining a Look-Locker scheme with a FLASH readout for blood velocity 
mapping at 3 T, and bFFE has been incorporated in a Look-Locker scheme for 
kidney perfusion imaging at 1.5 T [66]. TFE and bFFE were introduced in Section 
5.2.2 and shown to be more robust to geometric distortions than GE-EPI. bFFE 
would not be suitable to be combined with Look-Locker style readout at 7 T due 
to SAR constraints as bFFE uses a long train of high flip angle pulses, however 
using TFE this is possible. 
Here the combination of TFE with a Look-Locker readout to provide undistorted, 
perfusion weighted images at multiple readout times for use in clinical setting 
was investigated. The technique was applied to the assessment of cerebral 
tumours where transit time measures are required to interpret perfusion 
weighted maps due to abnormal vasculature. 
5.3.3.1 Methods 
The study was approved by the local ethics committees; 4 low grade glioma (LGG) 
patients (2 female, age range 28 Ȃ 63 years old) gave informed written consent. 
Experiments were performed on a Philips Achieva 7 T system, with a head 
volume transmit coil and 16-channel SENSE receive coil.  
In a healthy volunteer LL-TFE was demonstrated with a 2 mm and a 1 mm in 
plane resolution readout, at an inferior and superior axial plane. 75 dynamics 
were acquired at 2 mm, and 100 dynamics at 1 mm. In the Glioma patients data 
was acquired at 2 mm in-plane resolution. All scan parameters were matched 
between the two resolutions.  
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ASL parameters: FAIR labelling scheme (selective thickness 25 mm, non-selective 
thickness 230 mm, in-plane pre- and post-saturation pulses, ASL TR of 6 s per 
tag/control series with 50 averages collected), with a LL-readout (TI = 350 ms, ȟ ? ? ? ?ǡ  ?Ȍ	ǣ
(2 x 2 x 3 mm3, flip angle = 15°, TR/TE = 5/2.5 ms, FOV = 192 x 192 mm2). The ȟ          ȋ ? ? ?   ? Ȍ  keep 
within SAR limits. In addition an equilibrium magnetisation base image with a 
long TR was acquired.  
In patients, single-TI TFE data were acquired, (2 x 2 x 3 mm3, TI = 1500 ms, 5 
slice, 90 averages, TR = 6s / pair), imaging parameters as for LL-TFE. 50 averages 
were acquired in 5 minutes. Tumour borders were defined using a 3D-FSE (0.7 x 
0.7 x 1.6 mm3, FOV: 220 x 220 x 19 mm3, TR/TE = 2500/315 ms, refocusing angle 
40°, SENSE 2).  
In a healthy volunteer EPI base images were acquired to compare distortions (2 x 
2 x 3 mm2, 192 x 192 mm2 FOV, TE = 10 ms, SENSE 2, FA = 90°). 
5.3.3.2 Analysis 
Single TI label and control data were subtracted, inspected for motion and 
averaged across the dynamics. Any subjects that showed large motion (> 1 voxel) 
were discarded. LL-TFE data was subtracted and each phase was averaged across 
the dynamics. The FSE anatomical image was realigned to the LL-TFE anatomical 
space using FLIRT (FSL, Oxford). 
5.3.3.3 Results 
The results from a healthy volunteer are shown in Figure 5-38, where 2 mm and 
1 mm data were acquired at two locations in the superior and inferior planes. 
The TFE is more robust to susceptibility differences (Figure 5-38 E), compared to 
EPI. At both locations the perfusion weighted signal shows excellent cortical 
structure throughout the five readouts. 
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Figure 5-38: Demonstration of LL-TFE in a healthy subject at (A) 2mm and (B) 1mm in plane 
resolution, effective post-label delay shown below in ms (C) Base TFE images at the two 
locations (shown in (D)) and (E) demonstrates the distortions that EPI can have (right) 
compared to TFE (left). 
Two patients had small lesions (< 5 mm) located in deep structures not easily 
distinguishable from neighbouring healthy tissue, hence were excluded; the other 
two patients had large lesions. 
 
Figure 5-39: ASL LL-TFE data for patient with (A) LGG overlaid on their 3D-FSE image, post 
label delay shown below in ms; (B) tumour outlined as red ROI on 3D-FSE. 
Figure 5-39 shows the ASL LL-TFE PW data for a patient with a low grade glioma 
overlaid onto their co-registered FSE image. The tumour corresponds to an area 
of low perfusion and the LL acquisition provides clear evidence that this is not an 
artefact of a change in transit time as no blood is seen to arrive at any time point. 
Figure 5-40 shows LL-TFE and single TI TFE data, of a second patient, again 
overlaid on their FSE. The 4th phase is approximately equivalent to the single TI 
inversion time ASL acquisition. It can be seen that the Look-Locker acquisition 
provides information on the early arrival of tumour blood flow which has washed 
out by the time of the single TI acquisition (shown by white arrow). This further 
demonstrated in Figure 5-41 where LL-TFE timecourses are shown for an ROI in 
the tumour and the cortex. 
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Figure 5-40: (A) LL-TFE data for patient with LGG overlaid on their 3D-FSE image, arrow 
shows early blood arrival, effective post label delay in ms shown below (B) Single-TI ASL, 
slice from (A) highlighted. 
 
Figure 5-41: LL-TFE timecourse for a ROI in the cortex (solid line) and a ROI in the tumour 
(broken line), from data shown in Figure 5-40. Error bars represent standard error across 
voxels in the ROI. 
5.3.3.4 Discussion 
This study shows the feasibility of using TFE in combination with a Look-Locker 
readout for ASL at 7 T. This acquisition scheme overcomes the problems 
associated with susceptibility-based spatial distortion in EPI images, particularly 
in areas of high susceptibility difference (areas close to sinuses) allowing ASL 
data to be acquired in any brain region of clinical interest. Further this technique 
can be used to collect high resolution data and perfusion images can be directly 
overlaid on anatomical images.  
Currently the data has been collected without vascular crushing so the images are 
weighted by both arterial blood volume (at short delay times) and tissue 
perfusion (at late delay times), however this does provide an estimate of vascular 
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viability. Combination of vascular crushing with a TFE readout is not easy due to 
the multiple excitation pulses [27]. 
The Look-Locker time course provides an estimate of transit time, allowing PW 
signals to be examined in clinical situations where transit time may change due to 
pathology. It was seen that the Look-Locker readout provided more information 
on blood supply than the equivalent single-TI data, as the blood signal has gone 
by the late delay times of typical single TI ASL. 
Further work will model the perfusion signal to give transit time, CBVa and CBF. 
Currently this technique is limited to a single slice implementation; however with 
the increased SENSE factor achievable with a 32-channel coil the feasibility of 
multi-slice LL-TFE will be explored.  
5.4 CONCLUSIONS 
The experimental work in this chapter has shown several methods for ASL 
imaging at 7 T. It was demonstrated that gradient echo EPI could be used to 
acquire ASL data at 1.5 mm in plane resolution without a significant impact on 
image quality or stability. TFE and bFFE were compared for use as ASL readout 
methods; bFFE has higher SNR and CNR than TFE, but increases SAR reducing the 
number of slices that can be achieved. EPI has highest SNR but suffers at 1 mm 
resolution from image distortions due to a lengthened echo train, whereas TFE 
and bFFE, with short echo times, are more robust to susceptibility differences. 
3D-EPI was shown to increase the slice coverage achievable whilst maintaining 
perfusion signal across the slices. 
Look-Locker methodologies for the assessment of the temporal characteristics of 
the perfusion response were shown to be applicable at 7 T, even with increased 
SAR compared to lower field strengths. LL-EPI was used to measure arterial 
blood volume at rest and during a motor task with results in agreement to those 
measured at 3 T. The combination of 3D EPI with a Look-Locker ASL scheme was 
shown, providing increased spatial coverage through the use of parallel 
acceleration and Partial Fourier along two acquisition axes. LL-3D-EPI provides 
greater flexibility of the Look Locker technique, with fewer restrictions on slice 
coverage. Finally, the combination of TFE with a LL readout was shown to be 
feasible and to provide extra information in the assessment of Low Grade 
Gliomas compared to a single TI method. 
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6 THE EFFECT OF HYPERCAPNIA ON BRAIN FUNCTION 
6.1 OUTLINE 
This chapter describes the effect of hypercapnia, an increase in concentration of 
carbon dioxide (CO2) in the blood, on perfusion and neuronal activity.  
Hypercapnia is a modulation often used for calibrated BOLD studies [1], where it 
is assumed to only act on the vasculature and not induce metabolic or neuronal 
activation. The primary aim of the experiments described in this Chapter is to 
investigate the physiology behind hypercapnia, and whether the assumptions of 
calibrated BOLD are valid. 
Firstly, the known effects of hypercapnia on physiology and hence the BOLD 
signal are reviewed and the system used to induce hypercapnia in human 
volunteers is detailed. Two experiments are then presented; (i) the measurement 
of cerebral blood flow and transit time using ASL at 7 T during hypercapnia for 
the measurement of CMRO2 using calibrated BOLD, and (ii) the effect of 
hypercapnia on resting and stimulus induced magnetoencephalography (MEG) 
signals (published in Hall et al. NeuroImage 58 (2011) 1034-1043). 
6.2 INTRODUCTION 
Hypercapnia is the term used for the state of increasing the concentration of 
carbon dioxide in the blood (PaCO2). This can be achieved through breath holding, 
inhalation of  carbon dioxide or the administration of certain pharmaceuticals 
(e.g. Remifentanil [2]).  
The effects of hypercapnia that are reported in the literature include increased 
cerebral blood flow [3], cerebral blood volume [4] and baseline BOLD signal [5]. 
However, stimulus-evoked BOLD signal changes are reduced during hypercapnia 
(e.g. [6-8]). This effect can be explained by the deoxyhaemoglobin dilution model 
of Hoge et al. [9]     ǲ ǳ in, 
increasing the MR signal. If a neuronal stimulus is applied during a hypercapnic 
challenge, which has caused the flow to increase substantially from baseline, the 
BOLD change is reduced compared to that in the absence of hypercapnia, as 
demonstrated in Figure 6-1. The flow increases substantially for a combined 
hypercapnic and motor task compared to a motor challenge alone, but with no 
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change in CMRO2 the resulting BOLD response compared to hypercapnic baseline 
is reduced. 
 
Figure 6-1: Schematic of Hoge's deoxyhaemoglobin model, demonstrating that the stimulus 
evoked BOLD is reduced on hypercapnia compared to normocapnia. Black lines indicate 
contours of constant CMRO2, thick black line demonstrates no CMRO2 change. Grey shaded 
region indicates a CMRO2 increase. 
Posse et al. [10] showed that the functional response to a visual stimulus in 
humans decreased with both hypocapnia and hypercapnia (20 Ȃ 70 mmHg partial 
pressure of end tidal CO2 (PETCO2)) and that BOLD functional contrast was almost 
completely eliminated at 70 mmHg PETCO2. This effect has also been confirmed in 
the human motor cortex [11]. Gauthier et al. [7] showed that the BOLD response 
to a visual stimulus in humans can be eradicated by combined hypercapnia and 
hyperoxia (10 % CO2, 90 % O2 inhaled concentration). Cohen et al. [6] showed 
that increased PETCO2 lengthened the onset and the time to peak of the BOLD 
response in human visual cortex.  
The effect of hypercapnia on CBF has been used to provide a method of 
normalising the BOLD signal for variations in baseline CBF [12] and is widely 
used for calibrating the BOLD signal in terms of CMRO2  (cerebral metabolic rate 
of oxygen consumption) [1, 13].  
In 1997 Bandettini and Wong [13] first proposed hypercapnia based 
normalisation of the BOLD fMRI response. The aim of that study was to remove 
non neuronal-activation based effects from BOLD fMRI responses. The response 
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to a functional task was normalised by the BOLD response in that area of cortex 
to hypercapnia (inspired concentration of CO2 (FiCO2) = 5 %). This was shown to 
lead to the peak voxel of the finger tap BOLD response to move from a voxel 
containing a vessel to the cortex. 
The more quantitative method of BOLD calibration is the Davis model [1] which 
was introduced in 1998. Using this model, the cerebral rate of oxygen 
consumption (CMRO2) can be derived from BOLD and perfusion measures, 
CMRO2 is a measure thought to be more closely coupled to the underlying neural 
activity. The relationship between BOLD, CBF, CBV and CMRO2 has been 
formulated as: 
ȟ ? ? ? ? ? ? ?  ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?ఉ െ  ? ? ? ?  ? ? ? ? ? ? ? ? ? ? ? ? ?  ? ?ఉ  ? 6-1 
where CBV(t) is the fractional blood volume at time t, CBF is the cerebral blood 
flow, CMRO2          Ⱦ  
power factor relating BOLD signal change and magnetic susceptibility 
(ȟ ? ? ?ൌ ȟ ?ఉ) [1]ǤȾ ?Ǥ ?
1.5 T [1]ǡȾo 1 at 7 T [5].  
The coupling between CBF and CBV can be used to replace CBV in Equation 6-1. 
Grubb et al. [3] investigated the coupling between CBF and CBV in anaesthetised 
rhesus monkeys using 15O labelled water and haemoglobin. They showed the 
coupling between cerebral blood volume and cerebral blood flow was:  ? ? ? ൌ  ? ? ? ȉ  ? ? ?ఈ, 6-2 Ƚ ? ?Ǥ ? ?Ǥet al. [4] found a coupling constant of 0.29 between CBF and 
CBV in humans, measured using PET. However, the BOLD response is 
predominantly from the venous side, Chen et al. [14] found that the coupling 
between CBF and vCBV was 0.18 in humans, measured using MRI. The value 
Grubb derived is most commonly used to replace CBV in Equation 6-1, and this 
can be rewritten, ȟ ? ? ? ? ?ൌ  ?൭ ? െ ? ? ? ? ? ? ? ? ? ? ? ? ? ?ఉ ൬ ? ? ? ? ? ? ?൰ఈ ?ఉ൱ ? 6-3 
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ȟǡ0 is baseline signal; subscript 0 
represents resting values and M is the maximum BOLD signal achievable. M is 
generally calculated using a hypercapnic (increased CO2) challenge, which is 
assumed not to change metabolism at the concentrations used (typically inspired 
concentration of CO2 is 5 % e.g. [13]). By rearranging Equation 6-3, assuming no 
change in metabolism on hypercapnia, M can be derived as 
 ? ൌ ȟ ? ? ? ? ? ? ? ? ? ? ? ? െ  ? ? ? ? ? ? ? ? ? ? ?ఈ ?ఉ ? 
6-4 
If CBF and BOLD are measured during hypercapnia (HC) and normocapnia (0, 
baseline) M can be calculated. This can then be used to find the change in CMRO2 
due to a stimulus; 
 ? ? ? ? ? ? ? ? ? ? ? ?ൌ  ? െ ? ? ? ? ? ? ȉ  ? ? ? ? ?ൗ ? ? ? ? ? ? ? ? ?ఈ ?ఉ  ? 
6-5 
 
However, the Davis model relies on several assumptions. The model is derived 	ǯǡǤ
ǯ [3]ǡȽǡȟ2* and blood oxygenation given by Yablonskiy et al. 
[15], Boxerman et al. [16] and Ogawa et al. [17]. Results to date have given wide 
inter-subject and inter-study variability for values of M and the CMRO2:CBF 
coupling ratio measured at 3 T as outlined in Table 6-1. M will increase with field 
strength as M is directly proportional to BOLD signal change which is known to 
increase with B0 (e.g. [18]). 
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Study M CMRO2:CBF Coupling Ratio Brain Area 
Hoge et al. [9] 15 ± 6 % 0.5 ±  0.1 Visual 
Stefanovic et al. [11] 7.6 ± 1.3 % 0.22 ± 0.11 Visual 
Chiarelli et al. [19] 6.6 ± 3.4 % 0.34  ± 0.03 Visual 
Kastrup et al. [20] 9 ± 3 % 0.2 ± 0.1 Motor 
Uludag et al. [21] 25 % 0.45 ± 0.15 Motor 
Stefanovic et al. [11] 6.1 ± 1.1 % 0.49 ± 0.13 Motor 
Chiarelli et al. [19] 4.3 ± 3.5 % 0.24 ± 0.03 Motor 
Table 6-1: Literature values of the BOLD calibration constant M  and coupling between 
CMRO2 and CBF (adapted from [19]), all acquired at 3 T. 
The measurement of metabolic changes in response to a neuronal stimulus 
should allow for easier comparison across patient and control groups or in 
groups with perturbed baseline flow (e.g. due to pharmacological agents such as 
caffeine), as the impact of different baseline physiology will have been removed. 
A direct measure of a physiological parameter such as CBF is more useful than a 
compound effect like BOLD. However, BOLD is widely used due to the ease of 
performing the measurement and analysing the data. 
In addition to hypercapnia based calibration, there are other calibration methods 
used, with interest growing in the area of hyperoxia (increased levels of oxygen 
in the blood) based calibration. Chiarelli et al. [22] proposed a model that 
expressed the BOLD signal change in terms of changes in CBF and venous ǡ    Ƚ  Ⱦ   Ǥ  
constant M is similarly used to scale the BOLD signal change, and this is 
calculated using hyperoxia by assuming that hyperoxia does not cause a blood 
flow change. The value for M is equivalent to that calculated using hypercapnia 
calibration and Equation 6-5 is still valid. Hyperoxia is better tolerated by 
subjects compared to hypercapnia making this attractive for patient studies. 
However as with hypercapnia based methods there are several assumptions in 
the formulation of the model that are still being investigated and recent reports 
are investigating the combination of hypercapnia and hyperoxia calibration (e.g. 
[23]). 
A fundamental assumption of BOLD calibration using hypercapnia is that there is 
no neuronal response to hypercapnia, therefore in addition to the effect on 
haemodynamics recent interest has considered the impact of hypercapnia on 
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electrophysiology as a marker of this. For example, Zappe et al. [24] 
demonstrated that hypercapnia caused a reduction in the invasive 
electrophysiological signals (multi-unit activity and beta/gamma spontaneous 
activity) in the visual cortex of anaesthetised monkeys. They hypothesised that 
this reduction could be suggestive of a CMRO2 change with hypercapnia. If there 
is a direct CMRO2 change to hypercapnia itself the method of calculating M in the 
Davis model would be invalid. The Davis model assumes that hypercapnia is 
isometabolic allowing for M to be calculated by only measuring BOLD and CBF 
(Equation 6-4).  
MEG has rarely been used to study the neural response to hypercapnia. Schellart 
and Reits [25] investigated MEG and EEG responses to long breath holds to 
induce hypercapnia and hypoxia, and showed a frequency shift in the alpha band 
and an increase in the peak amplitude. Changes were not statistically significant, 
which is likely to be a result of breath holding being an unreliable way of 
inducing hypercapnia. DC-MEG measurements have shown changes under 
respiratory challenges. Carbon et al. [26] used hyperventilation to induce 
hypocapnia and showed a 1.1 Ȃ 6.2 pT increase in the global DC-MEG signal, 
however PaCO2 (arterial concentration of CO2) was not recorded and PaO2 was not 
controlled, making it difficult to separate these effects. There was also large 
variability in the response, possibly due to the difficulty in inducing repeatable 
hypocapnia by hyperventilation. Blockley et al. [27] demonstrated a change in the 
MEG sustained field between controlled hypo- and hypercapnia at rest. A  recent 
study of the effect of hypercapnia on the EEG signal [28] found a global reduction 
in oscillatory power in the alpha band during hypercapnia compared to 
normocapnia. In the same study, BOLD mediated functional connectivity in the 
default mode network was shown to be reduced (an effect also shown in the 
motor network [29]). Similarly [30] showed a reduction in alpha power, and also 
an increase in delta power, measured by EEG due to hypercapnia. Bloch-Salisbury 
et al. [31] showed in humans that the EEG evoked response to an auditory 
stimulus was unaffected by PETCO2 .  
6.3 THE RESPIRACTTM 
In order to investigate the effects of hypercapnia it is necessary to have a precise 
and accurate way of inducing hypercapnia without causing any other effects. 
Using breath holding or inhalation of fixed concentration gases to control levels 
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of carbon dioxide in the blood is not ideal. Breath holding is not reliable and is 
very dependant on the subject, plus concentrations of CO2 cannot be easily 
monitored during apnea (breathing cessation) as this is commonly performed 
using a nasal cannula (e.g. [11]). Breath holding also induces hypoxia, a reduction 
in the concentration of oxygen in the blood as the body is metabolising oxygen 
during the breath hold with no replenishment [32]. Fixed concentration 
inhalation also gives variable results within and between subjects [33]. Ideally 
oxygen concentrations should remain unchanged whilst the CO2 level is 
modulated so that the effects of the two can be uncoupled. 
The RespirActTM (Thornhill Research Inc, Toronto, Canada) is a gas blending 
system that targets end-tidal CO2 (PETCO2) and O2 (PETO2) separately. The aim of 
the RespirActTM is to allow prospective, independent, targeting of PETCO2 and 
PETO2 levels [34]. The system consists of a sequential gas delivery (SGD) circuit, 
Figure 6-2, attached to a non-vented face mask and a gas blender. 
The SGD circuit comprises two gas reservoirs and three valves, schematically 
represented in Figure 6-2. When the fresh gas bag is full, this provides all the 
inhaled gas. Exhaled gas always goes into the exhaled gas reservoir, which if full 
will expel air through a hole. If the fresh gas bag collapses during inhalation, 
previously exhaled gas is drawn from the exhaled gas reservoir. This is 
considered to be neutral gas as it has already equilibrated with the blood and 
does not contribute to gas exchange. The system relies on the subject emptying 
the fresh gas bag with each breath, as this ensures that on each breath the subject 
receives the calculated amount of fresh gas, topped up with neutral gas. 
The face mask has two connections back to the RespirActTM, one to measure the 
end tidal concentrations of CO2 and O2, the other to measure the pressure to 
detect periods of inspiration and expiration.  
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Figure 6-2 Schematic diagram of RespirAct face mask and SGD circuit. 
The RespirActTM uses four supply gases;  
100 % O2 
Medical air: 21 % O2, 79 % N2 
Gas A: 10 % O2 90 % N2 
Gas B: 10 % O2 20 % CO2 70 % N2 
These all have a minimum of 10 % O2 and a maximum of 20 % CO2 for safety. The 
RespirActTM has further safety functions; 100 % O2 is delivered in the event of 
software failure / power cuts, the software ensures the correct gases have been 
connected prior to setting up a sequence and there is an emergency button to 
deliver 100 % O2. Initial calibration of the system is performed using the [100 % 
O2] and a gas mixture of [9 % CO2, 91 % nitrogen]. This is connected to a different 
port, and the cylinder is removed before a mask is connected. 
Sequences to vary PETCO2 and PETO2 can be simply designed; they are calculated    ǯ   ȋ   ǡ
weight and gender), their resting PETCO2 and PETO2 (approximately 40 mmHg and 
100 mmHg [35], but measured on the day) and the typical and maximum flow 
rates. The typical flow rate is chosen so that the subject can comfortably empty 
the fresh gas bag with each breath. The maximum flow rate is the largest flow 
rate that can be used to induce transitions Ȃ if this is low it can take several 
breaths to achieve the desired change, but a flow rate that is too high can cause a 
build up of gas in the fresh gas bag as the subject is unable to inspire it. 
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6.4 THE EFFECT OF HYPERCAPNIA ON CBF AND BOLD: APPLICATION TO 
CALIBRATED BOLD 
ASL measurements of perfusion under hypercapnia are often used for the 
estimation of CMRO2 using the model of Davis et al. [1]. The most common 
implementation of ASL is to use a single-TI pulsed ASL sequence as this is the 
easiest method to implement. However, it has been shown that hypercapnia 
shortens the transit time of the label (e.g. [2, 36]) which can confound single TI 
perfusion methods as they lack temporal information.  
This has been highlighted by Tancredi et al. [37] who show that there is a weak 
CBF increase in response to CO2 as measured with ASL compared to visual 
stimulation using single TI PASL. They attributed this to a shortening of transit 
time causing the CBF response to CO2 to be reduced.  
This experiment aims to measure the perfusion change due to both a hypercapnic  
challenge and motor task at 7 T using a multiple TI Look-Locker EPI FAIR ASL 
sequence to account for and measure transit time changes. These measures are 
used together with BOLD signal changes to estimate the CMRO2 change 
associated with finger tapping in healthy human subjects using the Davis model 
of calibrated BOLD. The value of M, the Davis calibration constant, is determined 
at 7 T. Calibrated BOLD analysis is performed to assess the feasibility of 
voxelwise analysis to form CMRO2 maps as compared to region-of-interest (ROI) 
analysis, which is the standard method at 1.5 and 3 T (e.g. [19]).  
6.4.1 EFFECTS OF TRANSIT TIME ON CALIBRATED BOLD: SIMULATIONS  
To assess the impact of using only a single TI ASL acquisition for calibrated BOLD, 
simulations were performed to assess the effect of transit time changes. Transit 
time here refers to the time it takes the labelled blood to traverse from the ȋȟtissueǡɁ ?ȟa in Figure 4-10). In addition 
to transit time, the bolus duration is also modelled. The bolus duration is the 
temporal duration of the labelled blood, and is governed by the non-selective 
thickness. 
The effect of perfusion and transit time changes on the shape of the ASL 
perfusion curves for both an (i) infinite and a (ii) finite bolus are shown in Figure 
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6-3 for (A) a perfusion increase only and (B) a perfusion increase and transit time 
decrease.  
To quantitatively assess the impact of transit time changes on a single TI measure 
of perfusion, the % perfusion signal change at TI = 1.5 s was used to estimate the 
flow change. Simulation parameters were T1,b = 2.1 s, T1,tissue = 2.1 s, at baseline it ǡ ? ? ?Ȁ ? ? ?Ȁǡȟtissue = 0.4 s and 
bolus duration W = 1.5 s [38]. The effects of T2* decay were assumed to be 
negligible. To simulate activation, flow was increased with a corresponding 
decrease in transit time (e.g. CBFact = A.CBF0ǡȟact  ?ȟ0 / A ). Figure 6-4 shows that 
as activation induced flow change increases, the error in the measured flow 
change also increases. The flow change is overestimated and the magnitude of 
the measurement error was reduced at short transit times. 
 
Figure 6-3: Simulated perfusion curves for 7 T [38] with (i) an infinite bolus and (ii) a finite 
bolus. (A) a perfusion increase of 20 % with no change in transit time or bolus duration 
(broken line) and (B) a perfusion increase of 20 % and transit time decrease of 20 %. The 
Ǥɉ ?
0.98 ml/g, T1,b = 2.1 s, T1,tissue = 2.1 s, rest parameters f = 90 ml/100gȀǡȟtissue = 0.4 s, W = 
1.25 s). Vertical dashed line indicates typical single TI measurement time of 1.5 s. 
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Figure 6-4: % error in measured flow increase as a function of flow increase for different 
tissue arrival times. 
To quantitatively assess the impact on calibrated BOLD the % perfusion signal 
change at TI = 1.5 s for all cases was used to calculate M and CMRO2 using the 
equations from the Davis model (Equations 6-3 and 6-4). 
The simulations of effects of transit time changes on calibrated BOLD were split 
into four sections to address the effect of a single TI readout: (A) the error in M 
caused by error in the flow increase measured to hypercapnia, with different    ȋȟtissue) (B) the error in CMRO2 as a function of the flow   ǡ     ȟtissue assuming no error in M, 
(C) the error in CMRO2 caused by an error in M, assessing the impact of the 
magnitude of the BOLD response to the finger tap and M and (D) the combined 
effect of errors in the measurement of the flow response to hypercapnia and the 
finger tap on CMRO2ǡ  ȟtissue = 0.5 ms and W = 1.5 s. For clarity, the 
simulations performed have been summarised in Table 6-2. 
Figure Description Additional 
Variables 
Assumptions 
Figure 
6-5 A 
Error in M due to flow increase to 
hypercapnia  
ȟtissue W = 1.5s 
Figure 
6-5 B 
Error in CMRO2 due to flow increase 
to tap 
ȟtissue No account for error in M, W = 
1.5s 
Figure 
6-5 C 
Error in CMRO2 due to error in M BOLDTAP and 
M 
No account for error due to 
flow increase from tap 
Figure 
6-6 A 
Error in CMRO2 due to flow increase 
to hypercapnia and finger tap 
BOLDHC ȟtissue, W 
Figure 
6-6 B 
Error in CMRO2 due to flow increase 
to hypercapnia and finger tap 
BOLDTAP ȟtissue, W 
Table 6-2: Summary of simulations performed. 
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Figure 6-5: Simulation results assessing the impact of a single TI measurement on calibrated 
BOLD. (A) The error in M as a function of the flow increase to hypercapnia for different 
transit times (B) The error in CMRO2 as a function of the flow increase due to the finger tap 
for different transit times (C) The error in CMRO2 measurement due to errors in M with (i) 
different BOLD change to a finger tap and (ii) different values of M. The BOLD signal changes 
due to hypercapnia and the finger tap did not affect the % changes in M or CMRO2 for the 
simulations A,B and C(ii). 
The results of the simulations are shown in Figure 6-5 and Figure 6-6. Figure 6-5 
A shows that the use of a single TI model has a significant impact on the error in 
M. B demonstrates that as the response to the tap increases there is an increase 
in the error in CMRO2, with CMRO2 being overestimated. However this is small 
compared to the errors in M shown in A. Plots B did not take into account an 
underlying error in M, as seen in A. Plots C (i) and (ii) demonstrate how an error 
in M contributes to an error in CMRO2. They show that a large % error in M, 
causes a much lower % error in CMRO2 which is reduced if the BOLD response to 
the motor task is small or M is large. 
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Figure 6-6: Simulation results showing the % error in CMRO2 due to transit time errors in 
the measurement of the flow response to both hypercapnia and the finger tap, as a function 
of (A) the BOLD response to hypercapnia (assuming BOLDTAP = 3 %) and (B) the BOLD 
response to the finger tap (assuming BOLDHC = 2.5 %). Simulation parameters, at rest f = 90 
Ȁ ? ? ?Ȁǡȟtissue = 0.5 ms, W = 1.5 s. 
The results of the final simulations are shown in Figure 6-6. These show that the 
resulting error in CMRO2 is very dependant on the four measures (BOLD and CBF 
responses to hypercapnia and the finger tap). Typically the combined error in 
CMRO2 is between -10 and +30 %. However, with certain parameter 
combinations, e.g. a high BOLDTAP response, and high CBFHC response, the error 
can exceed + 50 %. 
These simulations demonstrate that single TI PASL can cause significant errors in 
measured flow changes as the shape of the perfusion curve is not taken into 
account. As shown in Figure 6-4, the flow change can be significantly 
overestimated which causes values of M to be significantly under or 
underestimated. However the CMRO2 estimate is relatively more robust to errors 
in the measured flow change due to the tap, and is also quite robust to errors in 
M.  
From Figure 6-5 C it can be seen that a large error in M does not lead to a 
corresponding large error in CMRO2. From Equation 6-5 it can be seen that as ȟ ? ? ? ?  ? ? ? ? ? ? ?  ?  ,  ? ? ? ? ? ? ? ? ? ? ? ? ? ൬ ? ? ? ? ? ? ?൰ ? ?ఈఉ 6-6  
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This demonstrates that CMRO2 tends towards a limit, restricting the range that 
CMRO2 can take for large M as demonstrated in Figure 6-7. The final CMRO2 value 
is then only dependant on the flow response to the motor task and the constants ȽȾǤ
stimulus is small compared to M, which could be due to an underestimated 
perfusion change to hypercapnia increasing M. 
 
Figure 6-7: Dependence of CMRO2 on M, dashed line represents the limit described in 
Equation 6-6 for (A) different values of the BOLD signal change and (B) the flow increase. 
The simulations demonstrate that using a single TI method in the presence of 
transit time changes can lead to large errors in CBF measurement and hence M 
and CMRO2. To reduce such errors a method of perfusion measurement that 
accounts for transit time changes is required. For the following experimental 
work a Look-Locker ASL method is used to measure CBF and transit time during 
hypercapnia, and a motor task to allow assessment of M and CMRO2 using the 
Davis model [1]. 
6.4.2 IN VIVO STUDY: EXPERIMENTAL METHOD 
5 healthy subjects participated in the study (3 female, age range 24 Ȃ 52 years), 
which was approved by the local ethics committee, and all subjects gave 
informed written consent. Data were acquired using a Philips Achieva 7 T system 
with head volume transmit coil and 16-channel SENSE receive coil.  
A FAIR ASL scheme (selective 10 mm wider than imaging volume, 250 mm non-
selective) with WET pre-sat and sinc post-sat pulses was used. LL-EPI-FAIR ȀȟȀ ? ? ? ?Ȁ ? ? ?Ȁ ? ? ?  ?readouts per 
TR; vascular crushing was applied using bipolar gradients with venc = 50 mms-1. 
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The image acquisition module comprised a GE-EPI readout; 5 contiguous axial 
slices, 2 x 2 x 3 mm3, FOV = 192 x 192 mm2, FA = 35°, TE = 23 ms, SENSE factor 2, 
partial kȂspace factor 0.8. An equilibrium EPI image with long TR and an 
inversion recovery EPI data set with 11 TIs (100 ms Ȃ 4000 ms) from which to 
form a T1 map were also acquired. 
Functional protocol: The hypercapnic challenge started with 2 min of subject 
specific baseline PETCO2 followed by 90s of hypercapnia (baseline + 10 mmHg 
PETCO2) and 90s of baseline. This was then repeated 4 times. PETO2 was targeted 
to remain at baseline throughout.  
In a separate LL-FAIR experiment a bilateral motor task was performed with 5 
cycles of 30s rest / 30s tapping. A schematic of the experimental protocol is 
shown in Figure 6-8. 
 
Figure 6-8: Schematic of the two functional paradigms performed, (A) a hypercapnic 
challenge and (B) a motor task comprising a bilateral finger tapping task. 
Data Analysis  
For the hypercapnic challenge, the first 30 seconds of each step was discarded 
and the average of the remaining PETCO2 data taken to allow the average CO2 
increase to be determined.  
For the motor task, BOLD and CBF regions of interest (ROI) in the motor cortex 
were determined using FEAT (FSL, FMRIB, Oxford). To increase CNR for defining 
active voxels, CBF perfusion weighted data was averaged over the first 5 readout 
phases to give one data point per TR, as shown schematically in Figure 6-9. The 
first 5 readouts were used as these points usually show the most difference 
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between rest and activation as shown in Figure 6-3 and Figure 6-12. The last 
readout of the control data was used for BOLD data analysis. Thus CBF and BOLD 
datasets had an effective temporal resolution of 6 s. BOLD data was smoothed 
with a 3 mm FWHM Gaussian kernel and CBF data was smoothed with a 5 mm 
FWHM Gaussian kernel due to lower SNR, both were temporally filtered with a 
highpass filter (cutoff 60s). The GLM analysis used a boxcar to represent the 
motor task, and a map of Z score was produced (cluster threshold with P<0.05). 
The ROI was selected as voxels with Z score greater than 60 % of the max Z score, 
to give a CBF ROI and a BOLD ROI. 
 
Figure 6-9: Schematic of analysis of the LLEPI data to determine CBF and BOLD ROI using 
GLM analysis. 
The 8 phase LL-EPI data was separated into hypercapnic and normocapnic 
periods by discarding the first 30s of each transition and averaging over the 
remainder. Similarly the motor task was divided into periods of tap and rest. The 
LL-EPI data was normalised globally by M0,b estimated from the grey matter long 
TR EPI images signal intensity to give fractional signal change. All the LL-EPI data 
was smoothed using a Gaussian kernel (FWHM of 3 mm) before fitting to a 
complex model. The ASL data was fitted (using the Powell algorithm) for CBF, 
transit time ('aȌȋɁȌȋ
be estimated ('tissue= 'a ?ɁȌǡ using the model of Francis et al. 
[39], both voxelwise data and the average LLEPI timecourses from the ROIs were 
fitted for CBF and transit time. 
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The BOLD data was spatially smoothed with a Gaussian kernel (FWHM 3 mm) 
and linearly detrended to remove drift. As for the ASL data, BOLD signal changes 
due to hypercapnia and the finger tap task were calculated voxelwise and for 
both the ROIs. 
CVR (cerebrovascular reactivity) measures were made voxelwise using both the 
% BOLD and % CBF changes due to hypercapnia over the entire grey matter ǯETCO2 change. The grey matter mask was formed from the 
inversion recovery data, which was fitted to form a T1 map; these were then 
thresholded to generate a grey matter mask (threshold of 1900 Ȃ 2300 ms). 
Analysis of M and CMRO2 was then performed in two ways (i) voxelwise (1 
subject was excluded from voxelwise analysis due to low SNR) with results then ǯȋȌǡ
the average signal curves from the ROI, for both the BOLD and CBF ROI. 
CBF and BOLD changes due to hypercapnia were used to determine M using the 
formula outlined in the Davis model [40] (Eqn. 6-4ǡȽ ? ?Ǥ ? ?ȏ ?ȐȾ ? ?), 
both voxelwise and using the CBF and BOLD ROIs. For the voxelwise analysis 
voxels were excluded from the ROI if they displayed a low hypercapnic reactivity 
(CBF increase due to hypercapnia < 5 % or BOLD increase due to hypercapnia < 1 
%). 
The CMRO2 change due to the finger tap relative to baseline CMRO2 was then 
calculated using the Davis model (Eqn. 6-5) for (i) a voxel wise analysis using M 
maps and (ii) the M values for the ROI analysis. 
6.4.3 RESULTS 
An example RespirAct trace is shown in Figure 6-10. The hypercapnic challenge 
caused the PETCO2 to increase by 6.6 ± 0.5 mmHg (averaged across subjects and 
repeats). 
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Figure 6-10: RespirAct traces from a single representative subject showing (A) PETCO2 and 
(B) PETO2. 
The motor ROI for all 5 subjects for BOLD and CBF data are shown in Figure 6-11. 
Good correspondence is seen between the two. The CBF ROI tended to be smaller 
and to not include the supplementary motor area (SMA) probably due to SNR 
limitations. It is expected that the BOLD ROI will include more voxels and include 
large veins as these produce large BOLD signal changes, but such changes would 
not be seen in the ASL data. 
 
Figure 6-11: BOLD and CBF ROI defined from GLM analysis for all 5 subjects. The ROI was 
formed from thresholding the GLM Z stat maps at 60 % of their maximum value. 
6.4.3.1 Cerebrovascular Reactivity Ȃ Effect of Hypercapnia on 
Perfusion and BOLD 
Example LL-EPI timecourses are shown in Figure 6-12. The shift in transit time 
and the change in perfusion between the three states are clearly visible. 
Hypercapnia caused the arrival time to reduce significantly (P < 0.05, Wilcoxon 
sign rank) from 484 ± 60 ms to 442 ± 65 ms (mean ± standard error, average 
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reduction of 9 %). Finger tapping caused a significant reduction in the arrival 
time to 420 ± 73 ms, an average reduction of 14 % compared to baseline (P < 
0.05). This highlights the need for a perfusion technique that accounts for transit 
time when studying hypercapnia or activation states. 
 
Figure 6-12: LL-EPI FAIR timecourses at normocapnia, hypercapnia and finger tap, for a 
representative subject in the CBF ROI (66 voxels). 
Example BOLD and CBF maps in response to hypercapnia are shown in Figure 
6-13. In grey matter, CBF reactivity was determined to be 5 ± 1 % / mmHg and 
BOLD CVR was 0.56 ± 0.06 % / mmHg (average across 5 subjects).   
 
Figure 6-13: CBF maps, equilibrium EPI and % BOLD changes due to hypercapnia and a 
finger tap in a single representative subject. 
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6.4.3.2 Comparison of Voxelwise and ROI Analysis for Calibrated 
BOLD 
Two ROIS were defined from the (A) CBF and (B) BOLD GLM analysis. Initially 
voxels where the reactivity to hypercapnia was low (CBF < 5 %, BOLD < 1 %) 
were excluded from the ROI defined from the GLM for the voxelwise analysis. The 
percentage of the voxels excluded was 26 ± 3 % in the BOLD ROI and 25 ± 3 % in 
the CBF ROI.   
An example map of M values is shown in Figure 6-14. It can be seen that M varies 
across the brain. Large values of M likely correspond to voxels with a large vein 
where the BOLD response to hypercapnia will be large but there will be a 
corresponding small CBF response. 
 
Figure 6-14: Example map of the calibration constant M as a % (left), for a representative 
subject, alongside their long TR EPI image (right) for anatomical reference. 
To assess the distribution of M, the histogram of M values within a grey matter 
and white matter mask was taken. The masks were defined from the T1 maps 
with grey matter defined in the range 1900 Ȃ 2,400 ms and white matter 1100 Ȃ 
1400 ms [41, 42]. Figure 6-15 shows that grey matter (solid line) exhibits the 
largest M values, as expected. White matter shows a shift to lower M values, as 
expected as the BOLD response to hypercapnia is reduced in the white matter [5].  
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Figure 6-15: Histogram of M values, averaged over the 4 subjects. Histograms shown for grey 
matter (solid line) and white matter (broken line). Error bars represent standard error 
across subjects. 
Figure 6-16 A shows the results for the voxelwise analysis averaged over the 4 
subjects for the BOLD ROI (dark grey) and CBF ROI (light grey). This shows a 
slight reduction in the BOLD signal change and M for the CBF ROI compared to 
the BOLD ROI. Only small differences were seen in the CBF measurements 
between the two ROIs. 
Figure 6-16 B shows the results of the ROI analysis for the BOLD and CBF ROI. A 
significant difference in the BOLD signal change due to both hypercapnia and the 
motor task was seen between the BOLD and CBF ROI, BOLD changes being 
significantly greater for the BOLD ROI. A significant difference in the calibration 
constant, M, can also be seen with a greater value of M for the BOLD ROI. No 
significant differences were seen in the CBF or CMRO2 measures between the two 
ROIs. 
Comparing the voxelwise and ROI based analysis the main difference is in the M 
values.  The M values were more consistent between the two ROIs for the 
voxelwise analysis, this is because the voxelwise analysis excluded voxels where 
the CBF and BOLD responses to hypercapnia were low. Large M, as seen in the 
BOLD ROI analysis, results from a large BOLD response to hypercapnia 
accompanied by a small flow response to hypercapnia, as might be expected if 
large veins are present.  
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Figure 6-16: Subject averaged fractional CBF and percentage BOLD changes due to 
hypercapnia and finger tap, calibration constant M and CMRO2 for (A) voxelwise and (B) ROI 
analysis. * represents significant difference between ROI values. Dark coloured bars are for 
the BOLD ROI and light gray bars are the CBF ROI. Error bars represent standard error 
across subjects. 
 
Figure 6-17: CMRO2 maps overlaid onto equilibrium EPI images for the 4 subjects in the 
voxelwise analysis for both ROIs. 
Figure 6-17 shows the CMRO2 maps for the four subjects used in the voxelwise 
analysis overlaid onto their equilibrium EPI images. Voxelwise analysis has the 
benefit of showing local variation of CMRO2 over the cortex. 
6.4.3.3 Alternative Measures for M 
As demonstrated in Figure 6-16, a large variation in M does not result in large 
variation in CMRO2. As M requires a separate experiment to measure this 
parameter, in addition to a functional finger tap task, it is important to consider 
alternatives to M for calculating the CMRO2 change. Figure 6-18 correlates 
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baseline CBF with the calculated value of M over the motor cortex for 4 subjects, 
defined from the CBF ROI. This demonstrates a positive correlation between M 
and CBF0 over the CBF ROI (R2 of fit, range of 0.4 Ȃ 0.66). 
 
Figure 6-18: Voxelwise plot of M versus baseline CBF (CBF0) for 4/5 subjects linear 
trendlines for the CBF ROI. R2 values of fit displayed. 
In the earlier discussion it was shown that as M increases, CMRO2 does not 
increase greatly. Figure 6-19 shows how CMRO2 varies with M, for small M 
CMRO2 is quickly varying but tends towards an upper limit as M increases. If  ȟ ?  ? ? ?  ? ?  ?  ? then CMRO2 tends to a limit only dependant on the evoked flow 
response to the finger tap. The experimental data, and the limit described in 
Equation 6-6, are shown in Figure 6-20. This shows that the CMRO2 limitation 
model (Equation 6-6, red line) overestimates, but describes the data well.  
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Figure 6-19: CMRO2 as a function of M for the BOLD ROI (data from the 4 subjects shown). 
 
Figure 6-20: CMRO2 as a function of the evoked CBF response to the finger tap for the BOLD 
ROI (black dots). Red line is the relationship given in Equation 6-6, (data from the 4 subjects 
shown). 
6.4.4 DISCUSSION 
Calibrated BOLD is a common technique used to estimate CMRO2 through the 
measurement of BOLD and perfusion changes. With this technique, a hypercapnic 
challenge is used to determine the calibration constant, M. This technique has 
been widely used at 3 and 1.5 T, however few studies have performed calibrated 
BOLD at higher field strengths in humans. The aim of this experiment was to 
measure the perfusion change and transit time change using LL-EPI ASL due to 
hypercapnia and a motor task. These results were then used to determine M and 
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CMRO2 changes using the Davis model at 7 T both on a voxelwise basis and using 
an ROI method that is typically performed. 
An increase in cerebral perfusion and reduction in blood arrival time in response 
to the hypercapnic challenge was found, changes in both of these parameters 
were less than the response to the motor task. CBF reactivity was found to be 5 ±  
1 % / mmHg and is comparable to that found by St Lawrence et al. (4 % / mmHg) 
[43] and Mark et al. (3 % / mmHg) [33]. BOLD CVR studies to hypercapnia have 
not been widely performed at 7 T. Driver et al. [5] measured R2* reactivity at 7 T 
and 3 T, and found a factor of 2 increase between the CVR measures made at the 
two field strengths, from 0.066 s-1/ mmHg to 0.141 s-1 / mmHg. BOLD CVR 
measures at 3 T have been found to be approximately 0.3 % / mmHg [33, 44]. As 
expected, this study found a higher BOLD CVR (0.56 ± 0.06 % / mmHg), a factor 
of 1.9 increase, due to the increased BOLD signal at 7 T.  
The ROI calibrated BOLD analysis demonstrates a significant dependence of the 
results on ROI definition [45]. The BOLD ROI showed an increased measured 
BOLD change and a larger value of M compared to the CBF ROI. This is likely to be 
due to the inclusion of large veins in the BOLD ROI. The voxelwise analysis was 
less affected by the ROI as further discrimination of the individual voxel data is 
available Ȃ voxels that are largely veins or white matter will be excluded due to 
low hypercapnic CBF reactivity.  
Voxelwise analysis produced maps of M, the Davis model calibration constant 
(Figure 6-14). This demonstrates that voxelwise analysis is feasible at 7 T and 
crucially it demonstrates that M varies over the brain. This highlights the fact that 
studies should measure M for the region under investigation and not average 
over entire grey matter or use an assumed value. There are no other reported 
measures of M at 7 T that can be compared with the values measured here (24 % 
voxelwise in the CBF ROI). However, it is known that M is largely variable across 
and within subjects. For example, Leontiev and Buxton measured M values 
ranging between 5 and 20 % at 3 T [45]. 
The large increase in M that was found for the BOLD ROI compared to the CBF 
ROI for the ROI analysis did not lead to a corresponding change in CMRO2. 
Equation 6-6 demonstrates that CMRO2 tends towards a limit, restricting the 
range CMRO2 can take for large M as demonstrated in Figure 6-7. The final CMRO2 
value is then only dependant on the flow response to the motor task and the 
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ȽȾǤFigure 6-7 A demonstrates that with a small BOLD response to 
the finger tap, the values of CMRO2 are close to the limit even with smaller values 
of M. The closer values of   ? ? ? ? ? ? ?  ? ? ? ? ?ൗ  are to 0, the closer that CMRO2 is to 
the limiting value. Experimentally this was shown in Figure 6-20, where the 
upper limit expression of CMRO2 was shown to describe the data well but 
overestimated. 
This result is counter intuitive as it is expected that as M increases there is a 
corresponding increase in the evoked BOLD response such that  ? ? ? ? ? ? ?  ? ? ? ? ?ൗ  does not tend towards 0. For voxels that are predominantly 
white matter, the BOLD and flow changes due to hypercapnia and the functional 
task will be low, equally for veins the BOLD response to hypercapnia will be high, 
but the flow response will be low (~ 1), so both white matter and veins are 
removed in the voxelwise analysis due to low CBF response to hypercapnia. The 
remaining voxels should be cortical grey matter but there is still a mismatch 
between M and evoked BOLD. Large M arises from a large BOLD response to 
hypercapnia coupled with a small flow response, then a relatively small BOLD 
response to the functional challenge to cause   ? ? ? ? ? ? ?  ? ? ? ? ?ൗ to tend to 0. 
The relationship in Equation 6-6 shows that CMRO2 is independent of the 
hypercapnia measurements; the voxelwise analysis was interrogated further to 
assess the dependence of M on basal CBF (Figure 6-18). Figure 6-18 suggests a 
positive correlation between M and CBF0. If the average linear relationship 
between M and CBF0 was used to estimate M and hence CMRO2, the value for 
CMRO2 would be 1.17 ± 0.07 which corresponds well with the other results (1.13 Ȃ 1.22). The origin of this dependence on M with basal CBF can be interrogated by 
taking the Taylor series of M as a function of fHC = CBFHC / CBF0 about a value of 
1.2; 
 ? ? ? ? ? ? ?ൌ  ? ? ? ? ?ൌ  ? ? ??൅  ? ? ? ?ฬ ?ಹ಴ ? ? ? ?ȉ  ? ? ? ?െ  ? ? ??൅  ? ? ? ? ? ? ? ?ಹ಴ ? ? ? ?ȉ  ? ? ? ?െ  ? ? ?? ? 6-7    Ƚ  ?  ?Ǥ ? ?ǡ Ⱦ  ?  ?ǡ  ? ? ? ?െ  ? ? ?? ? ? ?  and that CBFHC Ȃ CBF0  ? ɁǡɁ	0 (approximated from experimental data), it can be 
shown that 
 ? ? ? ? ? ? ?ൎ  ? ?  ? ? ? ? ? ? ?െ  ? ?  ? ? ? ? ? ? ? ? ? ? ? ?  6-8  
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where BOLDHC is the % BOLD change due to hypercapnia. Figure 6-21 shows 
graphs of this relationship as a function of CBF0, for different values of BOLDHC ɁǤ 	0 
values. 
 
Figure 6-21: Taylor series approximation for the relationship between M and CBF0, with 
variable (A) BOLD response to hypercapnia with Ɂ = 20 ml/100g/min ȋȌɁǡ
flow increase due to hypercapnia with BOLDHC = 3 %. 
Further consideration of this relationship should be investigated, as if M could be 
approximated by CBF0 this would simplify the experiment time. In addition, the 
functional task (e.g. motor) could be extended to ensure high SNR in the CBF 
measurements. This would make calibrated BOLD a more flexible technique for 
general use and for example for the study of longer fMRI tasks (e.g. cognitive) or 
in the study of patients where movement can significantly affect data quality.  
6.4.5 CONCLUSION 
This experiment has shown the marked effect of hypercapnia on cerebral blood 
flow and the BOLD effect at 7 T. These characteristics have been used in the Davis 
model to estimate the CMRO2 increase due to a simple finger tapping task. 
Through the standard ROI analysis and then voxelwise analysis it was shown that 
ROI definition can have significant effect on BOLD and M measurements but does 
not impact greatly upon CMRO2 [45]. 
Voxelwise analysis was seen to be more robust to ROI choice as further 
discrimination can be applied to reduce the impact of large vessels in the ROI. 
Voxelwise analysis allows for further interrogation of the relationship between 
the underlying physiological measurements and the metrics of the Davis model. 
This analysis demonstrated that M does not greatly impact CMRO2 measures and 
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further experiments are required to probe the feasibility of Davis model 
calibrated BOLD without hypercapnia measures. This would reduce experiment 
time, giving greater flexibility in the effects being investigated. 
6.5 THE EFFECT OF HYPERCAPNIA ON MEG SIGNALS 
The Davis model assumes that hypercapnia is isometabolic allowing for M to be 
calculated by only measuring BOLD and CBF (Equation 6-4) as demonstrated in 
the first experiment. However recent work by Zappe et al. [24] demonstrated that 
hypercapnia caused a reduction in multi-unit activity measured with invasive 
electrophysiology in anaesthetised monkeys. They hypothesised that this 
reduction could be suggestive of a CMRO2 change with hypercapnia. The 
following experiment was designed to investigate whether this is true in humans. 
Non-invasive measurement of human neuronal activity can be performed using 
electroencephalography (EEG) or magnetoencephalography (MEG). In the 
following study, MEG is used for assessment of neuronal activity. This was 
because the MEG system has more channels (275 compared to 64 in the available 
EEG system) and higher signal-to-noise. EEG is also further complicated by the 
inhomogeneous conductivity across the skull/scalp distorting the electric field 
produced by neurons; this makes source localisation in EEG more difficult [46]. 
6.5.1 MEG INSTRUMENTATION 
The MEG system uses superconducting loops to pick up the weak currents 
produced by the small neuromagnetic fields. These pick up coils are coupled to 
super-conducting quantum interference devices (SQUIDs) to produce a voltage 
output proportional to the current flowing in the pick up coil [46], schematically 
represented in Figure 6-22. An array of these detectors are used to give whole 
head coverage. 
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Figure 6-22: Schematic flow chart of MEG detection of neuronally generated magnetic fields, 
adapted from [46]. 
 As the neuronally generated magnetic field is very small (fT) compared to 
environmental magnetic noise (e.g. from computers and other lab equipment) 
MEG scanners are housed within magnetically shielded rooms to reduce 
interference. The shielded rooms are made from materials of high magnetic 
permeability (mu-metal Ȃ a nickel-iron alloy) to reduce static field noise, and 
aluminium to reduce eddy current magnetic fields. To stop the introduction of      ǯ        
create magnetic fields if it moves (e.g. with breathing). 
Furthermore, gradiometers are used to remove background magnetic field ǡǯ
from the head (1/r2 dependence) Ȃ whereas other sources of magnetic field are 
likely to originate further away and will be approximately constant across the 
detector coil. First-order gradiometers have two loops of wire connected in series 
but wound in opposite directions. These will produce two equal but opposite 
current for magnetic fields that are constant between the two loops, cancelling 
out the effect.  
The MEG data are dominated by neural oscillatory effects characterised by 
rhythmic electrical activity in cell assemblies. These signals can be broken down 
into specific frequency bands; these bands are associated with different activities 
or states, summarised in Table 6-3. 
Neuromagnetic fields generate a current in a superconducting wire 
loop. 
Current in loop generates a magnetic field which is detected by the 
SQUID 
Magnetic field causes critical current in SQUID to be exceeded, 
voltage drop occurs across junction 
Feedback current applied to counteract the induced current 
Magnitude of feedback current is output of the system 
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Name Frequency Information ǡɁ < 4 Hz Most pronounced during deep sleep ǡɅ 4 Ȃ 8 Hz Associated with sleep, and cognitive processing (e.g. 
[47]) ǡȽ 8 Ȃ 13 Hz Most pronounced in awake relaxed subjects, 
interrupted by stimulation (e.g. visual, motor) ǡȾ 13 Ȃ 30 Hz Predominantly associated with motor cortex 
ǡɀ 30 Ȃ 100 Hz Predominantly associated with visual cortex 
Table 6-3: Characteristic frequency bands, adapted from [48]. 
The MEG data are acquired in sensor space by detectors placed around the scalp 
and ideally need the measurements to be transformed into source space (i.e. in 
the brain) for interpretation. There are a number of different methods of source 
space projection; here a scalar beamformer is employed. For the scalar 
beamformer (e.g. [49, 50]) the strength of a source, y, at a particular location and 
orientation, Ʌ, and point in time, t, is given by a weighted sum of measurements 
(x) from the MEG sensors,  ?ఏ ? ? ?ൌ ࢃ ? ?ࣂ ? ? ࢞ ? ? ?  6-9 
The weights, W, are derived from the lead fields, LɅ, a measurement of the 
sensitivity of each MEG sensor to a current source at location and orientation Ʌ 
and the covariance matrix, C, of the measured data [48], (superscript T 
represents matrix transpose).  
ࢃࢀ ?ࣂ ?ൌ ࡸࣂࢀ࡯ ? ?ࡸࣂࢀ࡯ ? ?ࡸࣂ 6-10 
The current orientation is determined based on a non-linear search for maximum 
signal-to-noise. By using Equation 6-9 at each point in time, a timecourse of 
source strength can be found. Such timecourses will contain many independent 
signals from the different frequency bands. Hence band pass filters are applied to 
interrogate specific frequency bands, the main bands are given in Table 6-3. 
When looking at stimulus induced changes, the analytic signal can be used to 
form the envelope of an oscillatory signal. The envelope is calculated as 
 ? ? ? ?ൌ ට ? ?ఏ ? ? ? ? ?൅  ? ?൫ ?ఏ ? ? ?൯ ? ? 6-11 
where E is the envelope of the signal, H indicates the Hilbert transform [48]. 
Figure 6-23 demonstrates the envelope derived from the analytic signal of a 
173 
 
simulated oscillatory signal. This allows for calculation of amplitude changes in 
the signal due to a stimulus. For example in a motor task a reduction in beta 
power is expected, corresponding to a stimulus induced decrease in the beta 
band envelope. 
 
Figure 6-23: Example of the signal envelope derived from Hilbert transform, signal (solid 
line) and envelope (broken line) shown. 
6.5.2 EXPERIMENTAL METHOD 
Six healthy subjects (4 male, age range 24 Ȃ 33 years) took part in the study 
which was approved by the University of Nottingham Medical School Ethics 
Committee. All subjects gave informed, written consent. 
MEG Acquisition: MEG data were acquired using the synthetic third order 
gradiometer configuration of a 275-channel CTF MEG system (MISL, Port 
Coquitlam, BC, Canada), at a sample rate of 600 Hz and with a 150 Hz anti-aliasing 
hardware filter.   ǯ

and after each experiment by energising electromagnetic coils placed at 3 fiducial 
points on the head (nasion, left preauricular and right preauricular). Prior to data ǡ        ǯ   
using a 3D digitiser (Polhemus isotrack). An MPRAGE structural image was 
acquired on a Philips Achieva 3 T MRI scanner (1 mm3 isotropic resolution, 256 x 
256 x 160 matrix size, TE/TR/TI = 3.9/8.3/960 ms, FA = 8q, shot interval = 3s, 
and SENSE factor = 3). The locations of the fiducial markers and MEG sensors 
with respect to the brain anatomy was determined by matching the digitised 
head surface to the head surface extracted from the structural MRI.  
174 
 
Experimental Paradigm: The RespirActTM (Thornhill Research Inc, Toronto, 
Canada) was used for end-tidal targeting [34]. Three experiments were 
performed during which PETO2 was targeted to remain constant:  
Experiment 1: Subjects were instructed to fixate their eyes on a dot. The gas 
challenge comprised an initial 2 minute period of baseline (defined as each ǯ  ETCO2), followed by 3 cycles of 2 minutes of hypercapnia 
(PETCO2 level raised to baseline + 10 mmHg) and 2 minutes of baseline. The total 
duration of this experiment was 14 minutes. 
Experiment 2: Subjects fixated on the dot during a second gas challenge which 
comprised an initial 1 minute of baseline followed by 2 cycles, each comprising 2 
minutes of hypercapnia (baseline + 10 mmHg) and 5 minutes of baseline. The 
total experimental duration was 15 minutes.  Experiment 2 was used to 
investigate the recovery of the MEG signal after hypercapnia. 
Experiment 3: Here, the gas challenge was identical to Experiment 1, but during 
the experiment the subject was presented with a visual stimulus and performed a 
motor task. The visual stimulus was a drifting sinusoidal grating (3 
cycles/degree; 8 Hz drift rate; Michelson contrast of 1; shown in Figure 6-24) 
presented in a circular window which was central in the visual field (visual angle 
6 degrees).  A single trial comprised 5 s of visual stimulation followed by 5 s of 
rest during which the subjects viewed the fixation dot. Subjects were instructed 
to press a button using the index finger of their left hand (motor response) 
immediately after cessation of the visual stimulus.  
 
Figure 6-24: Visual stimulus used in Experiment 3. 
Experiments 1 and 3 were performed in the same session on all 6 subjects. 
Experiment 2 was carried out in 5 of the 6 subjects in a separate session three 
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weeks later to further investigate the timecourse of changes in neural oscillatory 
activity induced by hypercapnia. 
Data Analysis 
RespirActTM data: End tidal RespirActTM data were used to quantify the average 
PETCO2 and PETO2 change between hypercapnia and baseline.  
In order to assess the effect of hypercapnia on reaction time, the time between 
stimulus cessation and the button press was calculated for each subject. 
MEG data: Raw MEG data were visually inspected and trials with excessive noise 
were discarded. DC offsets were removed on a trial-by-trial basis and data 
filtered into frequency bands of interest: theta (4 Ȃ 8 Hz), alpha (8 Ȃ 13 Hz), beta 
(13 Ȃ 30 Hz) and low gamma (30 Ȃ 50 Hz). For all three experiments, data were 
processed using an adaptive beamformer [50-54]. The output comprises a 
timecourse estimate of electrical activity at the location specified, and sequential 
application to all voxels yields a set of timecourses that can be further analysed to 
create volumetric images of change in electrical activity (e.g. [55]). Covariance 
matrices were regularised as described previously [50]. This algorithm yields 
accurate source localisation across a large brain volume, but has also been shown 
to be an excellent means to attenuate channel level interference in MEG signals 
caused by environmental magnetic noise.  
Experiments 1 and 2 
The beamformer was used to produce images of the change in spontaneous 
neural oscillatory activity due to hypercapnia. A pseudo-T-statistical (T) 
approach was employed in which the oscillatory amplitude in an active time 
window (hypercapnic periods) was contrasted with that in a control time 
window (normocapnic periods), 
 ?ఏ ൌ  ?ఏ ?െ  ?ఏ ? ?ఏ ?൅  ?ఏ ? 6-12 
where y is the source power, and v the noise, a is the active window 
(hypercapnia) and c the control window (normocapnia) [50]. 
The number of samples in the active and control periods were equal to ensure no 
bias between measurements [56]. Covariance matrices were regularised with a 
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value of 4 times the minimum singular value of the unregularised matrix. Voxels 
were placed on a regular 5 mm grid spanning the entire brain.  
For each voxel, the timecourse of electrical activity was derived; its associated 
Hilbert envelope was also computed. The mean envelope amplitude in the active 
and control windows was then computed and the difference normalised by the 
control value. This was computed for all voxels, and independently for each 
frequency band. For each frequency band the statistical significance of frequency 
change was assessed using a Monte Carlo technique [47, 57, 58] in which 50 Ǯǯ -T statistical images were calculated with active and control 
windows randomly switched. Voxels were identified as having statistically 
significant changes in oscillatory amplitude if they fell in the upper 5th percentile 
of T-values computed in the randomised images. These maps, which depict 
change in oscillatory activity induced by hypercapnia, are termed reactivity maps. 
E ǯ    -registered to MNI space using FLIRT (FSL, 
Oxford) and the transform applied to the reactivity maps, which were then 
averaged across subjects. 
Following computation of average reactivity maps, three brain locations were 
further investigated. The first (location 1) was the voxel with peak value in the 
beta band reactivity maps, location 2 was in the visual cortex (based on the 
location of visual activation found in Experiment 3) and chosen specifically to 
draw direct comparisons with the work of [24] and location 3 was in the medial 
frontal area (MNI [-2 36 32] mm, an area associated with cognitive processing in 
working memory [47]). MEG data were frequency filtered into the following 17 
frequency bands; 1 Ȃ 4, 2 Ȃ 6, 4 Ȃ 8, 6 Ȃ 10, 8 Ȃ 13, 10 Ȃ 15, 13 Ȃ 20, 15 Ȃ 25, 20 Ȃ 
30, 25 Ȃ 35, 30 Ȃ 40, 35 Ȃ 45, 40 Ȃ 50, 45 Ȃ 55, 50 Ȃ 60, 55 Ȃ 65 and 60 Ȃ 80 Hz. 
Weights were constructed independently in each band for the three brain 
locations and the Hilbert envelope was derived for each band. Hilbert envelopes 
were averaged across hypercapnic and normocapnic periods yielding two 
spectra, the difference between which gives the change in neural oscillatory 
amplitude due to hypercapnia as a function of frequency. These spectra were 
averaged across subjects and significant differences between normocapnia and 
hypercapnia tested using a non-parametric Wilcoxon signed rank test. 
To assess dynamic changes the data were filtered in the 8 Ȃ 40 Hz band (based on 
results presented below), and the Hilbert envelope at location 1 computed and 
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down-sampled to an effective temporal resolution of 1 s to increase its signal-to-
noise ratio. Timecourses of the evolution of oscillatory amplitude across the 
experiment were then averaged across subjects.  
Experiment 3 
MEG data recorded during Experiment 3 were initially processed using a 
standard commercial implementation of synthetic aperture magnetometry (SAM) 
(MISL, Port Coquitlam, BC, Canada), a scalar beamformer technique widely used 
in MEG studies [50, 55]. Pseudo-T statistical images were computed [55] 
localising the induced changes in oscillatory power due to both the visual 
stimulus and the button press. To localise visual effects, the active window was 
defined as 0.5 Ȃ 4.5 s with respect to trial onset and the control window as 5.5 Ȃ 
9.5 s with respect to trial onset. To localise motor effects, the active window was 
0 Ȃ 0.75 s following the button press whilst the control window was 2 Ȃ 2.75 s 
following the button press. A regularisation value of 2 was used for weghts 
calculation for both stimuli, including a regularisation factor increases the signal 
to noise but also increases the spatial smoothness of the data [50]. Data were 
processed in the 30 Ȃ 50 Hz, 50 Ȃ 70 Hz and 70 Ȃ 90 Hz bands to localise visual 
cortex activity whilst beta band filtered data were used to localise the motor 
areas. Resulting images, termed functional maps, were subsequently transformed 
to MNI space and averaged across subjects. 
Locations of interest in visual and motor cortices were derived from peaks in the 
functional maps and Hilbert envelope data computed for each location in the 
frequency bands used above. Trials were divided into two sets, those in which the 
stimulus was presented during hypercapnia, and those in which the stimulus was 
presented during normocapnia. For each dataset, data within each trial were 
divided into active and rest time periods (for visual analysis the active period 
was taken as 0.5 Ȃ 4.5 s and the control was 5.5 Ȃ 9.5 s; for motor analysis the 
periods were 5 Ȃ 6 s and 7.5 Ȃ 8.5 s respectively).  
For both hypercapnia and normocapnia, the average change in oscillatory 
amplitude between the active and control periods was computed to give absolute 
change in mean amplitude, this was then normalised by the control value to give 
% change in mean amplitude due to the stimulus under the two conditions. These 
values were then averaged across subjects and significant differences between 
normocapnia and hypercapnia assessed using a Wilcoxon sign rank test. The 
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average timecourse of the Hilbert envelope in the 8 - 25 Hz frequency band was 
also computed for hypercapnic and normocapnic trials. Finally the visual evoked 
response (from the peak in visual cortex) was analysed by filtering the data in the 
1 Ȃ 40 Hz band. Beamformer timecourse estimates (without Hilbert envelope 
computation) were averaged across hypercapnic and normocapnic trials.  
6.5.3 RESULTS 
The average step in PETCO2 for all three experiments was 7 ± 1 mmHg (average 
and standard error across both experiments and all subjects); PETO2 increased 
from 111 ± 4 mmHg to 115 ± 4 mmHg between hypercapnia and baseline. 
No significant difference (470 ± 40 ms at normocapnia, 490 ± 70 ms at 
hypercapnia) was found in reaction time between hypercapnic and normocapnic 
trials.  
Figure 6-25 shows the group average reactivity maps depicting percentage 
change in the alpha, beta and low gamma (30 Ȃ 50 Hz) bands due to hypercapnia 
for Experiment 1 (A, B and C) and Experiment 2 (D, E and F). Widespread loss in 
mean oscillatory amplitude was observed in all three frequency bands.  
 
Figure 6-25: % Change in spontaneous MEG signals for Experiment 1 (A-C) and Experiment 2 
(D - F). 
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 Experiment 1 Experiment 2 
 MNI  % Change MNI % Change 
Alpha [-18 -74 50] -13 ± 4 [-22 -54 66] -16 ± 4 
Beta [-46 -22 56] -14 ± 2 [-42 -24 62] -15 ± 2 
Low Gamma [40 -24 54] -10 ± 1 [-40 -16 60] -11 ± 3 
Table 6-4: MNI positions of peaks in the reactivity maps for Experiments 1 and 2, with 
corresponding signal changes. Change expressed as % with respect to normocapnia, mean ± 
standard error across subjects. 
Alpha band changes were most apparent across the posterior parietal and 
occipital regions, including the medial and lateral visual areas, MNI coordinates 
of peaks are shown in Table 6-4. Beta band changes are most apparent in 
sensorimotor regions with areas of significant change spanning the sensorimotor 
strip and posterior parietal areas. Significant gamma band changes were less 
widespread and appeared more focal to the hand area of the sensorimotor.  
Figure 6-26 A shows the frequency characteristics of change in neural oscillatory 
activity in response to hypercapnia for: 1) the position of peak change in beta 
power in the sensorimotor cortex from Experiment 1 (MNI [-46 -22 56] mm) 
(blue); 2) the primary visual cortex (MNI [-8 -80 -6] mm) derived from the visual 
stimulus data in Experiment 3 (red) and 3) the medial frontal cortex (MNI [-2 36 
32] mm [47]) (green). In location 1 significant power loss is observed in the 8 Ȃ 
60 Hz band, with highest power loss being found at 20 Hz. Location 2 
demonstrates significant power loss in the 8 - 30 Hz band with the peak at 10 Hz. 
Changes were smaller in the location 3 as expected from the images shown in 
Figure 6-25, but significant power loss was observed in the alpha, high beta and 
gamma range. Interestingly a significant increase in theta power was also 
observed in medial frontal cortex.  
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Figure 6-26 (A) Power change due to hypercapnia at 3 brain locations, * indicates significant 
power change (P < 0.05) (B) Timecourse in 8 - 40 Hz for Experiment 1 (C) Timecourse in 8 - 
40 Hz for Experiment 2. Shaded areas indicate the periods of hypercapnia. 
Figure 6-26 B shows the group average time evolution of oscillatory amplitude in 
the 8 - 40 Hz frequency band across the duration of Experiment 1 extracted from 
the location of maximum beta band power change. Figure 6-26 C shows the 
equivalent timecourse for Experiment 2. Figure 6-26 C also shows a significant 
delay of approximately 100 s in the recovery of the MEG signal to baseline 
following hypercapnia 
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Figure 6-27 (A) Group average pseudo T-statistic images for the visual stimulus (B) Power 
change due to stimulus at hypercapnia (red Ŷ) and normocapnia (blue Ƈ) (C) % change due 
to stimulus (D) Time course  in 8 Ȃ 25 Hz range, thick black line indicates stimulus (E) Visual 
evoked response. All averaged across subjects. * Indicates significant difference between 
hypercapnia and normocapnia. Error bars represent standard error across subjects. 
Figure 6-27 A shows the group averaged functional map showing the location of 
change in gamma oscillations (30 Hz Ȃ 50 Hz range) due to visual stimulation. 
Functional maps are overlaid onto the standard brain and the MNI coordinate for 
the peak pseudo T-statistic in the group average map is [-8 -80 -6] mm. Figure 
6-27 B shows the absolute power change and C the corresponding percentage 
change in amplitude due to visual stimulation at normocapnia (blue) and 
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hypercapnia (red) plotted as a function of frequency. In both cases, a 
characteristic increase in gamma oscillations accompanied with a loss in 
amplitude in the lower frequency bands can be seen in response to the visual 
stimulus. Although the percentage change in oscillatory amplitude due to visual 
stimulation is similar for normocapnia and hypercapnia (C), hypercapnia reduced 
the visual induced change in low frequency (alpha and beta band) oscillations.  
Figure 6-27 D further characterises this effect by showing the Hilbert envelope, 
computed in the 8 Ȃ 25 Hz range, for the average stimulus cycle for normocapnia 
and hypercapnia. During the rest period (7 Ȃ 10 s), the average oscillatory 
amplitude in the visual cortex was 13 ± 1 nAm for normocapnia and this fell to 11 
± 1 nAm for the hypercapnic trials (mean ± standard error across subjects) (P < 
0.03), consistent with results of Experiment 1 (Figure 6-26 A). Despite this 
baseline change, the oscillatory amplitude following stimulus onset (0.3 s to 0.8 s 
window) falls to the same level for normocapnic (9.6 r 0.7 nAm) and hypercapnic 
(9.3 r 0.5 nAm) trials (no significant difference across subjects). Figure 6-27 E 
shows the visual evoked response, averaged across all normocapnic (red) and 
hypercapnic (blue) trials. It is worth noting that no significant differences were 
observed in the evoked response between normocapnia and hypercapnia. 
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Figure 6-28 (A) Group average pseudo-T statistic image of the response to the button press 
(B) Power change due to stimulus at hypercapnia (red Ŷ) and normocapnia (blue Ƈ) (C) % 
change due to stimulus (D) Timecourse in 8 - 25 Hz range, thick black line indicates time of 
button press, timing of active and control windows also shown. All averaged across all 
subjects. Error bars represent standard error across subjects. 
Figure 6-28 A shows the group average functional map depicting the spatial 
distribution of loss in beta power in response to the button press. As expected, 
the left hand button press induced the largest change in the right primary motor 
cortex (average MNI coordinate [34 -24 54] mm). Figure 6-28 B shows the 
absolute change and Figure 6-28 C the corresponding percentage change in 
oscillatory amplitude due to the finger movement at normocapnia (blue) and 
hypercapnia (red). Characteristic loss in beta band oscillations due to the button 
press is clearly evident in both cases. Again, some difference was observed 
between normocapnia and hypercapnia; this difference is accentuated in the 
absolute values compared to percent change values and this agrees with findings 
in the visual cortex. Figure 6-28 D shows the Hilbert envelope (8 Ȃ 25 Hz band) 
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with a clear desynchronisation at the time of the button press (~ 5 s). Again the 
effect of hypercapnia can be observed with the average oscillatory amplitude (8 - 
25 Hz) in the 7 - 10 s time window being significantly reduced (P < 0.03 
computed across subjects) from 9 ± 1 nAm for normocapnia to 8 ± 1 nAm for the 
hypercapnic trials. In agreement with the visual task, despite the change in 
baseline values, the oscillatory amplitude falls to the same value in response to 
the button press (6.2 r 0.6 nAm for normocapnia and 6.1 r 0.4 nAm for 
hypercapnia computed between 5.4 s and 5.8 s, no significant difference across 
subjects). 
6.5.4 DISCUSSION 
This experiment has shown that a hypercapnic stimulus causes significant and 
widespread changes in the level of spontaneous neural oscillations in a number 
of frequency bands, in agreement with previous studies [24, 28, 30, 59]. The 
changes in neural oscillations induced by hypercapnia are spatially specific, with 
the spatial pattern changing as a function of frequency band. Also, despite a 
difference in resting state baseline, the absolute oscillatory amplitude 
immediately following visual or motor events is unaffected by PETCO2.   
The reduction in oscillatory amplitude during hypercapnia was highly robust, 
exhibited by its repeatability across subjects and between Experiments 1 and 2. 
The spatial distribution of desynchronisation was predominantly bilateral with 
the greatest effects in the parietal and occipital lobes. The largest beta band 
effects were close to the hand area of sensorimotor cortices which could be due, 
in-part, to the predominance of beta oscillations in these regions. The alpha shift 
was highest in the occipital lobe, which again could again be because the largest 
alpha signals originate in this region.   
The precise cause of the desynchronisation observed in response to hypercapnia 
remains unknown. Zappe et al. [24] suggested a pH decrease caused by 
hypercapnia could affect neuronal excitability and therefore be responsible for 
the reduction in spiking and LFP activity. Participants reported an acidic taste 
due to the CO2 which is likely to have activated sensory areas. This effect would 
implicate sensory cortices; however this effect would be expected to induce 
maximal effects in the insula and inferior areas of somatosensory cortex which 
was not the case in the reactivity maps. Another possible explanation could result ǯ (e.g. taste, increased heart rate, 
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or need to breathe deeply). Beta desynchronisation in the motor network is not 
only associated with movement, but also with the intention to move (e.g. [60]). If, 
during unpleasant periods of hypercapnia, subjects contemplated movement (for 
example, removal of the mask) this might explain some of the effects observed.  
Another finding is that following hypercapnia-induced oscillatory power loss, the 
signal took ~ 100 s to return to baseline. The PETCO2 stimulus was a square wave 
and hence cannot explain the protracted recovery observed in this study. This 
slow recovery of the oscillatory amplitude should be a topic for future 
investigation.  
The motivation for Experiment 3 was to assess the effect of hypercapnia on 
stimulus induced changes in neural oscillations in the visual and motor systems. 
Whilst large robust changes in spontaneous oscillatory activity were observed in 
response to hypercapnia, Figure 6-27 and Figure 6-28 show that hypercapnia had 
a smaller effect on visual and motor task induced changes in neural oscillations. 
They show that percentage changes due to the stimulus with respect to baseline 
were similar for hypercapnic and normocapnic trials. However, absolute 
measures of oscillatory amplitude showed that stimulus induced changes were 
smaller under hypercapnia compared to normocapnia. This agrees with the 
electrophysiology study by Zappe et al. [61], who showed that the percentage 
response to visual stimulation relative to baseline, was unchanged by 
hypercapnia. Whilst Jones et al. [59] showed a decrease in current source density, 
which was measured as an absolute change. Taken together, these results suggest 
that absolute power change due to a stimulus differs at hypercapnia compared to 
normocapnia, whilst the relative change remains approximately constant which 
could account for the apparent discrepancy between the previous results of [59] 
and [61]. The reason for the difference between absolute and relative change is 
apparent from Figure 6-27 D and Figure 6-28 D. In both cases there are 
significant (P < 0.05) differences in the baseline oscillatory amplitude between 
normocapnia and hypercapnia, however on stimulation both exhibit a reduction 
to the same level (no significant differences were observed in the amplitude of 
oscillations following stimulation in either the visual or the motor task).  
Whilst a direct link between oscillatory amplitude change and CMRO2 has not yet 
been shown, a number of studies have suggested a link between BOLD 
measurements (related to CMRO2) and oscillations [49, 62-66]. A loss of neuronal 
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oscillatory synchrony is not necessarily indicative of an associated metabolism 
change. Hence, it is important for future studies to explore the mechanism behind 
these hypercapnia induced changes in neural oscillations. If the mechanism 
originates due to subject awareness of the CO2 then it is possible that these 
effects do not scale with the level of hypercapnia. Many fMRI calibration methods 
employ a graded hypercapnic stimulus using more than one PETCO2 level [9], and 
a graded hypercapnic stimulus should be assessed in future MEG studies to 
assess the mechanism behind these effects. 
6.6 CONCLUSION 
These two experiments have demonstrated the global brain response to 
hypercapnia. The results from the MEG experiment have supported the recent 
literature reports that hypercapnia affects CMRO2 by demonstrating a change in 
neuronal activity. With this in mind the use of hypercapnia to calculate M for the 
Davis model [1] could invalidate the CMRO2 calculations. However, the first 
experiment highlighted how the values of CMRO2 can be unaffected by M due to 
the form of the Davis model relationship where values of M are large and how 
basal CBF and M could be related without the use of hypercapnia.  
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7 LOOK-LOCKER T1 IMAGING: FAST MEASUREMENT 
OF CEREBRAL BLOOD VOLUME AND OPTIMISATION 
OF ANATOMICAL IMAGING AT 7 T 
7.1 OUTLINE 
This chapter outlines the theory behind T1 mapping and how developments have 
led to more rapid, larger volume coverage sequences. A sequence for fast, B1 
independent, measurement of the change in R1 is introduced. The sequence is 
applied to monitor gadolinium contrast agent uptake and to measure cerebral 
blood volume (CBV) in Multiple Sclerosis (MS) patients at 7 T. 
Furthermore the sequence is optimised for high spatial resolution (0.6 mm 
isotropic) anatomical imaging at 7 T. The sequence is designed to allow maximal 
contrast between grey and white matter using Phase Sensitive Inversion 
Recovery (PSIR) and bias field correction to remove artefacts from an 
inhomogeneous transmit field. 
7.2 INTRODUCTION 
The longitudinal relaxation time, T1, introduced in Chapter 2 can be used for 
monitoring the uptake of contrast agent. Contrast agents, as discussed in Chapter 
4, are the standard clinical tool for the assessment of cerebral blood volume 
(CBV), perfusion (CBF) and blood brain barrier (BBB) permeability. They are 
often used in diseases, such as tumours (e.g. [1]), stroke (e.g. [2]) and multiple 
sclerosis [3-5]. 
Multiple sclerosis (MS) is an inflammatory disease of the central nervous system, 
characterised by lesions predominantly in the white matter [6]. MS has many 
different symptoms, including vision problems, dizziness, spasms and memory 
problems. The degree and time of onset of these is dependant on the individual 
and the type of MS. The three types of MS are relapsing remitting (RRMS), 
primary progressive (PPMS) and secondary progressive (SPMS).  Relapsing 
remitting MS is where symptoms appear over a short period of time, and then 
usually completely recover. RRMS often eventually progresses into secondary 
progressive MS. SPMS is a gradual increase in disability, incomplete recovery 
occurs after symptom onset. Primary progressive MS is where the initial 
symptoms continue and worsen with time with no periods of remission [7]. 
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Clinically isolated syndrome (CIS) describes the first neurological symptoms 
caused by inflammation or demyelination. If this is accompanied by a lesion, the 
patient has a high likelihood of further symptoms and thus being diagnosed with 
MS in subsequent years [8].  
MRI is a useful tool in the monitoring of the progression of MS, and determining if 
structural abnormalities (i.e. number/volume of lesions) are correlated to 
disability. Current MR imaging in MS covers many different methods. For 
example; T2 weighted imaging [6], T1 histogram analysis [9] and gadolinium 
contrast for studying enhancing lesions [3-5]. The use of higher field for studying 
MS patients is also a growing area of research [6, 10]. 
Traditionally, T1 was measured by an inversion-recovery (IR) sequence, as 
introduced in Chapter 2. The longitudinal magnetisation is inverted then sampled 
at a time TI later. This is repeated for different values of TI, allowing full recovery 
of the magnetisation between each inversion. This is then fitted to an exponential 
recovery curve,  
 ? ൌ  ? ? ? െ  ? ? ? ? ?െ ? ? ?భ ?   7-1 
where S0 is the equilibrium signal (this takes into account readout flip angle, 
transverse decay and M0). To account for imperfect inversion a further 
parameter, K, can be used: 
 ? ൌ  ? ? ? െ ȥ ? ? ? ൬െ ? ? ? ?൰ ?  7-2 
where ȥ ൌ  ? െ  ? ? ?ǡɅ Ǥ 7-1 and 7-2 
assume full recovery of the longitudinal relaxation between each measurement 
(~5T1), which makes scan times long. This is exacerbated at higher field 
strengths as T1 lengthens [11, 12].  
7.3 LOOK-LOCKER METHODS 
To reduce acquisition time, Look and Locker [13] suggested the technique of 
making multiple readouts per inversion: continually sampling the magnetisation 
as it recovered. This would allow for the entire IR curve to be sampled in one 
shot, thus reducing the acquisition time. However in doing so, the recovery is 
perturbed (demonstrated in Figure 7-1) and does not follow a simple 
relationship as in Equation 7-1. 
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Figure 7-1: Longitudinal signal recovery curve for a standard inversion recovery experiment 
(light grey line) and a Look-Locker experiment (dark grey). Parameters T1 = 2 s (grey matter 
at 7 T), flip angle = 35°, TR = 0.5s. 
The model of Look and Locker iteratively applied the Bloch equations to calculate 
the complex relationship between the measured signal and T1. Kaptein et al. [14] 
proposed a simplification of the model for the recovery curve allowing for the 
recovery to be fitted to an exponential recovery curve with relaxation time T1*.  
The relaxation time T1* is related to T1 by   ? ? ?ൌ  ? ? ? ?൅  ? ? ? ? ? ? ?  ? 7-3 Ƚǡ	ǤT1* is 
always shorter than T1, so the sample appears to recover faster (demonstrated in 
Figure 7-1). This allows for quantification of T1 providing there is precise 
knowledge of the flip angle. The need for accurate flip angle quantification is 
shown in Figure 7-2 where a 40 % overestimation of flip angle would lead to a 
150 % overestimation in T1.  
 
Figure 7-2: Example of the dependence of T1 quantification on accurate flip angle knowledge. 
Simulated with T1 = 2000 ms, TR = 50 ms and FA = 10°. 
These two techniques were proposed for NMR sampling, and were soon adapted 
for MRI. Some of the first demonstrations of the Look-Locker technique were by 
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Young et al. in 1987 [15] who acquired T1 maps of the brain at 0.15 T. In 1990, 
Brix et al. [16] acquired 32 IR images for single-slice T1 mapping at 1.5 T at a 
resolution of 1.8 x 1.8 x 5 mm3. Their model did not assume total relaxation 
between inversion pulses, instead they allowed for a steady state to be 
established by repeated application of closely spaced RF pulses. This gave a total 
scan time of ~ 4 minutes; to obtain the equivalent using a standard IR approach 
allowing 5 seconds between inversion pulses would take approximately 5 hours. 
The approach of Brix et al. is similar to the implementation shown by Kay and 
Henklemann in 1991 [17]. 
 
Figure 7-3: T1 map produced using Look-Locker methods at 1.5 T in 1991, reproduced from 
[17]. A single slice T1 map took 8.5 minutes to acquire (FOV 30 cm, resolution 2.5 x 2.5 x 7 
mm3) with 20 readouts per shot. Image reproduced with kind permission from John Wiley & 
Sons.  
Deichmann and Haase [18] in 1992 proposed using SNAPSHOT-FLASH with 
Look-Locker sampling. By assuming equally spaced pulses, and that TR << T1* < 
T1 they derived a simplified form of the recovery curve allowing for T1 
quantification without knowledge of the flip angle of the readout pulse assuming ȋȽȌ ? ?Ǥ 
 ? ? ? ?ൌ  ? ? ?െ  ? ? ?൅  ? ? ? ?  ?െ  ? ? ? ? ?  7-4 
where M0* is  ? ? ? ? ? ? ? ? , this leads to a form similar to that in Equation 7-2: 
 ? ? ? ?ൌ  ? െ  ? ? ? ? ?െ  ? ? ? ? ?  7-5 
where A = M0* and B = M0 + M0*. As M0* is  ? ? ? ? ? ? ? ?  an expression for T1 in terms 
of the three parameters in Equation 7-5 can be formed; 
 ?  ? ?ൌ  ? ? ?൬ ? ?െ  ?൰ ? 7-6 
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By fitting the IR data to a simple 3 parameter exponential recovery, T1 can be 
determined from the 3 fitted parameters without knowledge of the flip angle. For 
their experimental design [18] it was determined through simulation that the flip 
angle must be less than 10° to maintain contrast between the T1 values of interest 
(1 Ȃ 2 s). The suppression of the relaxation of longitudinal magnetisation by the 
train of RF pulses can cause T1* to converge at higher FA ȋɅ  ?  ? ? ?ȌǤ    ȋɅȌ  ?  ?    1 measurement to 
increase with the flip angle of the RF pulse train (Figure 7-4). In addition 
Equation 7-6 only works for pulse sequences that have equally spaced RF pulses. 
 
Figure 7-4: Error in T1 as a function of increasing flip angle using the Deichmann and Haase 
method [18]. Simulated with T1 = 2000 ms, TR = 50 ms. 
Previously the image acquisition has been limited to simple gradient-echo where 
one line of k-space is acquired with each RF pulse, and the experiment is 
repeated stepping through the phase encode lines. In 1993, this was improved 
upon by Gowland and Mansfield [19] where an EPI readout was combined with 
the Look-Locker sampling for T1 measurement at 0.5 T. This allowed for the 
entire image to be acquired with a single RF pulse, allowing for a T1 map to be 
acquired in 3 seconds. 
From this point, Look-Locker based sequences have developed Ȃ using different 
image readout schemes, and methods for further shortening the acquisition time. 
For example, Deichmann [20] suggested a method of acquiring 2D slices in an 
interleaved fashion thus allowing for the magnetisation to fully recover, but still 
offering a reduction in the scan time. Shah et al. [21] implemented a saturation 
pulse prior to the 180° so that the magnetisation was in the same state prior to 
each inversion pulse, without requiring complete recovery to reduce scan time. 
However, for this method there needs to be a sufficient pause between the 
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saturation and inversion pulses to give adequate SNR, reducing the benefit of not 
waiting for full recovery. 
7.4 SIMULATING THE LL-TFEPI SIGNAL 
The aim of this work is to develop a T1 mapping sequence that can be used to 
produce high resolution, large volume coverage T1 maps of the brain at 7 T to 
monitor the uptake of a Gadolinium based contrast agent in MS patients, and to 
measure total cerebral blood volume. The sequence is an inversion recovery 
Look-Locker combined with a 3D-TFEPI readout [22] and is shown in Figure 7-5. 
For high volume coverage and high resolution in short scan times a Look-Locker 
method is necessary. The low EPI readout factor of 3 reduces the acquisition time 
by a factor of 3 without introducing susceptibility artefacts which are associated 
with EP images.  
 
Figure 7-5: Schematic diagram of the LL-TFEPI sequence. SSI is the shot-to-shot interval, TI is 
the inversion delay, TA is the time between the Look-Locker readouts, N is the number of 
ǡɒ	ǡ
block, TA is the time between readout blocks and TW is the time between the last readout 
pulse and the next inversion pulse. 
To fit the data a model had to be developed to describe the recovery of the signal 
due to the perturbation by the successive readout pulses. It is assumed that all 
transverse magnetisation is spoiled between each successive RF pulse; this is 
achieved through RF spoiling. Therefore only the longitudinal magnetisation is 
modelled. The centre of k-space, where the bulk image contrast arises, is taken as 
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defining the signal in the image. This sequence uses a low-high k-space 
acquisition where the centre of k-space is collected first. It was assumed that full 
relaxation does not occur between shots and that a steady-state will have been 
established that is not equal to M0. 
The following terms are defined to simplify the subsequent equations:  ? ൌ  ? ? ? ?   ? ൌ ? ?? ൬െ ? ? ?൰ ?   ? ൌ  ? ? ? ൬െ ? ? ? ?൰ ? 7-7  ? ൌ  ? ? ? ൬െ ? ? ? ?൰ ?   ? ൌ  ? ? ? ൬െ ? ? ? ?൰ ?  Ʌ     ǡ       Figure 7-5. The 
expression for longitudinal magnetisation prior to the first small RF pulse is  ? ? ?ൌ  ? ? ? ? ൅  ? ? ? െ  ? ?  7-8 
where  ? ? ? is the steady state magnetisation (the magnetisation after the 
inversion pulse once steady state has been established) and Me is the equilibrium 
magnetisation. By fully modelling the entire sequence, the expression for  ? ? ? can 
be determined 
 ? ? ?ൌ  ? ? ? ? ? ? ? ? ൫ ? െ  ? ?൅  ? ? ? ൅  ? ൅  ? ?൯ ? െ  ? ? ? ? ? ?? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? 7-9 
where 
 ? ൌ ? ? െ  ? ? ? ? െ ? ? ? ? ? ? ? ? െ ? ?  ?ȉ  ? ൅ ? ? ? ? ? ? ? ? ? െ ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? െ ? ? ? ? ? ? ? ?  ? 
 
  ? ൌ ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? െ  ? ?,
 
7-10
  ? ൌ ? ? ? ? ? ? ? െ  ? ? ? ? െ ? ? ? ? ? ? ? ? ? ? ? ? ? ? െ ? ? ? ? ? ? ?  ?
 
 Ʌinv is the angle of inversion (ideally 180°). The signal at the centre of 
k-space is modelled, which arises from the first pulse of each of the N readout 
blocks. For the first readout block (n = 1) the longitudinal signal prior to the first 
pulse is ? ? ?, and for the second readout block (n = 2) this is the signal prior to the 
m+1th small RF pulse and is given by  ? ? ?: 
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 ? ? ?ൌ  ? ? ? െ  ? ?൅  ? ? ? ? ? ? ? ? ? ?൅  ? ? ? ? െ  ? ? ? ? െ ? ? ? ? ? ? ? ? െ ? ?  ? 7-11 
This can be generalised to  
 ? ? ?ൌ  ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?൅  ? ? ? ? െ  ? ?൅  ? ? ? ? െ  ? ? ? ? െ ? ? ? ? ? ? ? ? െ ? ?  ?ȉ  ? ? െ  ?? ? ? ? ? ? ? ? ? ? ? ? െ ? ? ? ? ? ? ? ?  
7-12 
 ? ?ǡ ?ǥǤ transverse plane 
(neglecting transverse decay)  ? ?ൌ  ? ? ? ȉ  ? ? ?. 7-13 
Sn expresses the measured signal of the nth 	ǡ  ?  ?ǡ  ?ǥǤ
will be referred to as the full model in subsequent discussion. However Sn can be 
re-expressed in terms of an effective relaxation term; 
 ? ?ൌ  ? ? ? ? ? ? ? ? ? ? ?൅  ? ? ? െ  ? ? ? ? ? ? ? ?  ? ? ൌ ? ? ?൬ ? ? ? ? ? ? ?൬ ? ? ?െ  ? ?൰ ൅  ? ?൰ ? 7-14 
where   ? ? ? ? ? ? ?ൌ   ?െ ? ? ?భ ? ? ? ? ? ? ? ? ? ? ? ?െఛ ?భ  ? ? ? ? . Expressing this as an 
effective relaxation term, ? ? ? ? ? ? ?ൌ  ? ? ? ?െ ? ? ? ?భ ? ?, where  ? ? ? ?ൌ  ? ? ? ? ? ?൅  ? ? െ  ?? ? ?െ  ? ȉ ? ? ? ? ?  7-15 
This takes into account the fact that the small flip angle pulses are not applied at 
equal spacings, but in groups of pulses. This gives a simple expression to fit to: 
 ? ?ൌ  ?ᇱ െ  ?ᇱ ? ? ? ?െ  ? ? ? ? ?  7-16 
where ?ᇱ ൌ  ? ? ?ఏ  ? ? , ?ᇱ ൌ  ? ? ? ? ? ?െ  ? ? ?,  j = 0 , 1 .. N- ?Ǥǯǡǯ1*, and T1 calculated from Equation 7-15ǡɅǤ
will be referred to as the effective relaxation model.  
7.4.1 MEASURING THE CHANGE IN R1 AND CEREBRAL BLOOD VOLUME 
Often the motivation behind measuring T1 is to monitor the change in T1 ȋȟ1) 
due to the administration of a contrast agent, most commonly a Gadolinium 
based compound. If the change in R1 ȋȟ1) is only required then precise 
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knowledge of B1 is not required [23], since from Equation 7-15 it can be seen 
that: ȟ ? ? ?ൌ ȟ ? ? ? ൅  ? ? െ  ?? ? ?. 7-17 ȟ1 can be found by scaling the change in R1* by a factor of (TA + (m- ?ȌɒȌǤ
valid providing the patient/sample does not move greatly between scans so that 
the B1 in each voxel is approximately the same. This allows for quantification 
without knowledge of the flip angle, which can be difficult to quantify (see 
Section 7.5) and requires a separate scan to do so. This will speed up the 
acquisition time which is important in clinical protocols where the patients are 
undergoing several different scans in one session. ȟ1 can be converted to regional blood volume (RBV) using the method of  
Schwarzbauer et al. [24]. RBV is defined as the fractional intravascular volume. 
Two measurements of T1 are taken, one prior to administration of an 
intravascular contrast agent (T1), the other when the contrast agent has reached 
equilibrium (T1eq). The RBV is quantified through the relative changes in T1 
between tissue (T1) and blood (T1,b); 
 ? ? ? ൌ ? ? ? ?െ  ? ? ? ? ? ? ? ? ? ? ?െ  ? ? ? ? ? ? ? ?   ? ? ? ൌ ? ? ? ? ? ? ? ? ? 7-18  
It can be seen from Equations 7-17 and 7-18 that  
 ? ? ? ൌ ? ? ? ? ? ? ? ? ? ?  ? 7-19 
which is independent of both B1 and the scan parameters. The blood 
measurement can be formed from a blood sample or a large vessel if present in 
the imaging volume. This allows simple quantification of RBV, in this application 
CBV, from two T1 or R1 maps acquired pre- and post-contrast agent 
administration. Due to the B1      ȟ1 the 
measurement of CBV at 7 T could be achieved with only two scans. 
7.5 B1 MAPPING 
It has been sh  ȟ1 or cerebral blood volume can be mapped using 
contrast enhanced LL-TFEPI without knowledge of the flip angle. This is 
advantageous because mapping of the B1 field requires a separate scan, 
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increasing the total scan time required. However, if in ȟ1, 
absolute T1 is required, then accurate knowledge of the flip angle is needed or 
errors in T1 measurement increase (e.g. Figure 7-2 and Figure 7-4). B1 field 
homogeneity decreases with increasing magnetic field strength, due to the 
increase in Larmor frequency reducing the RF wavelength required. This reduced 
wavelength is comparable to the length scale of the human body (~ 1m), 
increasing interactions between the RF radiation and the dielectric tissues in the 
body. This results in higher flip angles being achieved in the centre of the image, 
than at the edges. This spatial variation can be visible in the maps of T1 produced. 
To overcome this, maps of the flip angle variation can be used. 
The most accurate way of mapping the B1 field is to acquire several images at 
different flip angles and fit M0ȋǤȽȌȽ
requested to each voxel. This gives a map of c which will vary for 7T typically 
between 0.5 and 1.5 and can then be used to convert T1* to T1. To implement this 
a long TR between RF pulses must be used to remove saturation effects from the 
measured signal intensity. For a TFE/FLASH acquisition with a 256 x 256 x 50 
matrix this would take over a day to acquire! However the B1 map can be 
acquired at a lower resolution as it is a smooth, slowly varying function. An 
alternative is to use an EPI readout, however the spatial distortions may not 
match those of the T1 acquisition, making it hard to realign. Also, for Philips 
scanners, if care is not taken, the RF pulse parameter (set by the scanner 
automatically) can change dependant on the readout used, further complicating 
the use of a faster method of B1 mapping. 
Hence, fast B1 methods have been proposed which attempt to overcome this. A 
popular method, with many variants upon it, is the dual angle method (DAM). 
Two sets of images, S1 and S2, Ƚ ?ȽǤ
on full relaxation to eliminate terms dependant on T1. The ratio of the two images Ʌ ? ?1; 
 ? ൌ  ? ? ? ? ? ? ൬ฬ  ? ? ? ? ?ฬ൰  7-20 
Cunningham et al. [25] modified this by preceding the image readout with a Ǯǯ  ȋ Ȍ      Ǥ  
designed to ensure the magnetisation was in the same state at the beginning of 
each TR period for both flip angles. However, this will rely on good saturation 
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pulses, and scan time will be long due to the period of time needed to allow the 
magnetisation to recover after the saturation pulse to give adequate SNR. 
Standard B1 mapping on the Philips system uses Actual Flip-angle Imaging (AFI), 
as proposed by Yarnykh [26]. The pulse sequence consists of two identical RF 
pulses with two delays TR1 and TR2, as shown in Figure 7-6, which generate two 
signals S1 and S2. 
 
Figure 7-6: Timing diagram for the B1 mapping sequence of Yarnykh [26] showing RF pulses 
and detected signals. 
The method allows for the lack of complete relaxation of the longitudinal 
magnetisation in the period TR2, which allows for a shorter acquisition. With 
TR1 < TR2 < T1 a new steady state is established which is accounted for. It is 
assumed that the transverse magnetisation is completely spoiled after each 
acquisition. Using the Bloch equations, expressions for the measured signals S1 
and S2 can be derived, 
 ? ?ൌ  ? ? ? െ  ? ?൅ ? ? െ  ? ?  ? ? ? ? ? ? െ  ? ? ? ? ? ? ? ? ? ?  ?െ ? ? ? ? ? ? ? ? ? ?   ? ?ൌ  ? ? ? െ  ? ?൅ ? ? െ  ? ?  ? ? ? ? ? ? െ  ? ? ? ? ? ? ? ? ? ?  ?െ ? ? ? ? ? ? ? ? ? ? 7-21  
where E1,2=exp(-TR1,2/T1). The ratio between these signals is  ? ? ? ?ൌ  ? െ  ? ?൅  ? ? െ  ? ?  ? ? ? ? ? ? െ  ? ?൅  ? ? െ  ? ?  ? ? ? ? ? ? 7-22 
By first order approximation of the exponential terms as 1-TR1,2/T1, Equation 
7-22 can be simplified to 
 ? ? ? ?ൎ  ? ൅ ? ?? ? ?? ? ? ? ? ?? ? ??൅  ? ? ? ? 7-23  
This can be rearranged to give an Ʌ; 
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 ? ൎ  ? ? ? ? ? ?൮ ? ? ? ?ȉ  ? ?? ? ??െ  ? ? ?? ? ??െ  ? ? ? ?൲ ? 
7-24 
 
An example slice from a B1 map acquired using this method at 7 T is shown in 
Figure 7-7. Clear structural information can be seen, which should not be present 
in the B1 map. This is indicative of tissue weighting in the B1 map which would 
introduce significant error into T1 quantification; the maps shown in Yarnykh 
[26] were acquired at 1.5 T and did not have any visible brain structure. Further 
investigation of the origin of this signal is described below. 
 
Figure 7-7: An example B1 map using the AFI method at 7 T. White arrows show structure 
from the ventricles, black arrows show grey/white matter boundary that is visible. 
At 7 T, B1 inhomogeneities are increased relative to 1.5 and 3 T. To investigate 
the appearance of structure in the B1 maps acquired at 7 T phantom and in vivo 
experiments were performed. 
7.5.1 PHANTOM EXPERIMENTS 
In Figure 7-7 it was seen that the B1 map produced using AFI displayed brain 
structure. To investigate the origin of this and the effect of the different scan 
parameters of the AFI B1 mapping technique was assessed on a phantom. 
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7.5.1.1 Methods 
A quadrant phantom of agar gel doped with gadolinium where each quadrant has 
a different T1 and T2 were used (T1 range 300 Ȃ 2,800 ms, T2 range 30 Ȃ 100 ms). 
The sequence used was AFI (Figure 7-6) with standard scan parameters: 3 x 3 x 5 
mm3 voxel size, FOV 200 x 200 x 75 mm3, TE 5 ms, TR1 / TR2 = 23 / 103 ms, 
gradient spoil factor 5, flip angle 60°. 
The scan parameters under investigation are TE, TR1, TR2, gradient spoil factor 
and flip angle. Each scan parameter was varied, keeping the remaining 
parameters constant at the value provided above. 
The average B1 scaling factor (termed B1 value) was averaged separately over 
each quadrant to look at the impact of the different scan parameters on B1 
estimation. 
7.5.1.2 Results 
Firstly, the standard B1 map was investigated to assess the dependence of the 
measured B1 value on T1 and T2, Figure 7-8. This suggests that the B1 value will 
increase with increasing T1, which corresponds to the B1 map in Figure 7-7, 
where grey matter with longer T1 has higher B1 value than the neighbouring 
white matter. There was not a strong correlation with T2.  
 
Figure 7-8: Dependence of measured B1 value on (A) T1 and (B) T2. Error bars represent 
standard error across voxels in the ROI. 
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Spoil factor, TR1 and echo time did not greatly impact B1 quantification Ȃ
measured values were stable across the values assessed, Figure 7-9 A, B and D. 
Both flip angle and TR2 affected B1 values strongly (Figure 7-9 C, E).  
 
Figure 7-9: Effect of (A) spoil factor, (B) echo time (C) flip angle (D) TR1 and (E) TR2 and on 
average B1 value. The four quadrants are plotted in different colours. Error bars represent 
standard error across voxels in the ROI. 
7.5.2 IN VIVO INVESTIGATION 
To verify the large effect of TR2 seen in the phantom data, in-vivo, B1 maps were 
acquired on one healthy volunteer. In addition, comparative B1 maps were 
acquired with a variable flip angle approach and in an additional healthy 
volunteer. 
7.5.2.1 Methods 
One healthy volunteer was scanned with the standard Philips B1 mapping 
sequence (TR2 = 103 ms) and with a reduced TR2 of 83 ms. In addition, a 
variable flip angle gradient echo EPI acquisition was performed to map the flip 
angle. A single slice, 3 mm isotropic, TE = 16 ms, 192 x 192 mm2 FOV GE-EPI was 
acquired with flip angles of 10 - 140°. A TR of 30 s was used to ensure full 
relaxation between acquisitions. The RF transmit bandwidth was fixed across the 
flip angles. The slice was positioned through the ventricles to allow CSF as well as 
grey and white matter to be interrogated. The EPI data was fitted in Matlab (The 
Mathworks, MA, USA) to S0sin(c.Ʌ) where c is the B1 scaling factor and Ʌ is the 
requested flip angle.  
204 
 
A further healthy volunteer was scanned, an EPI B1 map, using parameters above, 
and an AFI B1 map with the standard parameters were acquired in the cortical 
grey matter to assess if any structural information was present.  
7.5.2.2 Results 
The histograms of the two AFI B1 maps acquired with TR2 of 83 and 103 ms are 
shown in Figure 7-10. These demonstrate that, in agreement with the phantom, 
by reducing TR2 the B1 value increases by approximately 15 %. 98 % of brain 
voxels showed an increase in B1 value when TR2 was reduced. 
 
Figure 7-10: (A) Example slice from AFI B1 maps acquired with TR2 = 103 ms (standard 
parameter) and 83 ms. (B) Whole brain histogram of AFI B1 maps acquired in-vivo with TR2 
of 83 ms (broken line) and 103 ms (solid line). 
The EPI flip angle maps acquired in two volunteers are shown in Figure 7-11 
alongside the AFI map acquired with the standard parameters. These EPI B1 
maps demonstrate quite a slow variation in the flip angle with little brain 
structure visible. The ventricles are still distinguishable, but this could be due to 
flow in the CSF rather than a T1/T2 effect. This demonstrates that the AFI maps 
should not display significant structure, as expected. The EPI maps give lower B1 
values than AFI, however the RF pulse shape is different for the two methods 
which could lead to different pulse profiles. 
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Figure 7-11: EPI B1 maps acquired on two healthy volunteers using AFI and EPI, grey scale is 
the B1 value (%), and the corresponding S0 EPI image shown. 
7.5.3 SIMULATIONS 
To investigate the possibility of spoiling impacting on AFI, simulations were 
performed. Using real anatomical data, the AFI signals were simulated to give 
images of S1 and S2 which were converted to B1 maps.  
The signal was simulated using rotation and relaxation operators to model the 
effect of the train of RF pulses on the three components of magnetisation [Mx, My, 
Mz]. The input B1 field was modelled by a 2D Gaussian (  ? ? ? ?െ൫ ? ? െ  ? ? ? ?  ? ? ? ? ൅ ? ? െ  ? ? ? ?  ? ? ? ?ൗ ൯ ?Ȍ ǡɐx  ?  ? ?ɐy = 60 pixels 
(Figure 7-12 A) to give a distribution (similar to that obtained in vivo, as in Figure 
7-11). A 1 mm isotropic MPRAGE image was segmented into grey matter, white 
matter and CSF partial volume maps (FAST, FSL, FMRIB) to give structural 
information. T1 was taken to be 2100, 1300, 4000 ms [11, 12], T2 40, 33 and 125 
ms [27, 28] and M0 1.2, 1 and 1.6 [29] for grey matter, white matter and CSF 
respectively. The simulations were performed voxelwise to give a flip angle map. 
100 pulses were simulated to model the steady state condition; the two signals 
(S1 and S2) were then used to calculate the flip angle map using Equation 7-24.  
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Figure 7-12: (A) Simulated B1 profile and (B) modelled B1 maps as a function of spoiling 
factor. 
To model insufficient spoiling prior to the next RF pulse, the magnitude of the 
transverse signal was reduced by a factor ranging from 0 to 1, where 0 is 
complete spoiling and 1 is no spoiling. The simulated B1 maps obtained using the 
standard scan parameters with different spoiling factors are shown in Figure 
7-12 B. It is clearly seen that the amount of transverse magnetisation that 
remains prior to the subsequent RF pulse has significant impact on the resultant 
B1 map, with structure clearly visible with incomplete spoiling. 
7.5.4 DISCUSSION 
The B1 maps produced from AFI show structure (demonstrated in Figure 7-7) 
suggesting that the method is not working correctly as B1 is a slowly varying 
spatial function as shown in the EPI B1 maps (Figure 7-11). The EPI method of B1 
mapping is slow, taking 7 minutes to acquire one slice, due to the need for 
complete recovery between RF pulses to eliminate T1 effects. Here only a single 
slice was acquired to prevent subsequent slice acquisitions affecting the spins 
(e.g. through magnetisation transfer). In addition, the distortions are more 
pronounced in the EPI which would be hard to match to the LL-TFEPI acquisition 
to correct the T1* values. The EPI B1 maps would require distortion correction 
using a B0 field map, further increasing scan time; hence EPI maps are not an 
option for B1 mapping here. 
From the phantom experiments it can be seen that the scan parameters can have 
significant effect on the resultant B1 value measured using AFI. The effect of flip 
angle used on measured B1 could be due to pulse length changing (hence B1 
profile has changed). The assumptions in the mathematical description of AFI are 
207 
 
that TR1 < TR2 << T1 and that the transverse signal is adequately spoilt between 
successive RF pulses. The assumption TR1 < TR2 << T1 is used to allow 
simplification of the exponential terms to a Maclaurin series. With the lowest T1 
expected in-vivo at 7 T of ~1 s there is less than a 1 % difference between the 
exponential term and the approximation, suggestive that this assumption holds. 
The significant impact of TR2 on all four quadrants of the phantom (T1 values 
ranging from 300 Ȃ 2,800 ms), and the in-vivo data may be due to inadequate 
spoiling. With a reduced TR2, less transverse signal has decayed due to T2/T2*. 
The simulations support the fact that residual transverse signal may have 
significant impact on the estimated B1 resulting in structural information being 
visible. However, the phantom data did not show a correlation between T2 and 
B1, but the phantom has some short T1 (< 1s) compartments possibly invalidating 
the Maclaurin series assumption, and so competing effects could be present. 
With sequences, such as AFI, where TR < T2 the transverse magnetisation does 
not decay completely prior to the next RF pulse. With a train of pulses this signal 
can be rephased to give partial echoes and stimulated echoes in addition to the 
FID. The coherence plot in Figure 7-13 shows the evolution of the phase of the 
transverse signal and the impact of RF pulses. After an RF pulse there are three 
components; the transverse signal component that rephases, the transverse 
signal component that continues to dephase and a longitudinal signal component. 
Hahn/spin echoes and stimulated echoes are formed when the phase of the spin 
is zero (shown in Figure 7-13). It is assumed that components with non-zero 
phase will vectorally add to zero and not contribute to the signal [30].  
 
Figure 7-13: Coherence plot showing the evolution of phase of the transverse signal over 
time due to the application of three RF pulses and how these form spin (filled circle) and 
stimulated echoes (unfilled circle). After the RF pulse the signal has three components (1) 
longitudinal magnetization and the phase remains unchanged shown by solid horizontal 
line, (2) phase inverted and begins to rephase, broken line, or (3) continue to be dephased. 
Adapted from [31]. 
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A main assumption of AFI is that all the transverse signal is spoiled between RF 
pulses. To achieve this, two methods of spoiling are used; gradient and RF 
spoiling. Gradient spoiling uses additional gradients on the read and frequency 
encode axes after each RF pulse to spoil the transverse signal. This is achieved as 
the phase, ? , of a spin at a position r is equal to 
 ? ?࢘ ?ൌ  ?࢘න ࡳ ? ? ? ? ? ? ? ? ? 7-25 
where G is the applied gradient and TR is the time between successive RF pulses. 
Gradient spoiling dephases the signal but does not prevent the formation of Hahn 
echoes, as shown in Figure 7-14. The AFI sequence spoil factor varies the 
duration of these gradients, altering the degree of dephasing. Varying the 
strength of the gradients with the different RF pulses would reduce the amount 
of rephasing with sequential spoiler gradients. 
RF spoiling uses phase cycling of the RF excitation pulses to reduce the ǡɔn term (where n is the number of the RF pulse) to 
the expression for phase in Equation 7-25, demonstrated by the shift in Figure 
7-14 B; 
 ? ?࢘ ?ൌ  ?࢘න ࡳ ? ? ? ? ?൅  ? ? ? ? ?  ? 7-26 
The phase of the RF excitation pulse is incremented with each pulse, this reduces 
phase coherence of the spins resulting in reduced net residual transverse 
magnetisation. Optimisation of the phase cycling of the RF pulses leads to 
improved signal spoiling [30]. 
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Figure 7-14: Coherence plot showing the evolution of phase over time due to the application 
of two RF pulses, with (A) gradient spoiling, the grey shaded areas show the application of a 
spoiler gradient, (read and associated spoiler gradient waveform shown, not all phase 
pathways shown for clarity) and (B) RF spoiling, black broken line shows how a spin echo 
would have been formed if the phase had not been incremented. Adapted from [31]. 
From the results, it can be seen that the standard B1 mapping technique currently 
implemented on the Philips 7 T system has tissue weighting resulting in B1 being 
dependent on the scan parameters. From the effect of TR2, and simulations, this 
could be due to incomplete spoiling of the transverse signal. Further 
investigation as to the performance of the spoiling implemented for the AFI 
needs to be explored. Possibilities include implementing gradient spoiling that 
varies between the shots to avoid refocusing of the signal, and implementing 
spoilers on a third axes. The optimisation of RF spoiling can be tailored to the 
specific pulse sequence to see if an improvement is seen. 
Another area for further investigation is alternative methods for B1 mapping that 
do not rely on such assumptions. The most promising is the recently proposed 
method of B1 mapping by Sacolick et al. which utilises the Bloch-Seigert shift [32]. 
This method encodes B1 information into the phase of the signal by applying off-
resonance RF pulses (kHz range) after spin excitation. The off-resonance pulse 
causes a change in precession frequency, this shift is dependant on the B1 field. 
This was shown to produce B1 maps with reduced T1 effects in them at 3 T in the 
brain, abdomen, shoulder and knee compared to the dual-angle method (DAM). 
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7.6 INVESTIGATING THE EFFECT OF PARAMETER CHOICE ON SEQUENCE 
SENSITIVITY TO RANDOM NOISE 
Monte Carlo simulations were performed to assess the impact of the LL-TFEPI 
sequence parameters on random errors in fitting for R1*. The first simulations ȋǡǡɒǡǡ	ǡ ?
as the readouts were spaced evenly through the SSI) and varied that parameter 
keeping the remainder constant. 1000 LL-TFEPI curves were simulated using the 
full model and Gaussian random noise added with zero mean and standard 
deviation of 0.01M0 to model the noise present in-vivo. These were fitted to 
Equation 7-15 (fitting for R1*), the percentage difference between the fitted value 
and ideal value was then calculated. The variance in the 1000 measures was 
taken and the results are shown in Figure 7-15 (solid lines). 
The second set of Monte Carlo simulations took into account that the sequence 
parameters are not independent of one another, except for flip angle. A formula 
for scan time, ttotal, was calculated; 
 ? ? ? ? ? ?ൌ  ? ? ? ? ? ? ?  ? ? ? ? ? ? ?  ? ?  ? ? ? ?  ? ? ? ? 7-27 
where FOV is the field of view in mm, Nslice is the number of slices, 1.15 is the 
oversample factor, m is the number of RF pulses per block, VOX is the in-plane 
voxel size and 6 takes into account the EPI factor and the SENSE reduction factor. 
SSI is the shot-to-shot interval, given by  ? ? ?ൌ  ? ?൅  ? ?? ?൅  ? ? െ  ?? ?  ?, 7-28 
where the symbols are the sequence timings given in Figure 7-5. The scan time, 
ttotal, was chosen to be 5 minutes, with a FOV/VOX ratio of 160. When mǡɒ
were varied then TA changed to maintain SSI, using Equation 7-28, and hence the 
scan time. When TA was varied, SSI and hence M was changed correspondingly. 
The effect of TI was not simulated as the initial simulations demonstrated little 
effect of this on the error in the fit. The results of these simulations are illustrated 
in Figure 7-15 with the broken lines.  
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Figure 7-15: Standard deviation in fitted R1* values due to (A) number of readouts, N (B) 
Inversion time, TI (C) TFE factor, m (D) readout spacing TA (E) flip angle and (F) pulse 
ɒǤǡs. 
Figure 7-15ǡ     ɒǡ     intained, do not 
significantly effect the error in R1* quantification. N, m, TA and FA need to be kept 
large to minimise fitting errors in R1*.   
To investigate the sensitivity to errors in the expected flip angle in the 
quantification of R1, the systematic error in R1 was calculated as a function of the 
sequence parameters. Errors were estimated using partial differentiation of 
Equation 7-15 and results are shown in Figure 7-16. This demonstrates that a 5 
% error in the flip angle could lead to a 40 % error in R1 (e.g. Figure 7-16 A, m = 
15). Error in R1 due to errors in knowledge of the flip angle is reduced if m and 	ǡɒǤǡ
precise knowledge of the flip angle is critical, and that assessing the change in R1 
is preferable, as the B1 term is then removed. 
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Figure 7-16: Error in R1 due to error in flip angle estimate Ȃ variation with (A) TFE factor, m 
ȋȌǡȋȌȋȌǡɒǤ
a 10 % error in the expected flip angle, dashed line a 5 % error and the dotted line a 1 % 
error.  
Further consideration when deciding on scan parameters is SAR and acoustic 
noise. SAR can be minimised by reducing the number of pulses per SSI and 
keeping the flip angle low. Acoustic noise, which can make the scan 
uncomfortable for patients and increase movement, can be reduced by keeping m 
and N low, or TA high. 
Accounting for all the simulations, the following conclusions were drawn when 
finalising the sequence parameter choice for the experimental work. The ɒ
on fitting. A large flip angle would cause large errors if R1 or T1 were calculated 
directly, however increasing flip angle would improve the fit for R1*. To allow 
investigation into the quantification of R1 ȟ1* for CBV measurement, 
the flip angle was kept at 6°, providing adequate SNR for voxelwise fitting, but 
increasing the chances of accurate T1 quantification. TA was chosen to be the 
maximum possible within the SSI, as this reduced both the error in fitting for R1* 
and the systematic error in R1. SSI and m were balanced to allow short scan time 
(low SSI, high m) and lower levels of acoustic noise (long SSI, low m), also 
reducing m reduces the systematic error in R1. For the first in-vivo experiment, m 
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was kept low (15), with SSI = 3s, the longest SSI possible within a scan time of 5 
minutes 45 seconds, to improve estimation of R1. For the second in-vivo 
experiment, where the aim was fast high-resolution mapping of CBV and not 
absolute R1 quantification, m was increased to 31.  
7.7 USING LL-TFEPI TO MONITOR GADOLINIUM UPTAKE AND TO 
MEASURE CEREBRAL BLOOD VOLUME 
Here two studies are performed to assess the measurement of the change in R1 ȋȟ1) with the administration of a contrast agent and to use this to measure CBV. 
The first experiment studies six MS patients using the 16-channel coil. The 
second study on eleven MS patients uses the 32 channel coil which increases SNR 
allowing the spatial resolution to be increased. 
7.7.1 MEASURING RELATIVE CEREBRAL BLOOD VOLUME IN MS USING A 
GADOLINIUM CONTRAST AGENT 
7.7.1.1 Methods 
Six subjects took part in the study (3 females, 3 males, age 40 ± 11 years old), and 
all gave informed written consent. 5 subjects had Clinically Isolated Syndrome 
(CIS) and 1 had clinically confirmed relapsing remitting (RR) multiple sclerosis 
(MS). The scanning was performed on a Philips 7 T system with head volume 
transmit, and 16-channel SENSE receive coil. Patients were positioned in the 
magnet with foam padding to reduce head motion. 
Two LL-TFEPI scans were performed, one prior to contrast agent administration 
and one after the administration of a Gadolinium contrast agent (Gadovist, Bayer 
Healthcare) as a bolus at 0.1 mmol / kg body weight. The LL-TFEPI scan 
parameters were: SSI = 3s, N = 8, m  ? ? ?ǡ ? ?ǡȽ ? ? ?ǡɒ ? ?ǡ ? ? ? ? ms, TI = 21 
ms, TW = 242 ms, SENSE = 2, FOV = 200 x 170 x 72 mm3 with 1.25 mm isotropic 
voxels, and low-high Cartesian k-space acquisition order. This gave a total scan 
time of 5 minutes 45 seconds. Magnitude and phase data were saved allowing for 
sign correction. 
A B1 field map was also acquired using the AFI method of Yarnkyh [26] with 3D 
GE imaging parameters: 3 x 3 x 5 mm3 voxel size, FOV 200 x 200 x 75 mm3, TE 5 
ms, TR1 / TR2 = 23 / 103 ms, gradient spoil factor 5, flip angle 60°. 
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7.7.1.2 Data Analysis 
To define grey and white matter masks the modulus images were segmented 
using SPM8 (www.fil.ion.ucl.ac.uk). Lesions were included in the grey matter 
masks due to their longer T1, so these were then excluded manually (Analyze 9, 
Mayo Clinic, US) to avoid lesions affecting mean T1 measures. 
The phase data was used to sign correct the modulus data. The data were then 
fitted voxelwise for R1* in Matlab (The Mathworks, MA, USA). The B1 maps were 
realigned and resampled to the LL-TFEPI matrix size using the affine 
transformation in FLIRT, (FSL, FMRIB, Oxford). These were then used to produce 
maps of T1 pre- and post-contrast. The post-contrast inversion recovery images 
were realigned to the pre-contrast images to account for small movement 
between scans, and this transform applied to the post-contrast R1 and R1* maps. 
The R1ȗȟ1 maps independent of B1. The mean B1, ȟ1, and pre- and post-contrast R1* and T1, in grey and white matter was 
calculated.   ȟ1* maps were then converted to cerebral blood volume maps using 
Equation 7-19. The change in blood R1 was determined by applying a threshold to ȟ1 ǡȟ1. The threshold was chosen 
so t         ȟ1 in these voxels was ȟ1. The resulting CBV maps were spatially smoothed with a 
Gaussian kernel (FWHM = 2.5 mm). The average CBV in the grey and white 
matter masks was then calculated. 
 Wilcoxon signed rank test was used to assess differences between pairs of 
results for R1*, T1 and B1Ǥȟ1 is tested using a two tailed t-test for non-zero mean 
(SPSS v19, IBM). 
7.7.1.3 Results 
The high quality of the images and high SNR are shown in Figure 7-17. Figure 
7-17 A are the magnitude images for an example slice over the 8 readouts. Figure 
7-17 B is an example, single-voxel, inversion-recovery curve from grey matter 
(broken line) and white matter (solid line). The locations of the voxels are shown 
in A. 
An example fitted R1* map is shown in Figure 7-18; pre- (A) and post-contrast (B). 
MS lesions are highlighted in the pre-contrast images. The post contrast sagittal 
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view is chosen to highlight blood vessels, whose R1* is increased greatly post 
contrast due to the gadolinium.  
 
Figure 7-17 (A) Example LL-TFEP IR images with readout number shown below (B) IR curves 
from a grey matter (broken line) and white matter (solid line) voxel marked in (A). 
 
 
Figure 7-18 (A) R1* map pre-contrast, MS lesions highlighted by white ROI (B) R1* map post 
contrast showing enhancement in the vessels. 
The CBV maps calculated from the change in R1 are shown in Figure 7-19 for a 
single subject. These show that the grey matter (GM) has higher CBV than the 
white matter (WM). The average measured CBV was 5.1 ± 0.3 % and 2.5 ± 0.2 % 
in the grey and white matter respectively. CBV was significantly higher in the GM 
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than WM (P < 0.05, Wilcoxon sign rank test). As most of the patient group were 
diagnosed with CIS at time of scanning, few enhancing lesions were seen. One 
subject had a contrast enhancing lesion, shown in Figure 7-20. 
 
Figure 7-19: CBV maps from a single subject, (colour bar in %) 
 
Figure 7-20: One subject had an enhancing lesion shown on 4th readout image (TI ~ 900 ms) 
(A) pre contrast and (B) post contrast LL-TFEPI image. White arrow indicates contrast 
enhancing lesion. 
The group results for the 6 patients are shown in Figure 7-21. The results show a 
significant difference between white and grey matter for all metrics. Grey matter 
had a significant change in T1 ȟ1, but not white matter. The grey matter has 
significantly higher CBV, and hence will show a great change in R1. This is 
expected as the contrast agent is distributed in the blood, and will not leak into 
the tissue unless there is a break down of the blood brain barrier (BBB). 
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Figure 7-21: Results from gadolinium contrast experiment showing (A) average B1 scaling 
factor (B) T1 ǡǡȋȌȟ1 due 
to gadolinium and (D) CBV in white and grey matter. * indicates a significant difference, 
P<0.05. 
7.7.1.4 Discussion 
The baseline measured T1 values in grey (1639 ± 30 ms) and white matter (1112 
± 26 ms) are lower than would be anticipated at 7 T given the results of previous 
studies (e.g. [11, 12]). This could be due to an inaccurate B1 map giving the 
incorrect flip angle when converting from effective T1/R1 to actual T1 and R1 
values. The average B1 scaling factor in the grey and white matter is given in 
Figure 7-21 A. All the average B1 values were below 1, suggesting that the flip 
angle achieved is always lower than the expected flip angle. The average B1 value 
is higher in the white matter; this is expected as the white matter is 
predominantly in the centre of the brain where the flip angle profile is highest. 
There is a large variation in the B1 scaling values for both tissue types; this is due 
to the large volume covered by the B1 map (7 cm thick section). As the T1 values 
are low, it is suggestive of an underestimated B1 factor (increase FA to increase T1 
estimate, Figure 7-22). For contrast agent uptake, the change in R1 is normally 
adequate, and hence this method of measuring the change in R1 can be used, as 
no B1 information is required. 
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Figure 7-22: Relationship between calculated T1 value and B1 in (A) grey matter and (B) 
white matter. Data shown subject averaged, error bars represent standard error across 
subjects. 
7.7.2 HIGH RESOLUTION MAPPING OF CBV IN MS PATIENTS USING 
GADOLINIUM 
The second study was implemented to assess the change in R1 due to the 
administration of a Gadolinium based contrast agent in Multiple Sclerosis, with 
the emphasis on high resolution (1 mm isotropic).  
7.7.2.1 Methods 
11 subjects took part in the study (6 females, 5 males, age range 28 - 58 years 
old), and all gave informed written consent. 5 subjects had Clinically Isolated 
Syndrome, 5 had clinically confirmed relapsing remitting (RR) multiple sclerosis 
(MS) and 1 secondary progressive MS. The scanning was performed on a Philips 
7 T system with head volume transmit, and 32-channel SENSE receive coil. 
Patients were positioned in the magnet; foam padding was used to reduce head 
motion. 
Two LL-TFEPI scans were performed, one prior to contrast agent administration 
and one after the administration of a Gadolinium contrast agent at 0.1 mmol / kg 
body weight. The LL-TFEPI scan parameters were: SSI = 3 s, N = 8, m = 31, P = 3, Ƚ ? ?°ǡɒ ? ?ǡ ? ? ? ? ms, TI = 21 ms, SENSE = 2, FOV = 200 x 170 x 72 mm3 with 
1 mm isotropic voxels with a low-high Cartesian k-space acquisition. This gave a 
total scan time of 4 minutes 21 seconds. 
7.7.2.2 Data Analysis 
The data was analysed as in Section 7.7.1.2 to give CBV maps. Average CBV in 
grey and white matter was calculated. 
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7.7.2.3 Results 
The image quality achieved with the high resolution LL-TFEPI scan is 
demonstrated in Figure 7-23. Using the 32-channel coil is acquire higher spatial 
resolution data has not noticeably affected the SNR ratio of the acquired images. 
 
Figure 7-23: Example images from a representative subject for the high resolution LL-TFEPI 
sequence over the 8 readouts. 
Figure 7-24 shows an example CBV map acquired using the high resolution LL-
TFEPI scan. The expanded section shows how the cortical detail is maintained in 
the final CBV map. Over the eleven subjects, GM CBV was 5.2 ± 0.3, and WM CBV 
was 1.9 ± 0.1 %. These values agree well to the results obtained with the lower 
resolution scan. Only three subjects had any contrast enhancing lesions and 
examples are shown in Figure 7-25. 
 
Figure 7-24: High resolution CBV maps from a representative subject. White box shows 
expanded section. Colour bar is CBV in %. 
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Figure 7-25: Two enhancing lesions in the same subject, 4th phase pre (A, C) and post (B, D) 
contrast LL-TFEPI images. White arrows indicate contrast enhancing lesion. 
7.7.3 DISCUSSION 
These experiments have shown that the LL-TFEPI sequence can be used to 
achieve high spatial resolution,    ȟ1 maps following 
gadolinium contrast agent without dependence on the B1 Ǥȟ1 maps can 
be used to assess the uptake of gadolinium and converted into cerebral blood 
volume maps. 
The patients scanned demonstrated few enhancing lesions, likely due to the 
patient subgroups that were examined and the small sample size. Patients with 
CIS are least likely to have enhancing lesions, as they will only have presented 
with one neurologic episode up to that point. 
A possible confound for the CBV quantification is the choice of threshold to 
determine the change in R1 of the blood. Here, the threshold was chosen by visual 
inspection of the data so that the sagittal sinus was included in the mask but 
excluding minor vessels by increasing the threshold. To assess the impact of the 
threshold chosen on CBV this value was varied, the results are shown in Figure 
7-26. As the threshold increases the average CBV value decreases as this causes ȟ1,blood to increase. An alternative would be manually segment vessels, however 
this would be time consuming and an automated method is preferable when 
analysing multiple subject data sets. In addition the values found here from the 
two studies (GM 5.1 - 5.2 % and WM 1.9 Ȃ 2.5 %) agree well with literature values 
(GM 4.8 Ȃ 5.5 %, and WM 1.4 Ȃ 2.7 % from [33]). 
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Figure 7-26ǣȟ1 threshold on GM CBV quantification. Vertical line shows the 
mean threshold used for final CBV quantification, shaded region is mean ± standard error. 
All six subjects from the low resolution study shown. 
7.8 HIGH RESOLUTION BIAS FIELD CORRECTED ANATOMICAL IMAGING 
Anatomical imaging using T1 weighted contrast is very common in both clinical 
and research protocols as it allows for delineation of different tissue types (e.g. 
grey and white matter) and anatomical localisation. Many different types of T1 
weighted image sequences exist, with some inversion recovery based sequences 
summarised in Table 7-1. 
Name of Sequence Brief Description 
MPRAGE Ȃ Magnetisation Prepared Rapid 
Gradient Echo 
Inversion pulse prior to a rapid GE 
sequence. TI can be altered for different 
contrast. 
FLAIR Ȃ FLuid Attenuated Inversion 
Recovery 
Single inversion prior to imaging, TI is 
chosen to null the signal from fluid (e.g. 
CSF) 
DIR Ȃ Dual Inversion Recovery Two inversion pulses, timing optimised to 
null signal from two tissue types 
STIR Ȃ Short TI Inversion Recovery A short inversion time is used to null signal 
from fat to reduce fat artefacts 
Table 7-1: Common inversion recovery based T1 weighted imaging sequences. 
T1 weighted images (e.g. MPRAGE) are displayed as modulus images; this can 
mean discarding information from the inversion recovery, as different tissue 
types can have the same magnitude values but be on opposite sides of the null 
point due to different T1 values. The dynamic range of an image can be improved 
by incorporating the phase information, termed Phase Sensitive Inversion 
Recovery (PSIR) [34]. PSIR imaging is commonly used in heart imaging, such as 
for the study of myocardial infarction [35]. However, it is also used in 
neuroimaging [36], including the identification of intracortical lesions in Multiple 
Sclerosis [37]. 
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To enable the correction of the modulus images for PSIR imaging, the phase 
needs to be calculated. However a single phase image cannot be used, as the 
phase images do not give absolute quantities. Hence a reference image is 
collected, when all tissue types have recovered, this allows calculation of the 
phase change between the two images. The PSIR sequence is shown 
schematically in Figure 7-27. It is equivalent to the LL-TFEPI sequence but with 
only two readouts per inversion (N = 2). For example, Figure 7-28 shows PSIR 
images generated from data shown in Section 7.7.2. This demonstrates how the 
PSIR contrast changes with the effective post-inversion delay.  
 
Figure 7-27: Schematic of the RF pulses for the PSIR sequence. 
 
Figure 7-28: Example PSIR images created from LL-TFEPI data at three successive post 
inversion delays. 
Marques et al. [38] proposed an alternative scheme entitled MP2RAGE, where 
two MPRAGE images were collected as in Figure 7-27. Rather than phase correct 
the first image using the phase information in the second the complex signals for 
the two images were combined using the following relationship 
 ? ?  ? ? ? ? ൌ  ? ? ? ? ൬ ? ? ?ȁ ?ȁ ?൅ ȁ ?ȁ ?൰ ? 7-29 
where x is the signal from the 1st acquisition and y the 2nd, and * denotes the 
complex conjugate. This keeps the phase information, and allows for correction 
of transmit inhomogeneities, but it restricts the dynamic range of the image 
between -0.5 and +0.5. They obtained images at resolutions of 0.5 Ȃ 1 mm at 7 T, 
to achieve large coverage (160 slices) in a scan time of 12 minutes required 
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partial Fourier factor of 0.75 and parallel imaging factor of 3. PSIR requires a 
simpler reconstruction method whilst maintaining phase information and 
correction for B1 effects. 
The aim of this work is to develop a high resolution sequence that maximises 
contrast between grey and white matter structures for use in patient protocols, ǯǤ
was short, approximately 10 minutes, to reduce the impact of motion, of 
particular concern for patient studies. Large volume coverage, potentially whole ǡǯǤ 
7.8.1 BIAS FIELD CORRECTION  
Magnitude images, such as that in Figure 7-29 A, can display signal variations due 
to underlying inhomogeneities in the static magnetic field and the transmit and 
receive fields. These can be seen as bright areas in the centre of the image from 
the flip angle profile, or signal voiding from poor shim. Field inhomogeneities can 
make it difficult to see the fine structure in the centre of the image, for example 
deep gray matter structures, or structures low down (e.g. cerebellum). 
These inhomogeneities will be transmitted to phase corrected images, Figure 
7-29 B is the phase corrected image of A. This shows increased dynamic range of 
the image, but the inhomogeneities are clearly seen. To reduce this effect, the ȋȌǡǮǯ out the images. This is 
most effective in the centre of the image, such as around the ventricles where 
structures are now more clearly delineated and any asymmetry in the raw 
images has also been removed. This was shown to be effective at correcting 
MPRAGE images acquired at 7 T [39].  
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Figure 7-29: (A) Raw modulus image (B) Phase corrected version of (A), arrows represent 
signal abnormalities caused by underlying image inhomogeneity (C) PSIR normalised to 
reference image and (D) PSIR normalised to smoothed reference image. 
7.8.2 COMPARISON OF PSIR AND MP2RAGE 
PSIR and MP2RAGE both use the same acquisition sequence and only differ in the 
reconstruction of the images. To assess which sequence is the most appropriate 
the signal and contrast properties of the two was simulated.  
As highlighted in Marques et al. [38] the theoretical signal to noise of the 
MP2RAGE is higher due to the noise propagation in the PSIR, as summarised in 
Table 7-2. 
 PSIR MP2RAGE 
Signal, S  ? ?  ? ? ? ?൅  ? ? ǡɐ  ?ඨ ? ?൅  ? ? ? ?   ?ඨ ? ? ?െ  ? ? ? ? ? ? ?൅  ? ? ? ?  ? ? ? ൌ ? ? ? ? ? ? ? ? ? ? ?  ? ? ?ඨ  ? ? ? ?൅  ? ?  ? ? ? ? ? ?൅  ? ? ?ඨ ? ? ?൅  ? ? ? ? ? ? ?െ  ? ? ? ? ฬ ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?ฬ  ? ? ?൅ ? ? ? ?െ ? ? ? ൒  ? 
Table 7-2: Signal and noise characteristics of the PSIR and MP2RAGE sequences, where x and 
y are the signal from the tissue from the two images, it is assumed that the absolute error in 
ǡɁǤ 
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In addition to the SNR of the sequence, an important characteristic is the contrast 
to noise (CNR) between different tissue types for discrimination of different 
tissues, important in the study of Multiple Sclerosis lesions as the T1 differs from 
the surrounding normal appearing white matter (NAWM). The contrast to noise 
between two tissues is defined as 
 ? ? ? ൌ ? ? ? ? ? ? ? ? ?െ  ? ? ? ? ? ? ? ?ට ? ? ? ? ? ? ? ? ? ? ൅ ? ? ? ? ? ? ? ? ?  ? 7-30             ?
 ǡ  ɐ  
noise. The CNR for both sequences can be calculated using Table 7-2: 
 ? ? ? ? ? ? ?ൌ  ? ? ? ?െ  ? ? ? ? ?ඨ ? ? ?൅  ? ? ? ? ? ? ൅ ? ? ?൅  ? ? ? ? ? ?  ? 
 ? ? ? ? ? ? ? ? ? ?ൌ  ? ? ? ? ? ? ?൅  ? ? ?െ  ? ? ? ? ? ? ?൅  ? ? ? ?ඨ ? ? ? ?െ ? ? ? ? ? ? ? ? ?൅ ? ? ? ? ?൅  ? ? ? ?െ  ? ? ? ? ? ? ? ? ?൅  ? ? ? ? ? ? 7-31  
where x1, y1 and x2, y2 are the signals from tissue 1 and tissue 2 respectively. The 
ratio of CNRPSIR/CNRMP2RAGE is shown in Figure 7-30, demonstrating that the CNR 
between two tissue types is always greater for PSIR than MP2RAGE, with an 
improvement of a factor of 5 for PSIR. The range of the simulations are that y1>x1 
and y2>x2, shown here is the case where y1  ?  ?Ǥ ? ȋ   ǡ ǤǤ ? ? ? ? ? ? ? ?ൌ  ? ? ?  ? ? ? ?ൌ  ? ? ൌ  ? ? ? ? ? ?  ?ൌ  ? ?  ? ? ? ?ൌ  ? ? ? ? , y2 is kept equal to 1). 
For smaller values of y the improvement in CNR increases. 
 
Figure 7-30: Ratio of CNRPSIR/CNRMP2RAGE for different signal intensity combinations. Dark 
blue pixels identify the areas where the two tissue types are the same. 
An example PSIR and MP2RAGE image are shown in Figure 7-31, with the 
corresponding image histograms. It can be seen that MP2RAGE is confined 
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between -0.5 and +0.5 whereas PSIR has a larger dynamic range. The histogram 
of the PSIR easily allows identification of the different tissue types whereas the 
histogram of the MP2RAGE is more ambiguous. The PSIR histogram may allow 
identification of deep gray matter structures, due to the small peak at low 
positive values as the average signal intensity in the putamen from Figure 7-31 is 
0.077 ± 0.003 and in the caudate nucleus 0.067 ± 0.007. 
For the identification of lesions the improved CNR between tissue types that is 
afforded by the PSIR is crucial. The MP2RAGE, with the improved SNR, may be 
more appropriate if looking to quantify T1, as demonstrated in [38], where high 
SNR will be important. Whereas for tissue type discrimination (e.g. segmentation 
or lesion identification) the improved CNR of PSIR is more important. 
 
Figure 7-31: (A) PSIR image and (B) equivalent MP2RAGE image, (C) is the signal intensity 
histogram of PSIR (red) and MP2RAGE (blue). 
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7.8.3 OPTIMISATION OF PSIR FOR GREY-WHITE MATTER CONTRAST 
The PSIR signal was simulated, as described in Section 7.4, using the full model 
with N = 2. A steady state was established by simulating several shots. The 
optimisation criteria was to maximise  ? ? ? ? ?ൌ ȁ ? ?െ  ? ?ȁ ? 7-32 
where subscript 1 represents grey matter and 2 white matter. The signal ratio 
(x/y) was not optimised as the reference image (y) has little contrast remaining 
(y1  ?2) due to the high TFE factor required to acquire high resolution images in 
short scan times. The theoretical time taken for the scan (Equation 7-27) must be 
less than 12 minutes, for patient comfort and to reduce motion artefacts, and x1 
and x2 must be of opposite polarity (opposite sides of the null point) to benefit 
from PSIR. The scan optimised was of 0.6 mm isotropic resolution, FOV 192 x 172 
mm with 160 slices (coverage 9.6 cm), using an EPI factor of 3 and SENSE 
reduction factor of 2.5. 
The parameters of interest were TI, TA, TW, FA and mǤ ɒ    
minimum achievable value, as from previous simulations it was known to not 
greatly impact on the signal curves over a realistic range of values. The 
parameters were varied over a large range (TI 50 - 550 ms, TA 50 Ȃ 550 ms, TW = 
100 Ȃ 4,000 ms, FA = 2 - 12° and m = 40 - 150) to find the optimum sequence 
parameter combination. The sequence was chosen to have linear k-space 
ordering to allow shorter values of TI, but still allowing GM and WM signals to 
have opposite sign. 
Table 7-3 shows the results of the optimisation for GM/WM CNR for two different 
values of grey matter T1 (from literature values 1939 [12] and 2,132 ms [11],). T1 
of white matter was simulated as 1300 ms, with M0 simulated as 1.2 for GM and 1 
for WM [29].  
Parameter T1 = 2100 ms T1 = 1900 ms 
Flip Angle [degrees] 9 10 
TI [ms] 550 250 
TW [ms] 2000 3000 
TA [ms] 1300 600 
m 69 69 
Table 7-3: Optimised parameters for two different values of the T1 of grey matter. 
Further optimisation was performed for a scan that does not use the EPI factor 
but increases the SENSE reduction factor to maintain a short scan time but 
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reduces any distortions due to the lengthened echo time of LL-TFEPI. This gave 
TI/TA/TW= 150/400/3000 ms and m  ? ? ? ?ɒ ? ? ?ǡ ? ?
minutes with SENSE of 2/2.5 applied in two directions. 
7.8.4 METHODS 
Data Acquisition 
All experiments were performed on a Philips 7 T Achieva system with volume 
transmit and 32 channel SENSE receive coil. 
Two healthy volunteers were scanned, one using the PSIR LL-TFEPI scan 
optimised for a T1 of 2100 ms and the other for a T1 of 1900 ms. 
Further healthy volunteers were scanned with the PSIR LL-TFE scan to assess 
methods for reduction of flow artefacts. Two methods were compared; flow 
compensation and the use of saturation or rest slabs. Flow compensation uses 
gradients to ensure that the phase accumulated during the imaging is zero, by 
applying the same gradients but with opposite polarity should cancel the phase 
accumulated by the moving spins and not affect the stationary spins either [31]. 
This increases the echo time (hence the minimum pulse spacing), so will reduce 
the signal, here the echo time changes from 7 to 10 ms so the effect will be 
negligible. The rest slab saturates the signal using a 90° pulse inferior to the 
imaging volume prior to the acquisition of the images. This should reduce the 
signal from the blood, and also cause the phase to change less rapidly across the 
acquisition. 
A male patient with Multiple Sclerosis was scanned with the optimised LL-TFE ȋȀȀ ? ? ? ?Ȁ ? ? ?Ȁ ? ? ? ?ǡ ? ? ? ?ǡɒ ? ?ǡan time of 
12 minutes with SENSE of 2/2.5 applied in two directions). In addition, an 
MPRAGE was acquired for comparison. The MPRAGE scan parameters were FOV 
= 205 x 192 x 140 mm3, 0.5 mm isotropic resolution, TE/TR/TI = 7/15/275 ms 
with a flip angle of 8°. Total scan duration 10 minutes. 
Data Analysis 
The images were converted to PSIR by sign correcting the first image using the 
phase information. The phase corrected image was then normalized to the 
smoothed second image (3D Gaussian smoothing kernel, 9 vo ǡɐ  ?  ? ?
mm). The reference image was smoothed to reduce transmission of noise to the 
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PSIR image, as there is little structural information present in the reference 
image (Figure 7-33 D/E) smoothing has little impact on the PSIR image (Figure 
7-29 C/D) [39]. 
The PSIR images were converted to give an angiogram using similar methodology 
to [39].  The vessels are extracted by applying a threshold (PSIR signal > 0.5) to 
the PSIR images (interpolated to 0.3 mm isotropic), to exclude tissue and CSF. 
Mean intensity projections (MIP) of the vessels are then produced along the three 
axes. 
7.8.5 RESULTS 
The PSIR images using the optimised values for a grey matter T1 of 2100 ms are 
shown in Figure 7-32. The B1 receive inhomogeneity has been removed by 
normalising to the smoothed reference image. However, after phase correction 
both grey and white matter are positive. This means that the phase correction 
has not improved the dynamic range of the image (except for CSF which has 
intensity < 0).  
 
Figure 7-32: Example PSIR Image using optimised parameters for T1 of grey matter = 2.1s. 
The PSIR images using the second set of optimised parameters, where T1,GM = 
1900 ms are shown in Figure 7-33 A. Here grey matter has not crossed the null so 
is negative in the PSIR image Ȃ increasing the dynamic range and contrast of the 
resultant images compared to the modulus image shown in Figure 7-33 B and the 
previous PSIR in Figure 7-32. The B1 field correction has removed the hyper 
intensity shown in the middle of the images and the signal drop out on the right 
and left sides of the images in C-E. 
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Figure 7-33: (A) PSIR image (B) Modulus of (A), (C) and (D) are raw images (E) smoothed 
images of (D) used for bias field correction. 
Taking a histogram of the PSIR image from this scan shows two clear peaks on 
either side of 0 for grey and white matter. No clear peak is seen for CSF, this could 
be due to partial voluming between grey matter and CSF at the tissue boundaries. 
The deep gray matter is shown as the small positive peak (intensities of 0 Ȃ 0.1). 
The clear peaks allow for tissue segmentation using a simple threshold technique 
as demonstrated in Figure 7-34. 
 
Figure 7-34: (A) Histogram of whole head PSIR image (B) Example slice of segmented PSIR, 
black is CSF, GM is gray and white matter is white. 
The PSIR images show some artefacts, displayed as ripples, seen in the frontal 
regions of Figure 7-32. Removing the EPI factor, so that the scan was LL-TFE with 
a standard gradient echo readout, was found to remove these ripples (Figure 
7-35). In addition an artefact from the blood vessels, which appears as a line 
across the image, was visible, shown by the black arrow in Figure 7-35. This is 
caused by blood flowing through a vessel during the applied gradients causing 
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ranging resonant frequencies, the phase acquired will cause the signal to be 
spatially misplaced in the phase encode direction Ȃ resulting in a band across the 
image in the PE direction (here right-left) [31]. 
 
Figure 7-35: Example PSIR images from a single subject using LL-TFE, black arrow indicates 
blood artefact. 
Flow compensation was found not to significantly reduce the artefact due to the 
flow, and it had the disadvantage of increasing the TR which would increase the 
readout duration. Using a rest slab was found to reduce the artefact significantly, 
Figure 7-36. This has the benefit of not increasing the pulse spacing as it is 
performed prior to the readout. The optimised LL-TFE PSIR with 160 slices, 0.6 
mm isotropic resolution acquired with rest slabs is shown in Figure 7-37. This 
demonstrates whole brain coverage whilst maintaining good contrast between 
the white and grey matter. 
 
Figure 7-36: PSIR image where a rest slab has been used to reduce artefactual signal from 
the blood vessel. 
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Figure 7-37: PSIR images acquired using LL-TFE with 0.6 mm isotropic voxels and 160 slices, 
with SENSE factor 2/2.5. 
The mean intensity projections (MIP) produced along the three axes are shown in 
Figure 7-38.  These clearly show vessel structure and could be used in patient 
groups where arterial vasculature is affected. 
 
Figure 7-38: MIP produced from the PSIR image demonstrated in Figure 7-37. 
Figure 7-39 demonstrates the PSIR acquired in a male patient with MS and a 
corresponding MPRAGE. The MPRAGE displays large inhomogeneities in the 
image intensity due to the bias field, whereas the PSIR contrast is more 
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homogenous across the slice allowing for easier tissue type discrimination.  In 
this patient MS lesions are visible in the white matter surrounding the ventricles 
and this area on the MPRAGE is corrupted by the large scale inhomogeneities 
making lesion identification difficult. This demonstrates how PSIR could be useful 
in the assessment of clinical conditions. 
 
Figure 7-39: Anatomical images acquired in an MS patient using (A) PSIR and (B) MPRAGE. 
7.8.6 DISCUSSION 
LL-TFEPI has been shown to provide fast, high resolution T1 weighted images 
that can be phase and bias field corrected using a dual readout scheme. Through 
simple CNR optimisation parameters were found to allow phase information to 
increase the dynamic range of the images improving CNR between grey and 
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white matter. A whole head, B1 invariant scan, with 0.6 mm isotropic resolution 
was achieved in 12 minutes. 
This scan can be used for tissue segmentation (as shown in Figure 7-34) due to 
high resolution and reduced B1 artefacts, with applications in the study of 
pathology, such as Multiple Sclerosis, Figure 7-39, to aid in the identification of 
lesions.  
7.9 CONCLUSION 
The work in this chapter has shown the development of a sequence to measure ȟ1 due to the administration of a gadolinium based contrast agent to allow 
measurement of CBV. The difficulties associated with quantitative T1 mapping at 
ultra high field due to transmit inhomogeneity were demonstrated, as well as the 
problems with mapping the transmit field. An optimised method for bias field 
corrected, high resolution whole brain T1 weighted anatomical imaging at 7 T has 
been demonstrated allowing for ease of tissue segmentation and arteriogram 
imaging.  
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8 CONCLUSIONS 
This thesis has outlined work exploring MRI techniques at ultra high field (7 T) to 
measure aspects of cerebral haemodynamics and to assess the underlying 
mechanisms. This chapter summarises the conclusions of work presented in this 
thesis and describing possible future work arising from these findings. 
8.1 ARTERIAL SPIN LABELLING AT 7T 
Chapter 5 described methodological development of arterial spin labelling for 
ultra high field imaging, concentrating on readout strategies and multi-phase 
ASL. It was demonstrated how 7 T allows for improved resolution 2D-EPI ASL 
which reduces partial volume effects and improves anatomical information of the 
cortical structure in perfusion images. 3D-EPI was optimised for high SNR and 
large slice coverage acquisition, whilst maintaining image quality and perfusion 
sensitivity. 3D-EPI ASL allows for large volume coverage, an advantage for whole 
brain studies e.g. resting state, pharmacological or patient studies. TFE and bFFE 
were demonstrated to be more robust to field inhomogeneities than 2D-EPI, with 
bFFE having higher SNR than TFE but being limited by SAR to only a single slice 
acquisition. These will be most useful when studying areas of the brain near the 
sinuses or other air interfaces. In addition, due to reduced spatial distortions 
when compared to EPI these can be more easily compared to other sequences 
(e.g. MPRAGE, FSE) for anatomical comparison such as tumours. 
Look-Locker readout methods were shown to give temporal information to the 
vascular response ȋȟa ɁȌ, which aided in functional tasks where transit times 
reduce or in pathology where the vascular structure is different to healthy 
controls. LL-EPI was used to measure arterial blood volume and the effect of a 
motor task on haemodynamic parameters. 7 T allows for high resolution aCBV 
maps to be acquired in less than 1 minute. Look-Locker TFE was applied in 
patients with Low Grade Gliomas where the increased temporal resolution 
allowed for identification of different vascular compartments compared to a 
single TI acquisition. Further development would investigate modelling the 
perfusion signal of 3D-EPI and TFE Look-Locker methods for CBF or CBVa 
quantification. 
Future work should assess the reproducibility of these measurements. The 
possibility of ASL becoming a common alternative to contrast agent based 
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measures of blood flow requires robust, reliable techniques. These methods 
could then be applied to study perfusion differences between healthy controls 
and patient groups. ASL would be useful in the study of patients with renal 
disease, a contraindication of gadolinium based contrast agents. 7 T would allow 
the use of high resolution to maintain anatomical information and to improve 
upon previous ASL studies made at 1.5 and 3 T. 
8.2 EFFECT OF HYPERCAPNIA ON BRAIN FUNCTION 
The Look Locker ASL methods developed in Chapter 5 were applied in the 
calibrated BOLD work presented in Chapter 6 which demonstrates that voxelwise 
implementation of the Davis model is feasible at 7 T. This allows for estimation of 
the change in CMRO2 due to a motor task. CMRO2 changes can be used to compare 
functional responses across subject groups where baseline haemodynamics may 
be different (e.g. caffeine studies or patients with Cerebrovascular disease). The 
voxelwise comparison showed a possible positive correlation between baseline 
blood flow and the calibration constant (M). Further work should concentrate on 
this relationship, as a surrogate metric for M which does not require a 
hypercapnic challenge would increase the applicability of calibrated BOLD. 
Further mapping of M, across further brain regions would be required to assess 
the spatial distribution to determine if this relationship holds in other brain 
areas, e.g. visual cortex. 
The MEG study demonstrated a widespread change in MEG signal due to 
hypercapnia. However the mechanism behind this change is not fully understood 
and the impact on calibrated BOLD is also unknown. To probe the mechanism 
further a graded hypercapnia experiment would make it possible to determine if 
there is a component of perception to the MEG response as the 
desynchronisation was predominant around sensory/motor areas; applying 
levels of hypercapnia above and below the perception threshold would allow 
these two effects to be uncoupled. 
The impact of MEG results on calibrated BOLD would depend on whether the 
MEG response is accompanied by a metabolic change, which would make the 
assumptions used in the Davis model [1] no longer valid. Magnetic resonance 
spectroscopy (MRS) could be used to probe the metabolic effects of hypercapnia, 
using carbon-13 or phosphorous-31 MRS. In addition; it has been shown that 
MEG responses can correlate with MRS metrics in the proton spectrum (e.g. 
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GABA [2]). Hence looking at the neurochemical effect of hypercapnia may help 
explain the origins of the MEG response and hence the full impact on models of 
calibrated BOLD. 
8.3 LL-TFEPI: CBV AND PSIR 
Look-Locker techniques were shown to give high resolution cerebral blood 
volume maps with the administration of a Gadolinium contrast agent using a B1    ȟ1. In addition, Look-Locker TFE was shown to 
produce bias field corrected T1 weighted images. Using the phase information the 
dynamic range of an inversion recovery image can be recovered and image 
inhomogeneities arising from the B1 transmit field were removed by normalising 
to a reference image. Images with 0.6 mm isotropic resolution and whole head 
coverage were acquired in 12 minutes. 
From the work in Chapter 7 it was seen that the standard B1 mapping technique 
currently used on the 7 T system gave tissue weighting in the calculated B1 maps. 
This means that they cannot be used to correct T1 maps for the effect of the 
transmit field, which is essential for fast T1 mapping techniques such as Look-
Locker. Indications were that the problem was associated with spoiling of the 
transverse signal. Further work would concentrate on both improving the AFI 
method and the investigation of other B1 mapping techniques such as the Bloch-
Siegert shift [3]. This would benefit more sequences than T1 mapping; it could aid 
in the modelling of ASL, specifically Look-Locker ASL where many RF pulses 
perturb the perfusion signal. 
High resolution anatomical imaging with phase sensitive inversion recovery 
(PSIR) was optimised for 7 T imaging. It was demonstrated that PSIR would be 
beneficial in Multiple Sclerosis patients due to improvements in the visualisation 
of periventricular MS lesions. Further work applying the PSIR imaging technique 
in pathology, such as MS, and drawing comparison with standard anatomical 
imaging techniques such as MPRAGE would be beneficial. The PSIR developed 
here, is shown to be more easily interpreted than the MPRAGE sequence, which is 
often used for anatomical imaging and the improved anatomical information due 
to higher SNR and spatial resolution would make 7 T imaging attractive for 
clinical applications.  
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8.4 FINAL OVERVIEW 
7 T MRI has developed significantly over the 11 years since the first human 
imaging study [4]. However there are still challenges associated with RF 
inhomogeneity, static field inhomogeneities and image distortions. In this thesis, 
developments were presented for arterial spin labelling, contrast agent 
monitoring and anatomical imaging that overcame some of these problems that 
arise at ultra-high field. This allows the advantages of 7 T, such as increased 
signal to noise, to be realised. Furthermore, these developments were applied to 
monitor functional brain activity, perfusion in healthy volunteers and those with 
Low Grade Gliomas, and CBV measurements in MS patients. Through such 
developments, 7 T imaging can be seen to be more clinically relevant.  
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